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Preface and Outline
2Like eukaryotes, bacteria are constantly being attacked by viruses. Because infections 
by these (bacterio)phages are generally disadvantageous for bacteria, they have 
developed several defense mechanisms. Well-known examples include mutations of 
receptors that the phages use for attachment (and entry) to the host, and the restriction-
modification system that degrades DNA with a “non-self” methylation pattern. Phages 
in turn have developed methods to bypass these defense mechanisms, illustrating 
the fascinating ongoing evolutionary battle. Bacteriophages and their life cycles have 
been extensively studied in the early days of molecular biology research. However, the 
development of high throughput sequencing has initiated a new era for this research field. 
Since 1995, analyses of prokaryotic genome sequences (both bacteria and archaea), 
revealed the presence of typical repetitive regions, the CRISPR loci. These CRISPRs 
are composed of short direct repeats that are interspaced with unique spacer sequences 
of similar length. In 2005, several groups performed detailed analyses of the spacer 
sequences, resulting in the discovery of homology with phage and plasmid DNA. This 
has lead to the hypothesis that the CRISPRs might provide the bacteria with yet another 
defense mechanism against invading nucleic acids. A year later the group of Eugene 
Koonin released an article, which comprehensively described a putative model of the 
CRISPR-mediated defense system. This model was based on bioinformatics analysis 
of the CRISPRs and CRISPR-associated (cas) genes, and limited experimental data 
that was available at that time. At this point the research described in this thesis was 
initiated. We aimed at unraveling the molecular pathway of this fascinating heritable 
and adaptive immune system in our model organism Escherichia coli.
3Preface and Outline
Chapter 1 gives an overview of the different stages of CRISPR-mediated defense. It 
compares the different CRISPR/Cas subtypes and discusses the experimental data that 
is available in literature. Basically three stages of CRISPR defense are distinguished. 
During the first stage, fragments from invading nucleic acids are integrated as spacers 
into a CRISPR locus. During the second stage the CRISPR is transcribed and the 
CRISPR RNA is cleaved into small CRISPR RNAs (crRNAs) which each contain one 
spacer and part(s) of the repeat sequence. During the third and final stage these 
crRNAs guide the antiviral Cas protein machinery to the target; the crRNAs can base 
pair with invading nucleic acids that have been previously filed into the CRISPR locus. 
CRISPR/Cas thus provides prokaryotes with an adaptive and heritable immune system 
against potentially hazardous nucleic acids. Analogies with RNA interference (RNAi) in 
eukaryotes, which can also serve as an antiviral defense, are discussed.
Chapter 2 describes the identification of a CRISPR-associated complex for 
antiviral defense (Cascade) that is composed of 5 different subunits (CasABCDE). 
It is demonstrated that the CRISPR RNA transcript (pre-crRNA) is cleaved by the 
Cascade complex into small CRISPR RNAs (crRNAs) during the second stage of 
CRISPR-mediated defense. The CasE subunit is identified as a metal-independent 
endoribonuclease that specifically recognizes repeat sequences of the E. coli K12 
CRISPR. This chapter also describes the engineering of an E. coli strain to become 
resistant against the well studied bacteriophage lambda (λ).
The next stage after CRISPR expression and processing is that of target recognition, a 
process that has been studied in more detail in Chapter 3. It addresses the question how 
mature crRNAs can recognize and bind to their complementary target. An integrated 
analysis has been used to reveal insights in the structure and function of the Cascade 
complex. Mass spectrometry has been used to determine the subunit stoichiometry. 
In addition, the architecture of the crRNA has been studied in more detail. By using 
electron microscopy and small angle X-ray scattering, a first low resolution model of 
Cascade has been obtained.
In Chapter 4 it is shown that the CRISPR/Cas system can also inhibit plasmid 
transformation. This enabled us to study the sequential features of the target that are 
required for successful interference. A mutant library of CRISPR-targeted plasmids 
was created and transformed. Plasmids that were able to evade the CRISPR/Cas 
system could cause colony formation. Sequence analyses of these escape mutants 
revealed mutations in the protospacer (the targeted sequence identical to the spacer 
in the crRNA) and the conserved Protospacer Adjacent Motif (PAM). 
4One phage lambda particle can infect, replicate and release 50-100 particles in 
about 30 minutes, not only destroying the host cell but also threatening neighboring 
cells. Phages infect and replicate at the cellular poles. In Chapter 5 we checked the 
hypothesis that the Cas protein machinery might be located in this same location to 
rapidly counteract a potentially devastating infection. Indeed we observed with high 
resolution microscopy that Cas proteins may be located at the cellular poles.
Transformation of a phage lambda targeting CRISPR into E. coli K12 did not result 
in elevated immunity, due to transcriptional silencing of the cas genes and CRISPR. 
In Chapter 6 two regulators of the CRISPR/Cas system in E. coli are identified and 
characterized. H-NS functions as a transcription repressor, while its antagonist LeuO 
acts as a transcription activator. This regulation has been analyzed both at transcription 
level and functional level by means of plaque assays.
Chapter 7 finally summarizes and discusses the research described in this thesis. 
Remaining questions about the mechanism of CRISPR/Cas are addressed. It also 
describes the wide variety of potential applications of the fundamental research carried 
out here.
Partly adapted from:
Matthijs M. Jore, Stan J. J. Brouns, John van der Oost
RNA in Defense: CRISPRs protect prokaryotes against mobile genetic elements
in RNA Worlds: From Life’s Origins to Diversity in Gene Regulation, in press
Chapter 1
Introduction
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The evolution of micro-organisms is significantly influenced both qualitatively and 
quantitatively by the continuous exchange of genomic material with mobile genetic 
elements: viruses and plasmids. Viruses are among the most abundant entities on 
earth (Bergh et al. 1989; Wommack and Colwell 2000) and they proliferate by a series 
of events: adsorption of the virion to the host’s cell wall, injection of the viral genome 
(DNA, RNA) through the cell membrane(s), expression of viral genes, replication of 
the viral genome and assembly of viral protein capsids, and finally release of progeny 
virions (Sturino and Klaenhammer 2004). Plasmids are another main class of selfish 
mobile elements. After entry plasmid DNA resides in a host, either free in the cytoplasm 
or integrated in the host genome. Plasmids can be transferred from donor to recipient 
via conjugation, making use of dedicated transfer systems (Llosa et al. 2002).
 
Despite the occasional gain of function as a result of horizontal gene transfer, 
recombination with mobile elements can also cause severe damage; disruption of 
either structural or regulatory regions on the host genome leads to loss of function. 
Additionally phage infections can eventually lead to host cell lysis. To avoid these 
detrimental effects, sophisticated mechanisms have evolved to defend host organisms 
against nucleic acids from invading mobile elements. Several defense systems have 
been recognized in prokaryotes that are very different from the eukaryotic immune 
systems. A passive defense mechanism may act at the level of virion adsorption and/or 
injection of its genomic material. Spontaneous mutations in virus receptor proteins of 
the host can perturb virus attachment and genome injection, not affecting host fitness, 
e.g. the maltoporin of E. coli used by phage lambda (Hofnung et al. 1976). A well known 
active defense mechanism is the restriction-modification (R-M) system. Dedicated 
methyltransferases modify potential cleavage sites of the host DNA, preventing strand 
cleavage by restriction enzymes. Incoming invader DNA lacks these modifications, and 
is therefore a target for digestion by these endonucleases (Tock and Dryden 2005). An 
additional mechanism that appears functionally analogous to eukaryotic apoptosis, is 
the prokaryotic Abortive infection mechanism (Abi). This mechanism inhibits phage 
multiplication either by blocking the phage replication machinery, or by inhibiting host 
translation. This results in death of both host and virus, a sacrifice that will save the rest 
of the population (Chopin et al. 2005). 
Recently another defense mechanism has been discovered that is based on Clusters of 
Regularly Interspaced Short Palindromic Repeats (CRISPRs) and CRISPR-associated 
genes (cas genes). A timeline of major breakthroughs in CRISPR research is given in 
Figure 1.1. The CRISPR/Cas system can integrate nucleic acid fragments from invading 
mobile elements into the CRISPR locus. The CRISPR is transcribed and cleaved 
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into short mature RNAs (crRNAs). These crRNAs specifically guide the Cas protein 
machinery to their complementary targets: either DNA or RNA from invading viruses 
or plasmids. Thus the CRISPR/Cas system can provide the host with acquired and 
heritable resistance (reviewed in (Sorek et al. 2008; van der Oost et al. 2009; Horvath 
and Barrangou 2010; Karginov and Hannon 2010; Marraffini and Sontheimer 2010a). 
In this chapter we will describe mechanistic features of the CRISPR/Cas system, and 
we will discuss the similarities and differences with RNA interference in eukaryotes. 
CRISPR loci and cas genes 
CRISPRs were first discovered in 1987 when a chromosomal fragment from Escherichia 
coli K12 was sequenced (Ishino et al. 1987). Since then many CRISPR sequences 
have been identified in prokaryotic genomes (for overview, see: http://crispr.u-psud.fr/
crispr/CRISPRdatabase.php). CRISPRs have been detected in 48% of the sequenced 
bacterial genomes and in 95% of the sequenced archaeal genomes. CRISPRs are 
composed of a cluster of identical repetitive sequences that are separated by non-
identical spacer sequences of similar length (see below). The CRISPR array is often 
preceded by an AT-rich leader sequence of up to 500 basepairs (Jansen et al. 2002). 
The number of CRISPR loci per genome ranges from 1 to 20, varying in length from 
a few to hundreds of repeat-spacer pairs; the present record holder is a CRISPR of 
Chloroflexus sp. with 374 repeats and spacers. Twelve major types of CRISPR have 
Figure 1.1. Timeline of major advances in CRISPR research. See text for references.
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been proposed, based on sequence similarity of the repeats (Kunin et al. 2007). The 
repeat size varies from 24-47 bp, whereas the spacer size ranges from 24-72 bp; the 
size of repeats and spacers are typically around 30 bp. Some repeats have palindromic 
sequences that encode CRISPR RNAs with potentially strong secondary structures, 
while other sequences appear to lack such structures (Fig. 1.2B). Each cluster correlates 
mainly with one Cas subtype, as discussed below. In 2005, three different research 
groups independently observed that at least a subset of the spacer sequences are 
identical to phage and plasmid DNA sequences (Bolotin et al. 2005; Mojica et al. 2005; 
Pourcel et al. 2005). The virus or plasmid fragment matching the spacer sequence is 
called the proto-spacer (Deveau et al. 2008). The observation that spacer sequences 
were derived from viral sequences has led to the hypothesis that the CRISPR/Cas 
system might be involved in prokaryotic resistance to alien nucleic acids (reviewed 
in (Makarova et al. 2006)). The composition of the CRISPR is hypervariable and is 
rapidly shaped by extra-chromosomal elements in the host’s environment (Lillestøl et 
al. 2006; Andersson and Banfield 2008; Tyson and Banfield 2008; Banfield and Young 
2009; Held and Whitaker 2009; Lillestol et al. 2009). Extrachromosomal elements in 
turn respond by extensive gene shuffling (Andersson and Banfield 2008) or mutations 
(Deveau et al. 2008; Heidelberg et al. 2009; Semenova et al. 2009; van der Ploeg 
2009) to escape the CRISPR defense mechanism, illustrating that the ongoing battle 
between hosts and their predators. 
A set of conserved cas genes can be found in close proximity of the CRISPR array. The 
encoded proteins were initially thought to be involved in DNA repair, because they had 
predicted nucleic acid related functions (Makarova et al. 2002). The link between cas 
genes and CRISPRs was made shortly thereafter (Jansen et al. 2002) and the four most 
conserved cas genes were identified. The cas gene products were further classified into 
~45 distinct families (Haft et al. 2005); that number was later reduced to ~25 families 
(Makarova et al. 2006). The set of Cas proteins is composed of core proteins (Cas1-6), 
a diverse group of Repeat-Associated Mysterious Proteins (RAMPs) and more loosely 
associated Cas proteins, such as a polymerase. Based on the composition of the cas 
operons, eight Cas subtypes (Csa, Csd, Cse, Csh, Csm, Csn, Cst, Csy) by (Haft et 
al. 2005), or seven Cas systems (CASS1-7) have been proposed by (Makarova et al. 
2006), that each contain a certain set of core proteins and a subtype specific module 
that in most cases contains at least one RAMP (Fig. 1.2A). An additional subtype (Cas 
module RAMP, Cmr) includes many RAMP proteins and a polymerase/nuclease; this 
system seems to share core Cas proteins with another subtype that resides on the same 
genome. As discussed below, the Cmr cluster at least to some extent resembles the 
Csm-subtype. The distribution of the closely related subtypes in phylogenetically distant 
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Figure 1.2. Overview of the four CRISPR/Cas subtypes that are described in this chapter. For full colour ver-
sion see page 126. For an overview of all eight CRISPR/Cas subtypes, see (Haft et al. 2005; van der Oost et al. 
2009). (A) cas gene neighborhoods in 4 experimentally studied organisms, each representing a different subtype 
indicated between brackets. CRISPRs consist of a leader (grey box), repeats (red diamonds) and spacers (blue 
boxes); only a fragment of the CRISPR is shown. Genes are indicated as arrows. Blue arrows indicate genes that 
are (possibly) involved in spacer acquisition. Yellow arrows indicate genes that are involved in CRISPR transcription 
and processing and target interference. The endonucleases that cleave pre-crRNA generating crRNA are highlight-
ed as bold arrows. Hatching patterns indicate gene similarity: RAMP genes have vertical lines, polymerase genes 
have horizontal lines, CasC homologues have diagonal lines, and other genes that are not related to each other 
are filled. Genes that encode proteins from isolated complexes (Cse-complex from E. coli and Cmr-complex from P. 
furiosus) are underlined. (B) CRISPR RNA repeat sequences from each organism are given. The cleavage site is in-
dicated by a triangle. Although the repeat sequences are different, all CRISPR RNA cleavage events generate an 8 
nucleotide 5’ handle. Please note that the cleavage site in S. thermophilus CRISPR RNA has not been determined. 
Palindromic sequences are underlined. (C) Predicted secondary structures of the different CRISPR RNA repeats. 
Cleavage sites are indicated with an arrow. As described previously by Kunin et al., the repeat of P. furiosus is not 
likely to form a stem loop (Kunin et al. 2007). (D) Mature crRNA from E. coli K12.
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organisms, suggests that the CRISPR/Cas system has frequently been exchanged 
by horizontal gene transfer between distant micro-organisms (Makarova et al. 2006; 
Horvath et al. 2009). This hypothesis is supported by the observation that the CRISPR/
Cas can be located on plasmids (e.g. the megaplasmids from Thermus thermophilus); 
other plasmids have been reported to contain a CRISPR locus without associated cas 
genes (e.g. the pNOB8 conjugative plasmid from Sulfolobus solfataricus) (Godde and 
Bickerton 2006). 
The best conserved cas genes are cas1 and cas2 that are present in all subtypes (Haft 
et al. 2005). Therefore they are suitable markers for the presence of CRISPR/Cas. The 
putative nuclease/integrase Cas1 (Makarova et al. 2006) has been demonstrated to be 
a metal dependent nuclease that cleaves ssDNA and dsDNA, generating ~80 bp DNA 
fragments from dsDNA. The Cas1 structure reveals a novel fold with a two-domain 
architecture (Wiedenheft et al. 2009). The small Cas2 protein cleaves ssRNAs in U-rich 
regions. Crystal structures of Cas2 from several species have been solved, revealing a 
ferredoxin fold, which is not common for endoribonucleases (Beloglazova et al. 2008). 
Cas1 has been proposed to be involved in spacer integration (Makarova et al. 2006), 
a prediction that is in agreement with the observation that Cas1 and Cas2 in E. coli are 
not involved in the antiviral defense stage of the mechanism when a spacer is already 
present in the CRISPR array (Brouns et al. 2008; Hale et al. 2009). Fusion of cas1 and 
cas4 genes in several genomes, including that of Geobacter sulfurreducens, suggests 
that Cas4, a putative RecB-like nuclease (Makarova et al. 2006), might also be involved 
in spacer acquisition (van der Oost and Brouns 2009). Cas3 is a special case, typically 
being a single polypeptide composed of two domains: an HD domain that has metal-
dependent nuclease activity on double-stranded oligonucleotides (Aravind and Koonin 
1998; Han and Krauss 2009) and a DEAD/H box helicase domain (Makarova et al. 
2006). Interestingly, in the Csa-subtype the domains are separated, and in the Csy-
subtype Cas3 is fused to Cas2 (Makarova et al. 2006). Cas5 and Cas6, previously 
annotated as core Cas proteins as well, represent a group of distantly related Cas 
proteins referred to as RAMPs; they appear to have similar 3D structures, and share at 
least a C-terminal glycine-rich loop (Makarova et al. 2002). Two RAMP proteins (CasE 
and Cas6) have recently been demonstrated to be metal-independent endonucleases 
involved in the processing of CRISPR RNA (pre-crRNA), as described below (Brouns 
et al. 2008; Carte et al. 2008). Additionally, two types of multi-subunit Cas complexes 
have recently been characterized. In E. coli a complex is encoded by 5 clustered genes 
cse1-4 and cas5e (Cas5e and Cse3 are RAMPs) and the gene products form a Cse-
complex termed Cascade (CRISPR-associated complex for antiviral defense) (Brouns 
et al. 2008). A crRNA-binding Cmr-complex comprising Cmr1-6 has been isolated from 
11
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Pyrococcus furiosus (Hale et al. 2009). An overview of experimentally determined and 
putative activities and structures of core Cas proteins and Cas complexes is provided 
in Table 1.1.
Mode of action
The CRISPR/Cas mechanism can be divided into three distinct stages. The first 
stage concerns the integration of nucleic acid fragments of invading mobile genetic 
elements as new spacers into the CRISPR locus. In the second stage, the CRISPR is 
transcribed as a precursor (pre-crRNA), which is subsequently cleaved by a dedicated 
endoribonuclease, resulting in mature crRNAs that remain associated with a Cas 
protein complex. During the third and final stage the crRNA guides the Cas complex to 
known, invading nucleic acids to neutralize the invader, most likely by cleavage.
1. Integration of new spacers
The first experimental evidence that the CRISPR/Cas system is indeed an antiviral 
defense system was obtained from phage infection experiments of the lactic acid 
bacterium Streptococcus thermophilus that has a CRISPR/Cas locus of the Csn-
subtype (Fig. 1.2A) (Barrangou et al. 2007; Deveau et al. 2008; Horvath et al. 2008). 
Screening for adaptation of the CRISPR locus in the surviving bacteria revealed that 
Table 1.1. Cas proteins involved in different stages. Experimentally determined activities and PDB ID codes are 
indicated.
Stage involved Name Activity Remarks
Acquisition Cas1 DNA endonuclease (Wieden-
heft et al. 2009), RNA and DNA 
binding (Han et al. 2009)
Crystal structures (Wiedenheft et 
al. 2009) (3GOD, 2YZS)
Cas2 Ribonuclease activity (Belogla-
zova et al. 2008)
Crystal structures (Beloglazova et 
al. 2008) (2I8E, 1ZPW, 2I0X and 
2IVY)
Cas4 RecB-like nuclease
Processing CasE (part of Cas-
cade), Cas6
pre-crRNA cleavage (Brouns et 
al. 2008; Carte et al. 2008)
Crystal structures of CasE (Ebi-
hara et al. 2006) (1WJ9) and Cas6 
(Carte et al. 2008) (3I4H)
Interference Cse-complex (Cas-
cade)
Strand displacement of 
complementary target DNA 
(Chapter 3)
Comprises CasA-E. Crystal 
structures solved of CasB (Agari 
et al. 2008) (2ZCA) and CasE (see 
above)
Cas3 Nuclease activity of HD domain 
(Han and Krauss 2009)
Helicase, often fused to HD-
domain (Makarova et al. 2006). 
Possibly also involved in acquisi-
tion, according to fusion to Cas2 in 
Csy-subtype (van der Oost et al. 
2009)
Cmr-complex Cleavage of RNA complemen-
tary to crRNA (Hale et al. 2009)
Comprises Cmr1-6. Two structures 
of Cmr5 are available (Sakamoto 
et al. 2009) (2OEB and 2ZOP)
12
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a sub-population of survivors had acquired new phage-specific spacer sequences 
(Fig. 1.3). Subsequent deletion of these new spacer sequences resulted in loss of 
the acquired resistance, demonstrating the correlation of spacer presence and phage 
resistance (Barrangou et al. 2007). Comparative analysis of the spacer-targeted region 
of the viral genome revealed a sequence motif called CRISPR motif or proto-spacer 
adjacent motif (PAM) (i.e. NNAGAAW) downstream of the proto-spacer. The phages 
responded to the resistance of the host by mutations in the proto-spacer, but also by 
mutations in the motif (Deveau et al. 2008), illustrating the constant battle between 
phages and bacteria. Spacers that did not have a perfect PAM were integrated as 
well, but these were always accompanied by spacers with a perfect PAM (Deveau et 
al. 2008), the latter probably being essential for resistance. The data suggests that the 
PAM is crucial for target interference, but not for integration of new spacers. Genomic 
analysis of proto-spacers revealed the presence of slightly different PAMs in many 
extrachromosomal elements, and the conservation of PAM sequences correlates well 
with the CRISPR repeat types, and thus cas gene subtypes (Mojica et al. 2009). 
The spacers in S. thermophilus were integrated at the leader proximal end of the 
CRISPR locus, suggesting that a CRISPR array is a chronological record of past phage 
infections. The role of the leader sequence is not exactly known, but it is possibly 
required for repeat duplication and/or spacer integration. Polarity of the CRISPR 
integration had been previously predicted by Lillestol and coworkers after comparing 
the CRISPRs of two Sulfolobus solfataricus strains with major variation at the leader-
side of the CRISPR (Lillestøl et al. 2006). Next to acquired resistance by spacer 
integration in S. thermophilus, the above mentioned study also showed that cas genes 
are involved in CRISPR-mediated defense. Disruption of the csn1 gene resulted in 
loss of viral resistance. An interrupted csn2 gene did not lead to loss of resistance, but 
rather to a disrupted ability to integrate new spacers. This does not only show that both 
Figure 1.3. Integration of a new spacer.
For full colour version see page 127. A new 
spacer is acquired at the leader proximal 
side of the CRISPR during virus infection, 
resulting in resistance. The CRISPR con-
sist of a leader (grey box), repeats (red 
diamonds) and spacers (blue boxes). 
The newly acquired spacer is numbered 
0 and matches the sequence of the virus 
(proto-spacer). The protospacer adjacent 
motif (PAM) is located upstream or down-
stream the protospacer.
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cas genes are involved in resistance, but also that they play a role at different stages. 
Csn2 is apparently needed for integration of new spacers, but it is restricted to the Csn-
subtype. In Wollinella succinogenes, which carries the same subtype, csn2 is absent 
and seems to be replaced by cas4 (van der Oost and Brouns 2009). Thus, despite the 
unknown role of Csn2 in spacer integration, it is likely that it is replaced by Cas proteins 
with analogous functions in other Cas subtypes, Cas4 being a likely candidate. Csn1 
may have a function analogous to Cascade/Cas3 (as discussed below, Cas3 is also 
involved in target interference)(van der Oost and Brouns 2009). 
2. CRISPR transcription and processing
Before it was hypothesized that the CRISPR/Cas system protects the host against 
invading nucleic acids, studies on short RNAs in the archaea Archaeoglobus fulgidus 
and S. solfataricus had already indicated that CRISPRs are actively transcribed 
and the pre-crRNA processed (Tang et al. 2002; Tang et al. 2005). Although studies 
on transcription and processing in S. solfataricus showed that transcription can be 
bidirectional (Lillestøl et al. 2006; Lillestol et al. 2009), most other studies have reported 
unidirectional transcription from the leader proximal side(Brouns et al. 2008; Hale 
et al. 2008; Marraffini and Sontheimer 2008; Semenova et al. 2009). It is therefore 
anticipated that in most cases a single promoter at the leader side controls transcription 
of a CRISPR locus. It has recently been shown that in the case of E. coli K12 the 
promoter indeed resides in the leader region (Pul et al. 2010). CRISPR transcription 
and processing has been studied in more detail for this E. coli K12 system, which 
consists of 8 cas genes upstream of a CRISPR (Fig. 1.2A). The Cas proteins were 
overexpressed in E. coli BL21, a strain that lacks endogenous cas genes (Studier et al. 
2009). Pull down analysis revealed the presence of Cascade, a protein complex that 
contains 5 different subunits, CasABCDE. Northern blot analysis of crRNAs in E.coli 
K12 revealed short RNAs, the size of which corresponded to approximately 1 spacer 
and 1 repeat. Omitting the cas genes one by one identified CasE, a RAMP protein, 
as a potential candidate for pre-crRNA processing. This finding was confirmed by in 
vitro activity assays showing that CasE is a metal-independent endoribonuclease that 
specifically cleaves a precursor (pre-crRNA) into mature crRNAs. After processing, 
these crRNAs remain tightly bound to the Cascade complex. Cloning and subsequent 
sequence analysis revealed more crRNA products derived from the leader proximal 
end of the CRISPR (Brouns et al. 2008). Independent analysis of crRNA from P. 
furiosus also uncovered more products from the leader proximal side of the CRISPR, 
and fewer from the distal end. This can be explained by premature termination of 
CRISPR transcription (Hale et al. 2008). Mass spectrometry analysis of the E. coli 
crRNA products revealed that the product contains 8 nucleotides of the repeat termed 
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the 5’ handle, the spacer, and a large part of the next repeat including the stem-loop 
termed the 3’ handle (Brouns et al. 2008) (Fig. 1.2D). It has been proposed that these 
handles, the conserved parts of the crRNAs, are bound by subunits of Cascade (Brouns 
et al. 2008). Based on sequence conservation in CasE and the crystal structure of a 
CasE homolog from Thermus thermophilus (Ebihara et al. 2006) the histidine residue 
at position 20 has been predicted to be a residue involved in endonuclease activity. 
Indeed, the activity was lost when the histidine was substituted by an alanine. In vivo 
analysis showed that the mutation resulted in loss of resistance, thus showing that pre-
crRNA cleavage is a mechanistic requirement. 
Despite the fact that Cas6 from P. furiosus shares low sequence identity (except for 
the C-terminal glycine-rich loop, a common feature of RAMP proteins), its structure, 
a duplicated ferredoxin fold, is surprisingly similar to CasE from T. thermophilus 
(Fig. 1.4) (van der Oost et al. 2009). Like CasE, Cas6 displays metal independent 
Figure 1.4. The catalytic sites of CasE and Cas6, and the proposed reaction mechanism of pre-crRNA cleav-
age. For full colour version see page 127. (A) Proposed catalytic site of CasE from T. thermophilus showing the 
conserved histidine residue (H26) and the glycine-rich C-terminal loop. The catalytic site of Cas6 from P. furiosus 
(B) contains a catalytic triad of tyrosine (Y31), histidine (H46) and lysine (K52) and a glycine-rich C-terminal loop. 
The loop and the overall duplicated ferredoxin fold are conserved among CasE and Cas6. Pre-crRNA cleavage 
might follow a general acid-base hydrolysis mechanism (D). A base (B) draws a proton from the 2’OH of the ribose 
ring. A subsequent nucleophilic attack on the phosphorus atom is simultaneously compensated by the acid (A) that 
donates a proton to the leaving 3’RNA. The tyrosine residue of Cas6 is proposed to be the base and the histidine 
the acid residue (Carte et al. 2008). In CasE the histidine and a water molecule might be the catalytic residues. 
Pictures in (A) and (B) are generated with pymol (www.pymol.org), potential catalytic residues are depicted in blue; 
the glycine-rich loop is depicted in red. Coordinates were obtained from the Protein Data Bank (www.pdb.org).
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endoribonuclease activity (Carte et al. 2008). Although the folded secondary structure 
of the repeat RNA of P. furiosus is debatable (Kunin et al. 2007), its crRNA cleavage 
product also contains an 8 nucleotide 5’ handle (psi-tag; Fig. 1.2B and C). Unlike the 
proposed single histidine site in CasE (Brouns et al. 2008), a potential catalytic triad 
with a histidine, tyrosine and a lysine residue is present in Cas6  (Fig. 1.4) (Carte et 
al. 2008). This predicted catalytic site is structurally similar to that of tRNA splicing 
enzymes. Analysis of the cleaved pre-crRNA products revealed that cleavage occurs 
at the 3’ side of the phosphodiester bond, generating a 5’ end hydroxyl group and a 
2’, 3’ end cyclic phosphate group, analogous to tRNA splicing enzymes (Calvin and 
Li 2008; Carte et al. 2008). Like the tRNA splicing mechanism, recent analysis has 
revealed that crRNA from E. coli also possess a 2’,3’-cyclic phosphate (Chapter 3), as 
was predicted (Calvin and Li 2008; Carte et al. 2008). Both CasE and Cas6 probably 
cleave the pre-crRNA following a general acid-base hydrolysis mechanism (Fig. 1.4C). 
Besides its endoribonucleolytic activity Cas6 binds the 3’ handle of the crRNA. Unlike 
the situation in E. coli, in P. furiosus the endonucleolytic product is further trimmed to 
active mature crRNAs lacking a 3’ handle (Hale et al. 2008; Hale et al. 2009), whereas 
mature crRNAs in E. coli do contain a 3’ handle. Another difference is the fact that 
CasE remains part of the Cascade complex (Brouns et al. 2008) whereas Cas6 has not 
been identified as part of the pyrococcal Cmr-complex (see below) (Hale et al. 2009); 
apparently cleaved crRNAs in P. furiosus are transferred to the Cmr-complex. Besides 
the Cmr-complex, an additional Cst-complex might be present in P. furiosus, that is 
encoded by three cst genes downstream of the cmr module (Fig. 1.2A). Overall, it has 
become clear that despite some mechanistic similarity, also substantial differences 
exists between the different CRISPR/Cas subtypes.
3. Target interference
Although it was initially hypothesized that the CRISPR/Cas system would target alien 
RNA, analogous to RNAi (Makarova et al. 2006), several studies have indicated that the 
target of the CRISPR system rather is invading DNA. The first observation supporting 
this hypothesis was made in virus infection studies with Streptococcus thermophilus, 
revealing that spacer sequences corresponding to either the coding or non-coding strand 
were integrated (Barrangou et al. 2007). The CRISPR locus has been demonstrated 
to be transcribed only from the leader proximal side in E. coli, S. epidermidis and P. 
furiosus (Brouns et al. 2008; Hale et al. 2008; Marraffini and Sontheimer 2008); to date 
the only exception appears to be the case of S. solfataricus (Lillestol et al. 2006; Lillestol 
et al. 2009). A consequence of mono-directional CRISPR transcription would be that 
generated crRNAs have to be complementary to the mRNA of the virus, only spacers 
from one strand should be incorporated in case of an antisense RNA mechanism. 
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The observation that this is generally not the case suggests that DNA is the target. 
Additional evidence that DNA is the target was provided by a study on an engineered 
E. coli Cas system in which artificial spacers were unidirectionally transcribed. 
Generating crRNAs complementary to both the coding strand and the template strand 
were successful in inhibiting virus proliferation (Brouns et al. 2008). Furthermore, a 
study on plasmid conjugation in Staphylococcus epidermidis convincingly proved that 
DNA is being targeted (Marraffini and Sontheimer 2008). A natural spacer from the 
CRISPR of S. epidermidis has a perfect match with a gene of a conjugative plasmid. 
This spacer confers resistance and prevents conjugation of this plasmid. A self-splicing 
intron was inserted into the center of the proto-spacer sequence in the plasmid. After 
conjugation and subsequent transcription this intron is spliced, generating a mature 
mRNA that contains a fully complementary sequence to the crRNA. The plasmid was 
able to escape the CRISPR/Cas system showing that mRNA is not being targeted; 
hence, the target must be DNA that could not be recognized by the crRNA due to the 
intron DNA sequence interrupting the proto-spacer. This finding is confirmed by an 
additional experiment in which a fragment of the targeted gene is inserted in a plasmid, 
in both orientations. The fragment is not essential for propagation of the plasmid. 
Nevertheless, the inserted fragment, in both orientations, dramatically decreased the 
transformation efficiencies, again indicating that DNA is being targeted. Recently an 
exceptional CRISPR/Cas system has been described, i.e. the Cmr-subtype from P. 
furiosus that appears to target and degrade RNA (discussed below). For this system 
however, no natural targets have been found yet.
Most biochemical and mechanistic information on the pre-crRNA and target interference 
is derived from the above mentioned E. coli and P. furiosus model systems. Requirements 
for CRISPR-based resistance were determined in E. coli BL21. Artificial CRISPRs 
were designed to target four different genes of phage lambda. Overexpression of 
Cascade and CRISPR RNA was sufficient to yield mature crRNAs that were bound 
and protected by Cascade (Brouns et al. 2008). No resistance was observed when the 
CRISPRs targeting phage lambda were co-expressed with Cascade only. However, co-
expression of this crRNA-loaded Cascade with the Cas3 protein did result in a dramatic 
increase of resistance towards phage lambda infection. A recent study revealed that all 
the Cascade subunits are essential for immunity (Chapter 3). The mechanism of target 
recognition was studied in vitro by use of Electrophoretic Mobility Shift Assays (EMSAs) 
(Chapter 3). When loaded with crRNA, Cascade or CasCDE (a minimal core that is 
still capable of processing, binding and protecting crRNA) (Chapter 3) was shown to 
bind complementary ssDNA and ssRNA. Interestingly, the complexes are also able 
to interact with complementary dsDNA, but not dsRNA. The observation that only the 
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Figure 1.5. Antiviral DNA and RNA silencing pathways in prokaryotes and eukaryotes. For full colour version 
see page 128. (A) crRNA mediated DNA silencing pathway in E. coli. pre-crRNA is cleaved by the CasE subunit 
of Cascade (Cse-complex) and the mature crRNA remains bound to Cascade. When encountering viral dsDNA 
containing a sequence identical to the spacer sequence of the crRNA, it may basepair with the complementary 
DNA strand by a strand displacement event. The HD-domain of Cas3 is likely to be activated and cleave the viral 
DNA only when the 2 bases PAM on the viral DNA is present (marked with an asterisk). The helicase domain might 
subsequently separate the RNA:DNA duplex generating free Cascade that can be used in a next cleavage event. 
(B) crRNA mediated RNA silencing pathway in P. furiosus. Pre-crRNA is cleaved by Cas6 and then further trimmed 
to generate crRNAs of two different lengths. These crRNAs are bound by the Cmr-complex. This loaded Cmr-
complex specifically binds viral RNA and cleaves the complementary strand 14 nucleotides away from the 3’ end 
of the crRNA. This pathway shares functional analogies with siRNA mediated antiviral resistance in eukaryotes (C) 
siRNAs are generated from viral dsRNA by dicer. The first (random) cleavage event by dicer generates dsRNA with 
a 3’ dinucleotide overhang. The second cleavage by dicer takes place 20-25 bases away from the overhang gen-
erating short dsRNAs. The dsRNA is transferred to the Argonaute protein of the RISC complex and the passenger 
strand is removed. The retained guide strand can basepair with a complementary viral mRNA molecule, followed 
by a cleavage of the scissile bond between the 10th and 11th base from the 3’ end of the guide strand. The cleaved 
target RNA dissociates and the recycled RISC can be used in a second round of RNA binding and cleavage. Please 
note that dashed arrows indicate processes that are based on hypotheses.
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complementary strand remains bound to Cascade suggests this dsDNA binding occurs 
by local strand displacement. The ability to specifically target dsDNA indicates that the 
Cas machinery can immediately attack the incoming dsDNA from phage Lambda. The in 
vitro DNA binding is enhanced in the presence of CasA. In conclusion, Cascade loaded 
with crRNA recognizes and binds the incoming double stranded phage DNA. The role 
of the two-domain protein Cas3 remains to be elucidated, but it is tempting to speculate 
that the HD nuclease domain cleaves targeted DNA (Fig. 1.5A). This Cse-subtype from 
E. coli K12 targets DNA, but how does it discriminate between self DNA (namely the 
CRISPR that contains a spacer complementary to the crRNA) and non-self DNA (the 
invader)? A recent study in S. epidermidis revealed that the flanking sequence of the 
proto-spacer is crucial for self versus non-self DNA recognition, and thus for interference 
(Marraffini and Sontheimer 2010b). It was shown that a targeted conjugative plasmid 
could bypass host resistance by the CRISPR/Cas system if three bases downstream 
of the proto-spacer were complementary to the CRISPR repeat sequence (Marraffini 
and Sontheimer 2010b). In other subtypes however, the PAM might help prevent auto-
immunity by being present in the targeted invading DNA sequence, and absent from 
the CRISPR DNA sequence. The PAM determines if invading nucleic acids are being 
targeted in the case of S. thermophilus, as can be deduced from phages that have 
mutated their PAM sequence and thus can escape the CRISPR/Cas system (Deveau 
et al. 2008). The two mechanisms of self versus non-self DNA recognition appear to 
be fundamentally different. In S. epidermidis the potential of the downstream sequence 
of the proto-spacer to basepair with the CRISPR repeat determines whether the DNA 
is being targeted, while in e.g. S. thermophilus the PAM determines whether the DNA 
is being targeted. To bypass immunity in S. epidermidis the invader can only mutate 
its flanking nucleic acids to a sequence complementary to the repeat DNA, while in S. 
thermophilus the invader can mutate its PAM to any other sequence.
Interestingly, the Cas-system from P. furiosus has recently been reported to be capable 
of interfering with target RNA rather than DNA (Hale et al. 2009). With native Northern 
blot analysis a Cmr-type protein complex was identified that forms a stable interaction 
of crRNAs (psiRNA) (Hale et al. 2008; Hale et al. 2009). The crRNAs are 39 and 
45 nucleotides in length, containing an identical 5’ handle but different 3’ ends. The 
RNP complex isolated from Pyrococcus comprised 6 distinct Cas proteins: Cmr1-6. 
Cas6 was not part of the complex (Hale et al. 2009), unlike its functional analog CasE 
that is a core subunit of the Cascade complex (Cse-complex) in E. coli (Brouns et 
al. 2008). The isolated RNP complex cleaved complementary RNA but not ssDNA. 
The 39 and 45 nucleotide long crRNAs resulted in two different cleavage sites in the 
target mRNA; both cleaved 14 nucleotides upstream from the 3’end of the crRNA, 
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suggesting a molecular ruler mechanism for cleavage (Fig. 1.5B). Reconstitution of 
the RNP complex from purified subunits revealed that all except Cmr5 are essential 
for target RNA cleavage (Hale et al. 2008; Hale et al. 2009). The Cmr2 protein that 
is part of the Cmr-complex contains a PALM (polymerase) domain, fused to a HD-
nuclease domain. Whereas the biological function of the polymerase is not known, 
the HD-nuclease might be responsible for degradation of the target RNA. At least two 
proteins from the Cmr-complex are related to proteins that are encoded by the csm 
module in S. epidermidis (Fig. 1.2A); the polymerase Cmr2 is related to Csm1 and the 
RAMP protein Cmr4 is related to Csm3 (Haft et al. 2005). The Csm-type system from 
S. epidermidis has been demonstrated to target DNA in vivo which is in contrast to the 
observed in vitro RNA cleavage activity of the Cmr-complex. Future biochemical and in 
vivo analyses are required to resolve this apparent contradiction.
Analogy with RNAi in eukaryotes
The function and biogenesis of crRNAs and the mechanism of target interference 
display striking analogies with small regulatory RNAs in eukaryotes. The eukaryotic 
regulatory RNAs can be divided in three major groups; endogenous miRNAs that 
generally silence host gene expression, piRNAs that silence transposable elements 
in animal germ cells, and siRNAs that can be involved in viral RNA silencing (see 
elsewhere in this book for more details on eukaryotic small RNAs). In short, siRNAs are 
derived from dsRNA that is randomly cleaved by Dicer generating fragments with a 3’ 
dinucleotide overhang. Dicer subsequently binds the overhang and cleaves ~20 bases 
away from the first cleavage site following a molecular ruler mechanism, generating 
short dsRNAs with 3’ overhangs and 5’ phosphates (Bernstein et al. 2001; Macrae et 
al. 2006; MacRae and Doudna 2007). These dsRNAs are transferred to the Argonaute 
protein in the RNA induced silencing complex (RISC) that also consists of Dicer and a 
dsRNA binding protein; the latter determines in which orientation the dsRNA molecule 
is loaded onto Argonaute (Tomari et al. 2004). Argonaute recognizes the passenger 
strand and degrades it, retaining the guide strand (Rand et al. 2005). When RISC 
encounters a perfectly complementary RNA it can interact with it by Watson-Crick 
base pairing. Argonaute subsequently cleaves the complementary target RNA strand, 
10 nucleotides away from the 5’ end of the guide, after which the target fragments 
are released and the RISC complex is recycled for a new target degradation event, 
eventually resulting in silencing the virus (Baulcombe 2004) (Fig. 1.5C). 
Although sequence comparison of the prokaryotic CRISPR/Cas and the eukaryotic 
siRNA system indicates they are phylogenetically unrelated (Makarova et al. 2006), they 
share some functional and mechanistic analogies. Both crRNA and siRNA are derived 
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from large RNA precursors. Furthermore, both the Cmr-complex from P. furiosus and 
RISC complex specifically bind their target RNA by base pairing and degrade it by a 
molecular ruler mechanism. The major difference between the two systems is that 
crRNAs are transcribed from the host chromosome and are part of an adaptive immune 
system, while antiviral siRNAs are derived from the invaders and are part of an innate 
immune system. Moreover, the Cse- and Csm-type CRISPR/Cas systems target DNA 
rather than RNA. The RNAi pathways in which Dicer and Argonaute are the key players 
are restricted to eukaryotes. The only conserved component among prokaryotes and 
eukaryotes is the Argonaute protein. The ones from prokaryotes have been useful 
models in crystallization studies (Jinek and Doudna 2009; Wang et al. 2009). It has 
recently been hypothesized that prokaryotic Argonaute proteins are involved in yet 
another DNA-mediated antiviral defense mechanism (Makarova et al. 2009). 
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Chapter 2
Small CRISPR RNAs guide antiviral 
defense in prokaryotes
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Abstract
Prokaryotes acquire virus resistance by integrating short fragments of viral nucleic 
acid into clusters of regularly interspaced short palindromic repeats (CRISPRs). Here 
we show how virus-derived sequences contained in CRISPRs are used by CRISPR-
associated (Cas) proteins from the host to mediate an antiviral response that counteracts 
infection. After transcription of the CRISPR, a complex of Cas proteins termed Cascade 
cleaves a CRISPR RNA precursor in each repeat and retains the cleavage products 
containing the virus-derived sequence. Assisted by the helicase Cas3, these mature 
CRISPR RNAs then serve as small guide RNAs that enable Cascade to interfere with 
virus proliferation. Our results demonstrate that the formation of mature guide RNAs 
by the CRISPR RNA endonuclease subunit of Cascade is a mechanistic requirement 
for antiviral defense. 
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Small CRISPR RNAs guide antiviral defense in prokaryotes 
The clusters of regularly interspaced short palindromic repeat (CRISPR)–based defense 
system protects many bacteria and archaea against invading conjugative plasmids, 
transposable elements, and viruses (Bolotin et al. 2005; Mojica et al. 2005; Pourcel et 
al. 2005; Godde and Bickerton 2006; Lillestøl et al. 2006; Barrangou et al. 2007; Sorek 
et al. 2008; Tyson and Banfield 2008). Resistance is acquired by incorporating short 
stretches of invading DNA sequences in genomic CRISPR loci (Barrangou et al. 2007; 
Deveau et al. 2008; Horvath et al. 2008). These integrated sequences are thought to 
function as a genetic memory that prevents the host from being infected by viruses 
containing this recognition sequence. A number of CRISPR-associated (cas) genes 
(Jansen et al. 2002; Haft et al. 2005; Makarova et al. 2006) has been reported to be 
essential for the phage-resistant phenotype (Barrangou et al. 2007). However, the 
molecular mechanism of this adaptive and inheritable defense system in prokaryotes 
has remained unknown. 
Figure 2.1. The composition of the Cascade complex. (A) Schematic diagram of the CRISPR/cas gene cluster 
of E. coli K12 W3110. Repeats and spacers are indicated by diamonds and rectangles, respectively. A palindrome in 
the repeat is marked by convergently pointing arrows. Protein family nomenclature is as described in (Jansen et al. 
2002; Haft et al. 2005). (B) Coomassie blue–stained SDS-polyacrylamide gel of the affinity purified protein complex 
using either the N-terminal StrepII-tag (S) or C-terminal His-tag (H) of each of the subunits CasB, CasC, CasD, or 
CasE as bait. Asterisks indicate the 5.5 kD larger double-tagged subunits. Marker sizes in kilodaltons on the left; 
location of untagged subunits on the right.
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The Escherichia coli K12 CRISPR/cas system comprises eight cas genes: cas3 (predicted 
HD-nuclease fused to a DEAD-box helicase), five genes designated casABCDE, cas1 
(predicted integrase) (Makarova et al. 2006), and the endoribonuclease gene cas2 
(Beloglazova et al. 2008) (Fig. 2.1A and Table S2.1). In separate experiments, each 
Cas protein was tagged at both the N and C terminus and produced along with the 
complete set of untagged Cas proteins. Affinity purification of the tagged component 
Figure 2.2. Cascade cleaves CRISPR RNA precursors into small RNAs of ~57 nucleotides (marked by arrows). 
(A) Northern analysis of total RNA of WT E. coli K12 (WT), a non-cas gene knockout (Δu, uidA, β-glucuronidase), 
and Cascade gene knockouts using the singlestranded spacer sequence BG2349 (table S2.2) as a probe. (B) 
Northern blot as in (A) of total RNA from E. coli BL21 (DE3) expressing the E. coli K12 pre-crRNA and either the 
complete or incomplete Cascade complex. (C) Activity assays with purified Cascade using in vitro transcribed 
γ-32P-uridine triphosphate-labeled pre-crRNA from E. coli K12 (repeat sequence: GAGUUCCCCGCCAGCGGG-
GAUAAACCG), E. coli UTI89 (repeat sequence: GUUCACUGCCGUACAGGCAGCUUAGAAA), and non-crRNA as 
substrates. (D) Activity assays as shown in (C) for 15 min with purified MalE-LacZα and MalE-CasE fusion proteins. 
(E) Northern blot as shown in (B) with Cascade or Cascade-CasEH20A. (F) Activity assays as shown in (C) for 30 min 
with purified Cascade or Cascade-CasEH20A. 
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enabled the identification of a protein complex composed of five Cas proteins: CasA, 
CasB, CasC, CasD, and CasE (Fig. 2.1B). The complex, denoted Cascade (CRISPR-
associated complex for antiviral defense), could be isolated from E. coli lysates using 
any of the tagged subunits of the complex as bait, except for CasA. 
The function of Cascade was studied by analyzing the effect of in-frame cas gene 
knockouts (Baba and Mori 2008) on the formation of transcripts of the CRISPR region 
in E. coli K12 (Fig. 2.1A). Northern analysis of total RNA with single-stranded spacer 
sequences as a probe showed transcription of the CRISPR region in the direction 
downstream of the cas2 gene (Figs. 2.1A and 2.2A) and no transcription in the opposite 
direction. Analysis of control strains (wild type and a non-cas gene knockout) revealed a 
small CRISPR-RNA (crRNA) product of ~57 nucleotides (Fig. 2.2A). The same product 
was present in much higher amounts in the casA, casB, and casC knockout strains 
but absent from strains lacking the overlapping genes casD and casE (Fig. 2.2A). The 
small crRNAs seem to be cleaved from a multiunit crRNA precursor (pre-crRNA) (Tang 
et al. 2002; Tang et al. 2005; Lillestøl et al. 2006), as is evident from the presence of 
two and three repeat-spacer units (~120 and ~180 nucleotides) that show up in the 
ΔcasA, ΔcasB, and ΔcasC strains (Fig. 2.2A). The ΔcasE strain contained a large pre-
crRNA, suggesting that the disruption of this gene prevents pre-crRNA cleavage. 
To study the accumulation and cleavage patterns of crRNAs in the E. coli K12 knockout 
strains in more detail and to rule out any effects of the gene disruptions on the expression 
of downstream or upstream cas genes, the five subunits of Cascade and the K12-
type pre-crRNA were expressed in E. coli BL21(DE3), which lacks endogenous cas 
genes (Kim et al.). Northern analysis showed that crRNAs of ~57 nucleotides were 
only produced in strains containing the Cascade complex (Fig. 2.2B). By omitting the 
individual subunits one by one, it became apparent that the small crRNA was absent 
only in the strain that lacked casE (Fig. 2.2B), indicating that this is the only Cascade 
subunit essential for pre-crRNA cleavage. 
Activity assays with purified Cascade showed that the complex is capable of cleaving the 
E. coli K12 pre-crRNA into fragments of ~57 nucleotides in vitro (Fig. 2.2C). However, 
no cleavage was observed with either pre-crRNA from E. coli UTI89, which contains 
repeats with a different sequence (Kunin et al. 2007), or a non-crRNA template (Fig. 
2.2C). The RNA cleavage reaction proceeded in the absence of divalent metal ions and 
adenosine triphosphate and reached saturation level within 5 min. To investigate whether 
the CasE subunit is sufficient for pre-crRNA cleavage activity, it was overproduced as 
a fusion with the E. coli maltose binding protein (MalE). Like the complete Cascade, 
26
chaPter 2
2
the CasE fusion protein cleaved only the K12-type pre-crRNA (Fig. 2.2D), showing 
that CasE is an unusual endoribonuclease that does not require the other Cascade 
subunits. We cannot rule out the possibility that pre-crRNA cleavage is an autocatalytic, 
ribozyme-like reaction, in which CasE is an essential RNA chaperone. 
CasE belongs to one of the numerous families of repeat-associated mysterious proteins, 
the largest and most diverse class of Cas proteins (Haft et al. 2005; Makarova et 
al. 2006). The crystal structure of a CasE homolog from Thermus thermophilus HB8 
shows that the protein contains two domains with a ferredoxin-like fold, and displays 
overall structural similarity to a variety of RNA-binding proteins (Ebihara et al. 2006; 
Makarova et al. 2006). On the basis of structure and amino acid conservation analysis 
of this protein family (Fig. S2.1), the invariant residue His20 was mutated to Ala to 
analyze the effect on pre-crRNA cleavage. Northern blots indicated that crRNAs of 
~57 nucleotides were no longer formed in the strain containing Cascade-CasEH20A (Fig. 
2.2E). Moreover, although the mutated CasE was still incorporated into Cascade, the 
pre-crRNA cleaving ability of purified Cascade was abolished (Fig. 2.2F), providing 
further support for the essential role of CasE in pre-crRNA cleavage and suggesting 
that the conserved His residue is involved in catalysis. 
Figure 2.3. Cleaved crRNAs remain bound by Cascade. (A) Denaturing polyacrylamide gel showing the crRNA 
(marked by the arrow) isolated from purified Cascade in the absence and presence of co-expressed pre-crRNA. 
(B) Secondary structure of pre-crRNA repeats and example sequences of cloned crRNAs indicating the PCS and 
crRNA handles. 
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The crRNA cleavage sites were examined by simultaneous expression of K12-type 
pre-crRNA and Cascade. Under these conditions, the purification of Cascade yielded 
substantial amounts of copurified RNAs of ~57 nucleotides (Fig. 2.3A). Cloning and 
sequencing of this Cascade-bound RNA revealed that 85% of the clones [67 out of 79 
clones (67/79)] were derived from crRNAs, of which 78% (52/67) started with the last 
eight bases of the repeat sequence (AUAAACCG) (Fig. 2.3B and Fig. S2.2). This well-
defined 5′ end was followed by a complete spacer sequence and a less well-defined 3′ 
sequence ending in the next repeat region. A transcript of a single palindromic repeat 
can fold as a stable stemloop of seven base pairs, which may facilitate recognition by 
RNA-binding Cas proteins (Kunin et al. 2007; Sorek et al. 2008), such as CasE. The 
pre-crRNA cleavage site (PCS) appeared to be located immediately upstream of the 3′ 
terminal base of the stem-loop formed by the repeat (Fig. 2.3B). The clone library did not 
contain crRNAs of 61 nucleotides, which would be the result of a single endonuclease 
cleavage event in each repeat, given the size of a repeat (29 nucleotides) and most 
spacers (32 nucleotides). Instead, in agreement with experimental observations (Figs. 
2.2 and 2.3A), the crRNAs were truncated at the 3′ end by at least two guanosine 
bases from the endonuclease cleavage site, removing several stem-forming bases. 
To test whether crRNA-loaded Cascade gives rise to phage resistance, two artificial 
CRISPRs were designed against phage Lambda (λ). Each of these CRISPRs targeted 
four essential λ genes (Fig. S2.3). The coding CRISPR (C1–4) produced crRNAs 
complementary to both the mRNA and the coding strand of these four genes, whereas 
the template CRISPR (T1–4) targeted only the template strand of the same proto-spacer 
regions (Fig. S2.3). A nontargeting CRISPR containing wild-type (WT) spacers with 
no similarity to the phage genome served as a control. Plaque assays with E. coli 
showed that the introduction of either one of these anti-λ phage CRISPRs in a strain 
expressing only Cascade did not result in reduced sensitivity of the host to a virulent 
Lambda phage (λvir) (Fig. 2.4A). However, strains that expressed Cascade and Cas3 
were much less sensitive to phage infection. The template CRISPR rendered the 
strain insensitive to the phage at the highest phage titer tested (>107-fold less sensitive 
than the control strain), whereas the coding CRISPR reduced the sensitivity 102- fold 
(Fig. 2.4A) and produced plaques with a diameter ~1/10 of the standard l plaque. 
The phage resistance phenotype was lost when Cascade was omitted (Fig. 2.4A), 
proving that both Cascade and Cas3 are required in this process. Moreover, strains 
containing Cas3 and Cascade-CasEH20A displayed a sensitive phenotype, which shows 
that pre-crRNA cleavage is mechanistically required for phage resistance. The co-
expression of Cas1 and Cas2 had no effect on the sensitivity profile of the strain (Fig. 
2.4A), suggesting that these proteins are involved in other stages of the CRISPR/cas 
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mechanism. Plaque assays with single anti-λ spacers (Fig. S2.3) showed that the total 
reduction of sensitivity observed with the four anti-λ spacers (C1–4 and T1–4) (Fig. 2.4A) 
results from a synergistic effect of the individual spacers (C1 to T4) (Fig. 2.4B). 
Our results demonstrate that a complex of five Cas proteins is responsible for the 
maturation of pre-crRNA to small crRNAs that are critical for mediating an antiviral 
response. These mature crRNAs contain the antiviral spacer unit flanked by short RNA 
sequences derived from the repeat on either side termed the 5′ and 3′ handle, which 
may serve as conserved binding sites for Cascade subunits, as has been suggested 
previously (Kunin et al. 2007). The Cascade-bound crRNA serves as a guide to direct 
Figure 2.4. Engineered CRISPRs confer resistance to λ in the presence of Cascade and Cas3. (A) Effect of 
the presence of different sets of cas genes on the sensitivity of E. coli to phage λvir. Cells were equipped with one 
of two engineered CRISPRs containing four anti-λ spacers each (fig. S2.3). The C1–4 CRISPR produces crRNA 
complementary to the coding strand and mRNA of λvir, and the T1–4 CRISPR targets only the template strand. The 
sensitivity of each strain to phage λvir is represented as a histogram of the efficiency of plaquing, which is the plaque 
count ratio of the anti-λ CRISPR to that of the nontargeting control CRISPR. (B) Effect of single anti-λ spacers (fig. 
S2.3) on the sensitivity of E. coli to λvir. Error bars indicate 1 SD. 
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the complex to viral nucleic acids to mediate an antiviral response. We hypothesize 
that crRNAs target virus DNA, because anti-λ CRISPRs of both polarities lead to a 
reduction of sensitivity to the phage. The model is supported by previous observations 
that virus-derived sequences are integrated into CRISPR loci, irrespective of their 
orientation in the virus genome (Bolotin et al. 2005; Mojica et al. 2005; Pourcel et al. 
2005; Lillestøl et al. 2006; Makarova et al. 2006; Barrangou et al. 2007; Deveau et al. 
2008; Horvath et al. 2008). We conclude that the transcription of CRISPR regions - and 
the cleavage of pre-crRNA to mature crRNAs by Cas proteins - is the molecular basis 
of the antiviral defense stage of the CRISPR/cas system, which enables prokaryotes 
to effectively prevent phage predation. 
Materials and Methods
Strains
E. coli K12 gene knockouts from the KEIO collection were kindly provided by the 
National BioResource Project (NBRP, NIG, Japan) (Table S2.2).
Gene cloning, protein production and purification
The cas genes and CRISPRs were PCR amplified from E. coli K12 W3110 (BW25113) 
genomic DNA, and directionally cloned into a compatible expression vector set 
consisting of pET-52b (AmpR, 100 µg/ml), pCDF-1b (StrR, 50 µg/ml), pRSF-1b (KanR, 
50 µg/ml) and pACYCduet-1 (CamR, 34 µg/ml) (Novagen), or pIH1119 (AmpR) (New 
England Biolabs) as indicated in Table S2.2 and S2.3. Primers for the cas genes 
were designed based on their predicted translation start sites according to their latest 
annotation (Hayashi et al. 2006) (Table S2.2). Mutations were introduced using the 
QuikChange site-directed mutagenesis kit (Stratagene) (Table S2.2). Plasmids were 
transformed into E. coli BL21(DE3) (Novagen) which lacks endogenous cas genes, 
or E. coli DH5α in the case of pIH1119 and overproduced by inducing with 0.1 mM 
isopropyl-β-D-thiogalactopyranoside (IPTG) (Invitrogen) at an optical cell density at 
600 nm of 0.6 for 16 h at 37 °C. Cells were harvested, resuspended in 20 mM Tris-
HCl (pH 8.0) supplemented with 0.1 M NaCl, and disrupted using a French Pressure 
Cell. Tagged proteins were isolated using Strep-Tactin (IBA, Germany), HIS-Select 
(Sigma-Aldrich), or Amylose (New England Biolabs) affinity chromatography following 
manufacturer’s instructions. The identity of the proteins was determined by mass 
spectrometry, as described (Snijders et al. 2006).
Northern blotting
Total RNA from 11 ml of exponentially grown E. coli cells was isolated using the 
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mirVana miRNA isolation kit (Ambion). Strain E. coli BL21(DE3) containing various 
plasmid combinations (Table S2.3) was grown without IPTG induction, which 
resulted in low expression levels of the cas genes and CRISPR due to leakage of the 
expression system. Northern blots were performed by running 10 µg of RNA on a 9% 
polyacrylamide gels with 7 M urea in 0.5x TBE buffer (Sambrook et al. 1989). The 
RNA was then transferred to a Genescreen Plus membrane (PerkinElmer) by semi-dry 
blotting using a Trans-blot SD (Bio-Rad). After 1 min of UV-crosslinking and baking 
(80 °C, 15 min), the membrane was hybridized with QuikHyb (Stratagene) at 42 °C. 
Blots were probed for 12 hours with a 32P-5’-labelled DNA oligonucleotide of spacer 
4 in the E. coli K12 CRISPR (oligonucleotide BG2349, Table S2.2). The blots were 
subsequently washed with 2x SSC buffer (Sambrook et al. 1989) containing 0.1% SDS 
for 30 min, and 0.1x SSC buffer containing 0.1% SDS for 30 min. Blots were visualized 
using phosphorimaging with a Personal FX phosphorimager (Bio-Rad). RNA sizes 
were estimated by comparison with 32P-labeled Decade RNA marker (Ambion).
Cleavage reactions
Internally radiolabelled transcripts were generated by in vitro transcription using the 
MAXIscript T7 kit (Ambion) and α-32P-UTP (GE) (Table S2.2). Templates for in vitro 
transcription were generated by PCR using primers BG2559 and BG2374 for the E. 
coli K12 CRISPR, BG2462 and BG2463 for E. coli UTI89, and BG2452 and BG2461 
for the Full-length RNA substrates were gel-isolated from denaturing 2% agarose gels 
as described (Locker, 1979). Cleavage reactions were set up at 37 °C in 20 mM Tris-
HCl (pH 8.0) supplemented with 0.1 M NaCl and 1 mM EDTA. Protein samples (Table 
S2.3) were treated with 10 mM EDTA prior to the cleavage assay. Assays were started 
by adding 0.3 µg of Cascade, or 0.1 µg of MalE-CasE to a reaction containing 10 ng 
of gel-purified internally 32P labeled transcripts in a total volume of 10 µl. Samples 
were treated with 1 U of proteinase K for 5 min at 37 °C (Fluka) and acid-phenol 
extracted as described (Elbashir et al. 2001). Reaction products were analyzed using 
8% polyacrylamide gels containing 7 M urea.
RNA cloning
Protein-bound total RNA was isolated from Strep-Tactin-purified Cascade (Table 
S2.3) using the mirVana miRNA isolation kit (Ambion). Approximately 6 µg of RNA 
was denatured for 10 min at 65 °C, and subsequently 3’ polyadenylated for 75 min 
at 41 °C using Poly(A) polymerase (Ambion) as described (Botero et al. 2005). 
RNA products were separated from unincorporated nucleotides and enzymes using 
a NucAway gel filtration spin column (Ambion), and reverse transcribed with the 
Superscript III kit (Invitrogen) for 50 min at 50 °C with anchored primer BG2164 (5’-
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GCCCGCCCGGATCCTTTTTTTTT-TTTTTTTTTTTTTTTTTTTTTVN-3’) (BamHI site in 
bold face) (Botero et al. 2005). The RNA strand was degraded by RNase A (Fermentas) 
and RNase HI (Promega) for 15 min at 37 °C. Single-stranded cDNA was purified 
using the MinElute PCR purification kit (Qiagen). A 3’ poly(dG) tail was added to the 
cDNA by 60 min incubation with Terminal Deoxynucleotidyl Transferase (Invitrogen) 
at 37 °C, followed by purification using MinElute reaction cleanup kit (Qiagen). The 
single stranded cDNA was used as a template in a PCR using Native Pfu polymerase 
(Stratagene) and primers BG2220 (5’-GCGCCCGCGGATCCCCCCCCCCDN-3’) and 
BG2222 (5’-GCCCGCCCGGATCC-TT-3’). The PCR products were cloned into vector 
pUC29 and transformed into E. coli NEB5α (New England Biolabs).
Phage studies
Host sensitivity to phages was tested using a virulent variant of phage Lambda (λvir) 
(Jacob and Wollman, 1954) obtained from Centraalbureau voor Schimmelcultures 
(Utrecht, Netherlands) and E. coli BL21-AI (Invitrogen) as a host (Table S2.2 and 
S2.3). Strains were grown in 2YT-Lambda (2YTL) media (16 g/L tryptone, 10 g/L yeast 
extract, 5 g/L NaCl, 10 mM MgSO4, 0.2 % maltose) until the optical density (OD600 nm) 
reached 0.3. Cas protein and pre-crRNA production was then induced for 30 min by 
adding a final concentration of 0.2 % L-arabinose (Sigma-Aldrich) and 0.1 mM IPTG. 
Cells were spun down and resuspended in 10 mM MgSO4, before being used in plaque 
assays according to standard procedures (Sambrook et al. 1989). Plaque assays were 
performed in triplicate. Plates and top-agar contained 2YTL and above mentioned 
concentrations of inducers. The sensitivity of the host to phage infection was calculated 
as the efficiency of plaquing (Barrangou et al. 2007), which is the plaque count ratio 
of a strain containing an anti-λvir CRISPR to that of a strain containing a CRISPR 
with non-targeting spacers (N). Error-bars were calculated as one standard deviation. 
Anti-λ CRISPRs were designed by randomly picking proto-spacer sequences in four 
genes of the λ genome (Fig.S2.3). The artificial anti-λ CRISPR design did not take 
any S. thermophilus CRISPR motifs into account (Deveau et al. 2008, Horvath et al. 
2008). The motifs are conserved nucleotide sequences located downstream of proto-
spacers on the virus genome, which are important for the phage resistant phenotype 
in S. thermophilus. No CRISPR motif could be identified for the E. coli K12 CRISPR/
cas system using the flanking regions of the four known proto-spacers in phage P1 and 
plasmid F (Mojica et al. 2005). The anti-λ CRISPRs were synthesized by Geneart AG 
(Regensburg, Germany), and subcloned into vector pACYCduet-1 vector (Novagen) 
(C1-4, T1-4, Table S2.2) using restriction sites NcoI and Acc65I. CRISPRs with single 
targeting spacers (C1, C2, C3, C4, T1, T2, T3, T4) were obtained by exchange of single 
non-targeting spacers of the N CRISPR with the corresponding single targeting spacers 
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of C1-4 and T1-4 CRISPRs using restriction enzyme pairs NcoI and EcoRI, EcoRI and 
BamHI, BamHI and NsiI, NsiI and Acc65I (Fig.S2.3). The CRISPR sequences are 
provided in Figure S2.4.
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Figure S2.1 For full colour version see page 129. 
A. Multiple sequence alignment of CasE homologs. Sequences were aligned with TCoffee (Poirot et al. 2003) 
and aligned to the structure of TTHB192 (PDB ID: 1WJ9) (Ebihara et al. 2006) using ESPript (Gouet et al. 2003). 
TTHB192, Thermus thermophilus HB8; CasE, Escherichia coli K12 W3110; EcHS_A2895, E. coli HS; SDY_2955, 
Shigella dysenteriae Sd197; GSU1389, Geobacter sulfurreducens PCA; Ping_1587, Psychromonas ingrahamii 37; 
FRAAL0457, Frankia alni ACN14a; nfa44230, Nocardia farcinica IFM 10152; sce0560, Sorangium cellulosum ‘So 
ce 56’; STH669, Symbiobacterium thermophilum IAM 14863; RoseRS_0646, Roseiflexus sp. RS-1; SAVE7538, 
Streptomyces avermitilis MA-4680; cbdb_A1519, Dehalococcoides sp. CBDB1; Sfum_2829, Syntrophobacter 
fumaroxidans MPOB; CYA_0730, Synechococcus sp. JA-3-3Ab; Dgeo_2534, Deinococcus geothermalis DSM 
11300; Pmen_3756, Pseudomonas mendocina ymp; Ppro_2338, Pelobacter propionicus DSM 2379; Acry_1809, 
Acidiphilium cryptum JF-5; Rru_A0170, Rhodospirillum rubrum ATCC 11170; Mmwyl1_3543, Marinomonas sp. 
MWYL1; plu0750, Photorabdus luminescens subsp. laumondii TT01; Csal_0231, Chromohalobacter salexigens 
DSM 3043; Ecs3610, E. coli 0157:H7 str. Sakai; SBO_2764, Shigella boydii Sb227; EcE24377A_3058, E. coli 
E24377A; SC2871, Salmonella enterica subsp. Enterica serovar Choleraesuis str. SC-B67; STM2939, Salmonella 
typhimurium LT2; ESA_02833, Enterobacter sakazakii ATCC BAA-894; STY3066, S. enterica subsp. Enterica serovar 
Typhi str. CT18; SPA2795, S. enterica subsp. Enterica serovar Paratyphi A str. ATCC9150; Dde_0860, Desulfovivrio 
desulfuricans G20; Mhun_1376, Methanospirillum hungatei JF-1; Gura_0829, Geobacter uraniireducens Rf4. 
Secondary structural elements and amino acid numbering follows the TTHB192 structure and sequence. Disordered 
loops are indicated with a plus (+), and the highly conserved residue His26 is marked with an asterisk (*). The highly 
conserved C-terminal glycine-rich loop, which is the hallmark of this protein family, is highlighted with a box.
B. Ribbon diagram of the structure of TTHB192, a CasE homolog from Thermus thermophilus HB8 (PDB ID: 1WJ9) 
(Ebihara et al. 2006). Structural features are indicated as in A. Structurally disordered residues 108 to 115 and 156 
to 169 are depicted by dashed lines. Note that the highly conserved glycine-rich loop between secondary structure 
elements α5 and β12 is spatially close to His26.
B
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Figure S2.3
A Phage λ genome map indicating the main genes and transcripts (dotted arrows), and the positions of the proto-
spacers on the coding or template strand. 
B Design of two anti-λCRISPRs (repeats: diamonds, spacers: rectangles) producing crRNAs complementary to 
(indicated by α) either the coding strand (C1-4) of the four genes J, O, R and E (i.e. mRNA and plus strand of the viral 
genome), or the template strand (T1-4) of these four genes (i.e. minus strand). A third CRISPR (N) was designed 
as a non-targeting control containing the naturally occurring spacers 1, 3, 5, and 7 from E. coli K12, which have no 
homology to any known phage. The number of plaque forming units obtained in the presence of this CRISPR was 
used to calculate the efficiency of plaquing (Fig.2.4). Restriction sites were introduced in spacer 2, 4 and 6 (EcoRI, 
BamHI and NsiI, respectively). 
C CRISPRs with single targeting spacers (C1, C2, C3, C4, T1, T2, T3, T4) were obtained by exchange of single non-
targeting spacers of the N CRISPR with the corresponding single targeting spacers of C1-4 and T1-4 CRISPRs using 
restriction enzyme pairs NcoI and EcoRI, EcoRI and BamHI, BamHI and NsiI, NsiI and Acc65I.
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Chapter 3
Structural basis for CRISPR RNA-
guided DNA recognition by Cascade
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Abstract
The CRISPR immune system in prokaryotes utilizes small guide RNAs to neutralize 
invading viruses and plasmids. In Escherichia coli, immunity is dependent on a 
ribonucleoprotein complex called Cascade. Here we present the composition and 
low-resolution structure of Cascade and show how it recognizes double-stranded 
DNA targets sequence specifically. Cascade is a 405 kDa complex comprising five 
functionally essential Cas proteins (CasA1B2C6D1E1) and a 61 nucleotide crRNA 
with 5’-hydroxyl and 2’, 3’-cyclic phosphate termini. The crRNA guides Cascade to 
the complementary sequence of double-stranded DNA by ATP-independent strand 
displacement, indicating that invader DNA surveillance takes place without continuous 
investment of resources. The structure of Cascade reveals an unusual seahorse-
shape that undergoes conformational changes upon target DNA binding. Based on the 
composition of Cascade and structures of Cascade core subcomplexes a structural 
model is presented that provides insight into the molecular basis of crRNA-guided 
target DNA recognition.
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Introduction
The constant pressure of invading viruses and conjugative plasmids has shaped the 
evolution of host defence systems in prokaryotes. The widely distributed CRISPR 
(clustered regularly interspaced short palindromic repeats) immune system represents 
the most recently discovered prokaryotic defence strategy (reviewed by (van der Oost 
et al. 2009; Horvath and Barrangou 2010; Karginov and Hannon 2010; Marraffini and 
Sontheimer 2010a)). The system consists of repeats that are interspaced by unique 
sequences called spacers, which are derived from viral and plasmid DNA (Bolotin et 
al. 2005; Mojica et al. 2005; Pourcel et al. 2005). CRISPR-based immunity is adaptive 
and inheritable because it can both memorize invaders by storing fragments of their 
DNA, and pass that information on to subsequent generations following a Lamarckian 
type of evolution (Koonin and Wolf 2009; van der Oost et al. 2009). 
The CRISPR-associated (Cas) protein machinery is encoded by gene clusters that are 
located in close proximity of the CRISPR locus (Jansen et al. 2002) which has allowed 
for the extensive horizontal transfer of complete CRISPR/Cas systems (Godde and 
Bickerton 2006). Multiple types of cas-gene sets have been recognized (Haft et al. 
2005; Makarova et al. 2006) that correlate with specific families of repeat sequences 
(Kunin et al. 2007). 
The mechanism of CRISPR/Cas-induced immunity has been divided into three stages. 
In the first stage, CRISPR adaptation, the host encounters an invader and integrates a 
fragment of foreign DNA non-directionally into the CRISPR as a new spacer, resulting 
in resistance to foreign genetic elements carrying this sequence (Barrangou et al. 2007; 
Horvath et al. 2008; van der Ploeg 2009). Although the molecular determinants of foreign 
DNA recognition have not been elucidated, the crystal structure and metal-dependent 
DNase activity of Cas1 indicated that this enzyme maybe involved in generating small 
DNA fragments that are used as precursors for CRISPR adaptation (Wiedenheft et al. 
2009). Newly acquired spacers from both the coding and template strand of the viral 
genome have been shown to confer immunity (Barrangou et al. 2007). 
In the second stage, CRISPR expression, the CRISPR locus is transcribed and the 
repeat regions within the precursor CRISPR RNA (pre-crRNA) are cleaved (Tang et al. 
2002; Hale et al. 2008; Lillestol et al. 2009) by a specific Cas endoribonuclease. Two 
pre-crRNA processing endonucleases have been described: CasE from Escherichia 
coli (Brouns et al. 2008) and Cas6 from Pyrococcus furiosus (Carte et al. 2008). In E. 
coli, CasE is an essential component of the Cascade complex (CRISPR-associated 
complex for antiviral defence), which consists of five Cas proteins from the Cse-type 
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(CasABCDE) (Fig. 3.1A). CasE-generated mature crRNAs remain bound to Cascade 
to guide host defence. This is distinct from the situation in P. furiosus in which Cas6-
generated crRNAs (also called psiRNAs) end up in the Cmr-complex encoded by the 
RAMP module of Cas proteins, where they are further trimmed at the 3’-end from ~67 
to 39 or 45 nucleotides. The guide RNA-loaded Cmr-complex cleaves single stranded 
target RNA sequence-specifically (Hale et al. 2009). In E. coli, the third stage, CRISPR 
interference, not only requires Cascade loaded with anti-invader crRNA, but also the 
participation of the predicted nuclease/helicase Cas3. Because crRNAs complementary 
to the either strand of the phage DNA provided resistance, it was proposed that 
Cascade is a crRNA-guided complex that targets DNA rather than mRNA (Brouns et 
al. 2008). A series of genetic experiments in Staphylococcus epidermidis involving 
a conjugative plasmid showed that the Csm-type CRISPR/Cas system targets DNA 
as well (Marraffini and Sontheimer 2008). Although DNA is the prime candidate for 
the target molecule in the E. coli and S. epidermidis model systems, direct molecular 
evidence of Cas proteins interacting with their target DNA has been lacking. In this 
study we show how Cascade recognizes target DNA and present a structural model 
of Cascade that provides insight into the mechanism of crRNA-guided recognition of 
DNA targets. 
Results
Core sub-complexes of Cascade
The E. coli K12 CRISPR/Cas system (Cse-subtype) consists of a gene cluster encoding 
eight cas genes (cas3, casABCDE, cas1 and cas2) and a downstream CRISPR locus 
(Fig. 3.1A). Five Cas proteins (CasABCDE) form the Cascade complex, which cleaves 
a long precursor transcript of the CRISPR region (pre-crRNA) into small crRNA 
molecules. These crRNAs remain bound to the complex to guide antiviral defence 
(Brouns et al. 2008). To investigate the role of the individual subunits, we first tested 
whether each subunit is required for antiviral defence. Viral plaque assays with Cas3 
and Cascade lacking one type of protein subunit showed that all protein components of 
Cascade are indispensible for the virus resistant phenotype of E. coli (Fig. S3.1). 
We then systematically overproduced and affinity purified different combinations of 
Cascade subunits and checked for the presence of mature crRNA. This analysis showed 
that CasA or CasAB could be omitted without affecting the apparent stoichiometry of 
the remaining subunits or the mature crRNA (Figs. 3.1B and 3.1C). We noticed that 
Cascade, unlike CasBCDE and CasCDE, always co-purified with large nucleic acid 
molecules (>300 nt) (Fig. 3.1C). Removal of the Cas proteins followed by nuclease 
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treatments showed that RNase A only hydrolyzed the crRNA, while DNase I removed 
the long nucleic acids, thereby identifying the co-purified nucleic acid as DNA (Fig. 
3.1D). Size exclusion chromatography of the three types of complexes revealed that 
the vast majority of CasBCDE and CasCDE were present in a single form, whereas 
Cascade displayed a substantial void peak in addition to a discrete peak at ~11 ml 
(Fig. 3.1E). DNase I treatment prior to gel filtration eliminates the void peak without 
disruption of the discrete Cascade peak, again indicating the presence of Cascade-
bound DNA (Fig. 3.1E). 
Architecture of crRNA
The characteristics of the mature crRNA species were accurately determined by 
subjecting mature crRNAs isolated from Cascade to denaturing RNA chromatography 
(Dickman and Hornby 2006; Waghmare et al. 2009) and electrospray ionization 
mass spectrometry (ESI-MS). To simplify the analysis, a uniform crRNA preparation 
was obtained by co-expressing Cascade with a designed CRISPR containing eight 
repeats and seven identical spacers (denoted R44 CRISPR (Fig. S3.2)). This setup 
resulted in a Cascade preparation in which each molecule was loaded with the same 
Figure 3.1. Core complexes of Cascade retain crRNA. A) Schematic diagram of the CRISPR/Cas locus in E. coli 
K12 containing cas3 (ygcB), casA (cse1, ygcL), casB (cse2, ygcK), casC (cse4, ygcJ), casD (cas5e, ygcI), casE 
(cse3, ygcH), cas1 (ygbT), cas2 (ygbF) (Jansen et al. 2002; Haft et al. 2005). B) Coomassie blue-stained SDS-
polyacrylamide gel showing StrepTactin purified Cascade, CasBCDE and CasCDE. Protein marker sizes in kDa. 
The asterisk marks the Strep-tagged subunit. C) Ethidium bromide-stained denaturing PAA-gel showing nucleic 
acids isolated from purified Cascade (sub-)complexes. RNA marker sizes in nucleotides. D) RNase A or DNase I 
treatment of Cascade bound nucleic acids from Cascade. E) Size exclusion elution profiles of CasCDE, CasBCDE 
and Cascade before and after DNase I treatment.
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crRNA. Chromatography demonstrated the purity and homogeneity of this crRNA 
preparation (Fig. 3.2A). Furthermore, the observed retention time was consistent with 
an approximate length of 60 nt. The ESI-MS spectra indicated that the crRNA had a 
molecular weight of 19,660.80 Da (Fig. 3.2B), which corresponds well to an expected 
molecular weight of 19,660.82 Da for a 61 nt crRNA resulting from a single CasE 
endoribonuclease cleavage event in each repeat. The purified mature crRNA was also 
analyzed using ESI-MS/MS analysis following RNase T1 and RNase A digestion. A 
number of oligoribonucleotide digests were assigned to the mature crRNA sequence 
(Fig. S3.3) and were consistent with the previously determined CasE cleavage site, 5’ 
of the terminal base of the hairpin (Brouns et al. 2008). The molecular weight analysis 
of the crRNA indicated a 5’-hydroxyl group and a 2’,3’-cyclic phosphate terminus. The 
presence of a cyclic phosphate terminus was confirmed by acid treatment of the crRNA, 
which showed a mass shift of 18 Da, corresponding to the hydrolysis of the 2’,3’-cyclic 
phosphate to a 2’ or 3’ phosphate (Fig. 3.2C). Mature crRNA is 61 nucleotides long and 
contains the 32 nucleotide spacer sequence, flanked by repeat-derived sequences on 
either end: 8 bases at the 5’ terminus (5’-handle) and 21 bases forming a hairpin with 
a tetra-nucleotide loop at the 3’ terminus (3’-handle) (Fig. 3.2D). 
Figure 3.2. Architecture of crRNA. A) Ion-pair reversed-phase HPLC purification of mature R44 crRNA (Fig.S3.2) 
at 75 °C. B) Multiple-charged ESI-MS spectra of the purified mature crRNA. C) Enhanced view of the 18- charged 
species before (upper graph) and after acid treatment (lower graph) indicating the hydrolysis of the 2’,3’-cyclic phos-
phate. D) Diagram of mature crRNA derived from the R44 CRISPR showing the 5’ hydroxyl group and 2’,3’-cyclic 
phosphate.
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Target recognition by Cascade
The observation that DNA co-purified with Cascade (Figs. 3.1C and 3.1D) prompted 
us to analyze the DNA binding behaviour of Cascade in detail. Electrophoretic mobility 
shift assays (EMSAs) demonstrated that Cascade was able to bind single-stranded 
(ss) DNA containing the protospacer, a sequence complementary to the spacer 
sequence of the crRNA (Figs. 3.3A, 3.3C and S3.4). Double-stranded (ds) target DNA 
was also bound, without the need for additional co-factors such as divalent metal-
ions or ATP (Figs. 3.3B and 3.3D). The dissociation constant (Kd) of Cascade for 
single- and double-stranded target DNA was 8 and 790 nM, respectively. In addition to 
target DNA, Cascade also displayed weak non-target DNA binding, i.e. DNA without 
a protospacer (Figs. 3.3C and 3.3D). Competitor DNA blocked Cascade from binding 
non-target DNA, and at very high competitor concentrations also from binding target 
DNA (Figs. 3.3A-D). The competitor had little effect on preformed Cascade-target DNA 
complexes, indicating a stable interaction between Cascade and complementary DNA 
substrates, while non-target interaction was transient (not shown). At high competitor 
concentrations the binding of target DNA by a proportion of Cascade lacking CasA was 
observed, as was evident from the faster migration rate of the CasBCDE-DNA complex 
(Figs. 3.3A, 3.3C and S3.4). 
Cascade sub-complexes lacking CasA (CasBCDE and CasCDE) displayed only 
sequence-specific binding to ss- and dsDNA targets, and did not bind non-target DNA 
(Figs. 3.3E-H). Consistent with that observation, the target DNA binding behaviour of 
these subcomplexes was not affected by the addition of competitor DNA. The addition 
of purified CasA to CasBCDE preparations restored Cascade-like non-specific DNA 
binding ability (Fig. S3.5), but neither CasA alone (Fig. S3.5) nor the combination CasA 
and CasCDE (not shown) displayed non-specific DNA binding. Because the mobility 
shift caused by Cascade or CasBCDE binding could be distinguished (Figs. 3.3A, 3.3C 
and S3.4), competition assays were performed between the two types of complexes. 
This showed that addition of target to a mix of equal amounts of Cascade and 
CasBCDE resulted in substantially more target DNA being bound by Cascade; a 
CasBCDE:Cascade ratio of 25:1 was required to distribute the target equally between 
the types of complexes (Fig. 3.4A). Furthermore, less dsDNA target was shifted by 
CasBCDE than Cascade at equivalent conditions (Figs. 3.3D and 3.3F), again indicating 
that CasA enhances target DNA localization. 
It appears that Cascade recognizes dsDNA targets by base pairing of the crRNA 
spacer sequence with the complementary DNA strand. Analysis of long dsDNA targets 
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Figure 3.3. Target recognition by Cascade. A-B) Effect of the type of crRNA bound. Cascade was loaded with 
either targeting crRNA (derived from the R44 CRISPR, Fig. S3.2) or non-targeting crRNA (derived from the K12 
CRISPR). The binding of these two types of Cascade complexes to one type of probe is shown. DNA probes are 86 
nucleotide ssDNA or dsDNA sequences containing the R44 protospacer (32 nucleotides), flanked by 27 nucleotides 
on either end C-H) Effect of uniform crRNA-loaded complexes (R44 CRISPR) on the binding of DNA probes with 
and without protospacer (denoted target and non-target, respectively). The binding of Cascade, CasBCDE and 
CasCDE to an 86 nucleotide target or non-target ss/dsDNA is shown. Non-target DNA probes contain a scrambled 
R44 protospacer sequence. I-J) Effect of uniform crRNA-loaded Cascade (R44 CRISPR) on the binding of target 
and non-target ssRNA and dsRNA. A-H) Labeled probe concentration 1 nM. DNA competitor concentration is 2500, 
500, 50, 5 and 0.5 ng/μl (the highest concentration was not used for CasCDE), protein concentration is 200-300 nM 
except in I-J where the Cascade concentration range is 200, 100, 50, 25 and 12.5 nM.
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(protospacer with 27 bp flanks) showed that both strands shifted (Fig. 3.4B) due to 
base pairing of the flanking regions. Only the complementary strand shifted when 
short dsDNA targets (corresponding to the protospacer) were used, indicating that 
crRNA base pairing with the complementary strand caused displacement of the non-
complementary strand (Fig. 3.4C). Cascade-mediated target DNA cleavage was not 
observed under any of the conditions tested. Binding to complementary ssRNA could 
be demonstrated (Fig. 3.3I), but this did not result in target RNA cleavage. In contrast 
Figure 3.4. A) Competition assay between R44 crRNA-loaded Cascade and CasBCDE for R44 ssDNA target. Total 
protein concentration is 500 nM in each reaction, and the Cascade:CasBCDE ratio is 1:0, 100:1, 10:1, 1:1, 1:10, 
1:100 and 0:1. When used, DNA competitor concentration is 1 mg/μl. B) Effect of labeling the complementary or 
non-complementary strand of a long dsDNA target containing the R44 protospacer with 27 bp flanks. C) as A) but 
with a short dsDNA target encompassing only the R44 protospacer. B-C) Cascade concentration range is 1500, 
300, 60 and 12.5 nM. 
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to dsDNA, no binding to dsRNA was observed (Fig. 3.3J). In addition, very little non-
specific interaction occurred between Cascade and ss- or dsRNA (Figs. 3.3I and 
3.3J). 
Subunit stoichiometry of Cascade
To understand the structural basis of the interaction between Cascade and target 
DNA, the composition of the Cascade protein assembly was determined using an 
array of mass spectrometric analyses. Denaturing and tandem mass spectrometry 
analyses resulted in accurate mass measurements for each component of Cascade 
(Table S3.1). The measured masses CasA, CasB and CasD were in agreement with 
the expected values, and the mass of CasC and CasE with the primary amino acid 
sequence lacking the N-terminal methionine. A complex composed of one copy of 
each Cascade component (CasA1B1C1D1E1/crRNA1) would have a mass of 184 kDa. 
However, analysis of the intact assembly by native mass spectrometry (Heck 2008) 
showed two major charge state distributions, corresponding to masses of 405,365 ± 
135 Da and 349,399 ± 84 Da (Fig. 3.5A and Table S3.1). A third low intensity charge 
Figure 3.5. For full colour version see page 129.  A) Native nano-ESI mass spectrum of Cascade. Two charge state 
distributions are present at high m/z values, corresponding to complexes of 405 kDa (purple) and 349 kDa (pink). 
The charge state distribution indicated in red indicates the CasB dimer. B) Cascade (sub-)complexes analyzed by 
native mass spectrometry. The sub-complexes were formed in solution after adding 5% 2-propanol to the buffer 
solution containing Cascade.
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state distribution around 2,200 m/z was observed with a mass of 42,524 ± 8 Da, which 
is close to the theoretical molecular weight of a CasB dimer (42,521 Da). Proteolytic 
removal of the affinity tag on CasB unambiguously confirmed the presence of two 
CasB copies (Fig. S3.6A). 
The two major complexes of 405 and 349 kDa likely resemble the intact Cascade and a 
Cascade sub-complex lacking CasA, in agreement with the mass difference of 55,966 
Da. The presence of this sub-complex suggests that at least one CasA copy is located 
at the periphery of Cascade with a rather low affinity. Tandem mass spectrometry 
experiments on intact Cascade ions revealed that CasA was the first subunit to be 
expelled from the complex under collisional activation conditions, again indicative 
of a peripheral position of CasA within the complex (Fig. S3.6B). In addition to the 
elimination of CasA, also the loss of CasC was observed by tandem mass spectrometry. 
Similarly, selection and activation of the 349 kDa Cascade sub-complex showed the 
loss of one CasD and up to two CasC subunits. Unfortunately, Cascade could not be 
further disrupted by tandem mass spectrometry, hampering the full assignment of its 
stoichiometry. Therefore a number of alternative strategies were devised. 
Since Cascade was loaded with a single type of crRNA (R44, Fig. S3.2), the number 
of bound crRNA molecules could be determined by adding a complementary ssDNA 
probe. The total molecular weight of Cascade increased by the mass of a single 
ssDNA-probe, indicating the presence of one accessible crRNA (Fig. 3.6C). For 
further characterization we used a combined approach of in solution and in gasphase 
dissociation of Cascade (Lorenzen et al. 2007; Zhou et al. 2008). By adding a low 
percentage of 2-propanol, Cascade was partially disrupted, resulting in a variety of 
Cascade sub-complexes (Fig. 3.5B, Table S3.2)). In addition to the intact Cascade 
(405 kDa), we also detected Cascade lacking CasA (349 kDa), and seven additional 
sub-complexes, the largest of which is a 307 kDa species. The difference between the 
349 kDa and 307 kDa sub-complexes is 42,442 Da and likely reflects the loss of the 
CasB dimer, which was previously observed (Fig. 3.5A). 
The apparent consecutive loss of five times a mass of around 40 kDa (from 307 
kDa down to 107 kDa) is directly evident from this catalogue of sub-complexes (Fig. 
3.5B). This implies that at least five CasC subunits are present in intact Cascade. 
This hypothesis was confirmed by subjecting each of these sub-complexes to tandem 
mass spectrometry (Table S3.2). In addition to CasD, CasE and one crRNA molecule, 
this analysis revealed the presence of even a sixth CasC subunit in the 107 kDa sub-
complex (Fig. 3.5B). Combining all mass spectrometry data resulted in a Cascade 
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stoichiometry of CasA1B2C6D1E1/crRNA1. The theoretical mass of this complex is in 
excellent agreement with the experimental mass (405,095 Da versus 405,365 ± 135 
Da), band intensities on protein gels (Fig. 3.1B), and elution profiles on a calibrated 
size exclusion column (Fig. 3.1E). Similar analyses of the purified sub-complexes 
revealed masses and compositions consistent with Cascade: 349 kDa for CasB2C6D1E1/
crRNA1 and 324 kDa for CasC6D1E1/crRNA1 (data not shown). The constituency of the 
complexes and the elimination of specific subunits in solution and under tandem mass 
spectrometry conditions reinforced the assignments of subunits in the structural model 
presented below. 
Structure of Cascade
First insights into the structural organization of Cascade were obtained by single 
particle electron microscopy (EM) and small angle X-ray scattering (SAXS). The 
Cascade complex is an elongated particle with no discernible symmetry. The particle 
has approximate dimensions of 10 x 20 nm, and resembles a seahorse with a curled-
up tail (Figs. 3.6A-C). The particle displays a striking indentation on one side which 
gives rise to the head and neck features of the seahorse. Three types of projection 
maps with minor variation were obtained for Cascade (Figs. 3.6A-C), indicative of a 
strong adsorption orientation preference on the carbon support film. In addition to DNA-
free Cascade, we also examined the structure of Cascade with target ssDNA bound, 
resulting in six diverse groups of projections in multiple adsorption orientations (Figs. 
3.6D-I). The comparison between DNA-free and DNA-bound Cascade projections in 
a similar orientation reveals differences in the head and back of the seahorse-shaped 
morphology of Cascade (Figs. 3.6J-L), which suggest that Cascade undergoes 
conformational changes upon target DNA binding. 
Subunit localization
Given the availability of stable sub-complexes of Cascade and knowing their subunit 
compositions allowed for the investigation of subunit localization within the Cascade 
structure. Some of the projections show a regularly shaped and evenly spaced feature 
with sharp edges that spans the torso of the complex (Fig. 3.6I). This repeated feature 
traverses the spine of this structure and is consistent with the six copies of CasC that 
are present in the complex and comprise the backbone of Cascade. The position of the 
target DNA recognition enhancing subunit CasA was determined from difference maps 
between target DNA bound forms of Cascade and Cascade lacking CasA (CasBCDE) 
(Figs. 3.6M-O). The analysis revealed that CasA is located in the curled-up tail of 
the seahorse (Fig. 3.6O). The position of CasB was identified using difference maps 
between target DNA bound CasBCDE and CasCDE complexes (Figs. 3.6P-R). Apart 
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Figure 3.6. Electron Microscopic structure of Cascade. A-C) Cascade projections showing an elongated par-
ticle with 20 x 10 nm dimensions. D-I) Cascade projections bound to target ssDNA. J-L) Difference map indicating 
morphological changes to the Cascade particle that result from target DNA binding (L). The difference map was 
generated from Cascade (J) and Cascade with target ssDNA bound (K). M-O) Difference map showing the location 
of the CasA subunit (O). The difference map was generated from Cascade (M) and CasBCDE (N) projection maps 
with target ssDNA bound. P-R) Difference map showing the location of the CasB subunit (R). The difference map 
was generated from CasBCDE (P) and CasCDE (Q) projection maps with target ssDNA bound. On average, each 
image is the sum of 1,500 single particle projections. The scale bar equals 10 nm. 
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from the six better resolved CasC subunits in these projections of CasBCDE and 
CasCDE (Figs. 3.6P and 3.6Q), the difference map showed one region compatible with 
two CasB copies (Fig. 3.6R), consistent with the CasB homodimer observed with mass 
spectrometry (Fig. 3.5A). The CasB dimer is contributing the nose to the seahorse-
shaped morphology of Cascade (Fig. 3.6R). 
In addition to the position of some of the subunits in the Cascade structure, we also 
investigated the topological constraints of Cascade. Protein pulldown experiments 
between CasC and one of the remaining Cascade components showed that CasB, 
CasD and CasE form stable two-component complexes with CasC, whereas CasA does 
not (Fig. S3.7). The association of this subunit with the CasC backbone is mediated by 
CasE (Fig. S3.7). 
Solution structure of Cascade
Ab initio small-angle x-ray scattering (SAXS)-based reconstruction of Cascade and 
Cascade bound to target DNA result in well-supported models (Fig. 3.7) that are of 
similar shape and size to what was observed by EM (Fig. 3.6). Scattering curves for 
Cascade (Fig. 3.7A) and Cascade bound to target DNA (Fig. 3.7B) were generated 
from data collected at two protein concentrations and include scattering vectors (q), 
ranging from 0.015 Å-1 to 0.127 Å-1 and 0.015 Å-1 to 0.133 Å-1 for the two complexes 
respectively. Guinier approximations of each curve estimates the radius of gyration 
(R(g)) for Cascade and for Cascade bound to target DNA at 5.6 nm. The pair-
distribution function (P(r), Fig. 3.7A and 3.7B), which is the frequency of interatomic 
vector lengths within the scattering particle and provides real-space information about 
the molecule shape, was calculated from the entire scattering curve I(q). This analysis 
indicates that the most frequently sampled interatomic distance is 5.6 nm for each of 
the two complexes, which is consistent with the R(g) estimated by the Guinier analysis. 
The SAXS models of Cascade and Cascade bound to target DNA were generated 
from a total of ten independent reconstructions for each complex. These individual 
reconstructions were in good agreement with one another and used to generate the 
average models (Fig. 3.7C and 3.7D) with resulting particle volumes of 1024 and 1235 
nm3, respectively. 
Cascade’s association with target DNA induces a conformational change that results 
in a shape with fewer prominent features, including the loss of the indentation on one 
side which gives rise to the head and neck features of the seahorse (Fig. 3.7D). These 
structural changes in Cascade involve regions of the complex assigned to CasB and 
CasC subunits. The conformational change is more apparent when the DNA-free and 
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Figure 3.7. Solution scattering model of Cascade obtained with Small-Angle X-ray Scattering. For full colour 
version see page 130.  Scattering data for Cascade were collected at 10 keV (1.24 Å λ) from two protein concentra-
tions, and include scattering vectors (q), ranging from A) 0.015 Å-1 to 0.127 Å-1 for Cascade and B) 0.015 Å-1 to 0.133 
Å-1 for Cascade bound to target DNA. The pair-distribution function (insert) indicates that the radius of gyration for 
both particles is ~5.6 nm. C) Ab initio reconstructions of Cascade reveal a seahorse shaped complex, consistent 
with EM imaging. D) DNA binding induces a conformational change in Cascade. E) Superposition of the solution 
structures of Cascade without (yellow) and with target DNA (mesh) suggest that regions of the complex assigned 
to the CasA and CasB are repositioned in the DNA bound state. Images have been rendered using Chimera (God-
dard et al. 2005). 
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DNA-bound models are superimposed (Fig. 3.7E). In addition to the loss of the nose-
shape feature consisting of CasB, which is so prominent in a DNA-free complex (Fig. 
3.6A and 3.7A) is gone in the DNA-bound state, and the CasA tail appears to be more 
extended in the DNA-bound form. These changes in shape are not a consequence of 
DNA-induced changes to the subunit stoichiometry of the complex, as determined by 
mass spectrometry, but are indicative of a ligand-induced conformational change. 
Discussion
Composition of Cascade
Cascade is a ribonucleoprotein complex in E. coli that plays a central role in CRISPR-
based defence against mobile genetic elements, such as phages and conjugative 
plasmids. Despite its crucial role as the main effector complex, very little is known 
about how the host counterattack is accomplished. Cascade has a mass of 405 kDa 
and consists of five proteins (CasA, CasB, CasC, CasD and CasE) and one guide 
RNA (Brouns et al. 2008). The core of the protein complex consists of six CasC (Cse4) 
subunits, presumably to provide a structural backbone for the other subunits and the 
crRNA. Given the presence of CasC-homologues (COG1857) in the majority of Cas 
subtypes (Cse4, Csd2, Csh2, Cst2, Csa2, Csy2) (Makarova et al. 2006), these proteins 
could be components of Cascade-like protein complexes from other microbes. The next 
most frequently found subunit of the complex is CasD (Cas5e), which belongs to the 
Cas5-type (Cas5e, Cas5d, Cas5h, Cas5t, Cas5a, Csy3) RAMP protein class (Repeat-
Associated Mysterious Proteins). This protein co-occurs with CasC-homologues in five 
subtypes (Makarova et al. 2006).   CasD is present in a single copy in Cascade and 
together with six CasC subunits and one CasE (Cse3) subunit part of a minimal Cascade 
core that accommodates a single mature crRNA. This minimal core is expanded by 
a dimer of CasB (Cse2), a positively charged protein (pI 9.2). A crystal structure of 
the CasB from Thermus thermophilus HB8 shows a strictly α- helical protein with a 
conserved basic surface patch that suggests a role in nucleic acid interactions (Agari 
et al. 2008). Cascade is completed by one copy of CasA (Cse1), the largest and most 
loosely attached subunit of the five. Gene synteny analysis of the various Cas gene 
clusters shows that CasA and CasB only occur in the Cse-subtype, and that the CasAB 
pair is substituted by other Cas proteins (e.g. Csy1) containing the CasCD core (van 
der Oost et al. 2009). 
The crRNA is remarkably stable when bound by Cascade or the CasBCDE and 
CasCDE sub-complexes, indicating that it is tightly associated with the CasCDE core 
of the protein complex and well shielded from cellular ribonuclease activities. Yet it 
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is sufficiently exposed to allow for base pairing with complementary nucleic acids. 
Interestingly, the length of the 5’ handle is conserved among crRNAs from E. coli, 
S. epidermidis and P. furiosus (Brouns et al. 2008; Carte et al. 2008; Marraffini and 
Sontheimer 2008), suggesting a general mechanism of binding. A recent study in S. 
epidermidis (Csm-type) showed that differential complementarity of the 5’-handle of 
the crRNA with the downstream protospacer flank allows discrimination between self 
DNA (the CRISPR) and non-self DNA (the target) (Marraffini and Sontheimer 2010b). 
While non-complementarity of the 5’-handle results in a sequence that is targeted, 
base pairing of at least nucleotide 5, 6 and 7 of the 5’-handle provides self protection 
(Marraffini and Sontheimer 2010b). In other CRISPR/Cas systems the regions flanking 
the protospacer (i.e. opposite of the 5’ or 3’-handle of the crRNA) often harbour short 
sequence motifs that are known as CRISPR motifs (Deveau et al. 2008; Horvath et al. 
2008) or protospacer adjacent motifs (PAM) (Mojica et al. 2009). The relevance of these 
short nucleotide sequences was originally shown in S. thermophilus by sequencing 
phages that had overcome host immunity by mutating a single nucleotide of the 
motif (Deveau et al. 2008). In E. coli this region contains the PAM sequence 5’-AWG-
protospacer-3’, which gives rise to non-basepaired rC:dT, rC:dW and a basepaired 
rG:dC between the sixth, seventh and eighth base of the 5’-handle, respectively (Fig. 
3.8A). This signature in the target DNA-Cascade complex might serve to verify that 
a target sequence has been located before downstream interference processes are 
commenced. 
The crRNA is further characterized by the presence of a 5’-hydroxyl group, as was 
observed for Cas6-generated crRNA (Carte et al. 2008). Eukaryotic small interfering 
RNA (siRNA) and microRNA (miRNA) by contrast need to be 5’-phosphorylated in order 
to bind to Argonaute and serve as a guide for the RNA-induced silencing complex (RISC) 
(Ma et al. 2005). E. coli crRNAs are unmodified, unlike plant siRNAs and miRNAs as 
Figure 3.8. For full colour version see page 130.  A) Schematic diagram of crRNA base paired to double stranded 
target DNA, indicating the local strand displacement, and the additional rG-dC basepair between the eighth base of 
the crRNA (rG) with the PAM (dC). B) Seahorse morphology and structural model of Cascade.
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well as vertebrate piwi-interacting RNAs for example, which are methylated at the 2’-
hydroxyl group of the 3’-terminal ribonucleotide to prevent uridylation and associated 
destabilization (Li et al. 2005; Houwing et al. 2007). The cyclic 2’,3’-phosphate of 
crRNA results from a metal ion-independent endonuclease activity on the 3’-side of the 
phosphodiester bond of pre-crRNA, as suggested previously (Carte et al. 2008). These 
initial pre-crRNA endonuclease cleavage products are the mature form of the crRNA 
in E. coli, in contrast to crRNAs from P. furiosus, S. solfataricus and S. epidermidis 
which are trimmed at the 3’-end (Hale et al. 2009; Lillestol et al. 2009; Marraffini and 
Sontheimer 2010b). It is worth mentioning that the cyclic phosphate 3’-end is not a 
substrate for E. coli poly(A) RNA polymerase (Zaug et al. 1996), and this explains 
why only shorter, apparently partly degraded crRNAs were cloned and sequenced 
previously (Brouns et al. 2008). 
Cascade targets DNA
Multiple lines of evidence suggest that crRNAs directly target invader DNA in the E. 
coli (Cse), S. epidermidis (Csm) and likely also S. thermophilus (Csn) model systems 
(Barrangou et al. 2007; Brouns et al. 2008; Marraffini and Sontheimer 2008). However, 
molecular evidence of Cas-effector complexes recognizing their target DNA has been 
lacking, limiting our understanding of how CRISPR/Cas systems operate. Binding 
studies showed that Cascade is guided by the crRNA to dsDNA sequences containing 
the protospacer without supplemented co-factors such as ATP. This surprising 
characteristic of Cascade is physiologically important, since most cellular and invader 
DNA is of double-stranded nature. The ATP-independence of this scanning process 
allows cells to continuously survey nucleic acids for crRNA matches without major energy 
investments. In addition to sequence-specific DNA recognition, Cascade also interacts 
non-specifically with DNA. Cascade sub-complexes lacking CasA, however, display 
only sequence-specific DNA recognition. Direct competition assays between Cascade 
and CasBCDE demonstrate the superiority of Cascade in locating the protospacer 
DNA, suggesting a role for CasA as an enhancer. Cascade thus appears to interact 
with DNA in two different modes, non-specifically via CasA and sequence-specifically 
via Watson-Crick base pairing of the crRNA (Fig. 3.8A). We hypothesize that the non-
specific affinity of Cascade for DNA enables Cascade to associate fast enough with 
incoming foreign DNA to neutralize a rapidly proliferating phage or conjugative plasmid 
in a cell. Further analysis showed that although Cascade exhibits little non-specific 
affinity for RNA, it binds complementary ssRNA as well. Base pairing of the crRNA 
with mRNA occurs when the coding strand of an invading nucleic acid is targeted. This 
could titrate out unpaired Cascade-bound crRNAs, reducing the effectiveness of the 
immune response when the coding strand is targeted (Brouns et al. 2008). Cascade 
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does not recognize a protospacer within a dsRNA molecule, indicating that the ability 
to locate protospacers in a nucleic acid duplex is restricted to dsDNA. Recently, a 
distinct Cas protein complex of the Cmr-subtype from P. furiosus was shown to cleave 
ssRNA complementary to the bound guide RNA (Hale et al. 2009), akin to RISC 
in eukaryotes. Target RNA hydrolysis takes place 14 bases from the 3’-end of the 
guide RNA, suggesting that target RNA cleavage occurs by a ruler mechanism. The 
difference in target nucleic acid - RNA or DNA - between the Cmr- and Cse-subtypes 
may illustrate the remarkable diversity present among CRISPR/Cas systems. 
Structural basis for target DNA recognition
Cascade displays an unusual seahorse-shaped architecture. The backbone of this 
structure is composed of six CasC subunits that are arranged in an arch, representing 
the torso of the Cascade particle. CasC only assembles into this stable hexameric 
arrangement in the presence of CasD, CasE and crRNA. Although the location of these 
latter three components in the structure could not be determined by direct methods, 
mass spectrometry showed the existence of a 107 kDa 2-propanol-induced sub-
complex containing single copies of CasC, CasD, CasE and crRNA (Fig. 3.5B). This 
subassembly of Cascade implies that these four components are in close proximity of 
each other. Further disassembly of Cascade reveals a CasE-crRNA particle, suggesting 
that CasE holds on tightly to the crRNA after pre-crRNA cleavage. Despite the fact that 
the location of the crRNA remains unclear, we expect that the 61 nucleotide molecule 
is bound by a substantial part of Cascade. In an unpaired state, the crRNA likely 
experiences some conformational flexibility, whereas in a DNA base-paired state, the 
conformation of the spacer sequence is constrained by the formation of the RNA:DNA 
hybrid helix, which in contrast to the B-type dsDNA helix is close to A-type (Noy et al. 
2005). This constraint might induce the conformational change observed in the EM 
and SAXS structures of Cascade, and may serve to recruit Cas3, which is required for 
neutralizing the targeted invader. The length of the 32 bp spacer sequence base paired 
to its target ssDNA is approximately 8.2 nm. Together with the 5’ and 3’ handles, the 
crRNA could be up to 10 nm in length. 
These combined observations result in a structural model in which the position of CasA, 
CasB and CasC can be assigned with confidence, contributing the curled-up tail, nose 
and torso of the seahorse, respectively (Fig. 3.8B). The model predicts that CasD, 
CasE and at least part of the crRNA are located in the main body of Cascade at the tail-
end of the CasC spine, in the proximity of CasA. The crRNA could also be bound along 
the spine of the CasC backbone and in this way define the number of CasC subunits 
by the length of the crRNA. 
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In conclusion, Cascade is a highly unusual ribonucleoprotein complex capable of 
specifically recognizing double stranded invader DNA archived in the CRISPR blacklist. 
The direct attack on invader DNA rather than its RNA transcripts may be a defence 
strategy that enables prokaryotes to neutralize the invasive source of selfish genetic 
elements effectively. 
Methods
Protein production and purification
Cascade complexes were produced and purified as described previously (Brouns et 
al. 2008), using the expression plasmids listed in Table S3.3. Cascade was routinely 
purified with an N-terminal Strep-tag II fused to CasB (or CasC in CasCDE). Size 
exclusion chromatography (Superdex 200 HR 10/30 (GE)) was performed using 20 
mM Tris-HCl (pH 8.0), 0.1 M NaCl, 1 mM dithiotreitol. Cascade preparations (~0.3 
mg) were incubated with DNase I (Invitrogen) in the presence of 2.5 mM MgCl2 for 15 
min at 37 °C prior to size exclusion analysis. Copurified nucleic acids were isolated by 
extraction using an equal volume of phenol:chloroform:isoamylalcohol (25:24:1) pH 
8.0 (Fluka), and incubated with either DNase I (Invitrogen) supplemented with 2.5 mM 
MgCl2 or RNase A (Fermentas) for 10 min at 37 ºC. 
Lambda phage infection
Plaque assays were performed using bacteriophage Lambda and the efficiency of 
plaquing (EOP) was calculated as described previously (Brouns et al. 2008).
HPLC purification of crRNA
All samples were analyzed by ion-pair reversed-phased-HPLC on an Agilent 1100 
HPLC with UV260nm detector (Agilent) using a DNAsep column 50 mm × 4.6 mm I. D. 
(Transgenomic, San Jose, CA). The chromatographic analysis was performed using 
the following buffer conditions: A) 0.1 M triethylammonium acetate (TEAA) (pH 7.0) 
(Fluka); B) buffer A with 25% LC MS grade acetonitrile (v/v) (Fisher). The crRNA was 
obtained by injecting purified intact Cascade at 75 °C using a linear gradient starting 
at 15% buffer B and extending to 60% B in 12.5 min, followed by a linear extension 
to 100% B over 2 min at a flow rate of 1.0 ml/min. Hydrolysis of the cyclic phosphate 
terminus was performed by incubating the HPLC-purified crRNA in a final concentration 
of 0.1 M HCl at 4 ºC for 1 hour. The samples were concentrated to 5-10 μl on a vacuum 
concentrator (Eppendorf) prior to ESI-MS analysis. 
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ESI-MS analysis of crRNA
Electrospray Ionization Mass spectrometry was performed in negative mode using 
an UHRTOF mass spectrometer (maXis) or an HCT Ultra PTM Discovery instrument 
(both Bruker Daltonics), coupled to an online capillary liquid chromatography system 
(Ultimate 3000, Dionex, UK). RNA separations were performed using a monolithic 
(PS-DVB) capillary column (200 mm ´ 50 mm I.D., Dionex, UK). The chromatography 
was performed using the following buffer conditions: C) 0.4 M 1,1,1,3,3,3,-Hexafluoro-
2-propanol (HFIP, Sigma- Aldrich) adjusted with triethylamine (TEA) to pH 7.0 and 
0.1 mM TEAA, and D) buffer C with 50% methanol (v/v) (Fisher). RNA analysis was 
performed at 50 ºC with 20% buffer D, extending to 40% D in 5 min followed by a linear 
extension to 60% D over 8 min at a flow rate of 2 μl/min. 
Protein and Native Mass spectrometry
Cascade was analyzed in 0.15 M ammonium acetate (pH 8.0) at a protein concentration 
of 5 μM. This protein preparation was obtained by five sequential concentration and 
dilution steps at 4 ºC using a centrifugal filter with a cut-off of 10 kDa (Millipore). Proteins 
were sprayed from borosilicate glass capillaries and analyzed on a LCT electrospray 
time-of-flight or modified quadrupole time-of-flight instruments (both Waters, UK) 
adjusted for optimal performance in high mass detection (Tahallah et al. 2001; van 
den Heuvel et al. 2006). Exact mass measurements of the individual Cas proteins 
were acquired under denaturing conditions (50% acetonitrile, 50% MQ, 0.1% formic 
acid). Sub-complexes in solution were generated by the addition of 2-propanol to the 
spray solution to a final concentration of 5% (v/v). Instrument settings were as follows; 
needle voltage ~1.2 kV, cone voltage ~175 V, source pressure 9 mbar. Xenon was 
used as the collision gas for tandem mass spectrometric analysis at a pressure of 1.5 
10-2 mbar. The collision voltage varied between 10-200 V. 
Electrophoretic mobility shift assays (EMSA)
EMSA was performed by incubating Cascade, CasBCDE or CasCDE with 1nM labelled 
nucleic acid in 50 mM Tris-Cl pH 7.5, 100 mM NaCl. Salmon sperm DNA (Invitrogen) was 
used as competitor. The EMSA reactions were incubated at 37 °C for 20-30 min prior 
to electrophoresis on 5% polyacrylamide gels. The gels were dried and analyzed using 
a PMI phosphor imager (Bio-Rad). DNA targets were gel-purified long oligonucleotides 
(Isogen Life Sciences or Biolegio), listed in Table S3.3. The oligonucleotides were 
end-labelled using γ 32P-ATP (PerkinElmer) and T4 kinase (Fermentas). Double-
stranded DNA targets were prepared by annealing complementary oligonucleotides 
and digesting remaining ssDNA with Exonuclease I (Fermentas). Labelled RNA targets 
were in vitro transcribed using T7 Maxiscript or T7 Mega Shortscript kits (Ambion) with 
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α 32P-CTP (PerkinElmer) and removing template by DNase I (Fermentas) digestion. 
Double stranded RNA targets were prepared by annealing complementary RNAs and 
digesting surplus ssRNA with RNase T1 (Fermentas), followed by phenol extraction. 
Electron microscopy
Purified protein samples were negatively stained with 2% uranyl acetate on glow-
discharged carbon-coated copper grids. R44 target ssDNA (BG3028, Table S3.3) was 
added to Cascade sub-complexes loaded with R44 crRNA in a two-fold excess at least 
5 min prior to sample preparation. Electron microscopy was performed on a Philips 
CM120 equipped with a LaB6 tip operating at 120 kV. Images were recorded with a 
Gatan 4000 SP 4K slow-scan CCD camera at 130,000× magnification at a pixel size 
(after binning the images) of 0.23 nm at the specimen level with GRACE software for 
semi-automated specimen selection and data acquisition (Oostergetel et al. 1998). 
Single particle projections were selected from micrographs mainly by reference-based 
automated particle selection procedure incorporated into GRIP (GRoningen Image 
Processing) software (van Heel et al. 2000). Approximately 400,000 single particles 
were selected and extracted from 17,000 electron micrographs. Single particle data 
sets were analyzed with the GRIP software using multi-reference alignments and 
no-reference alignments, multivariate statistical analysis, and hierarchical ascendant 
classification. The final two-dimensional projection maps were calculated from the 
best resolved classes by summing the best 5–20% of the projections based on the 
correlation coefficient determined in the alignment step. 
Small Angle X-ray Scattering
SAXS data were collected at the Advanced Light Source (Lawrence Berkeley National 
Laboratory) on beamline 7.3.3. Solution scattering of Cascade was collected at room 
temperature (~22 °C) using at least two different concentrations (between 1 mg/
ml and 18 mg/ml) in a 20 μl sample at 10 keV (1.24 Å λ). The sample-to-detector 
distance was set to 3056.69 m resulting in scattering vectors (q) ranging from 0.012 
Å-1 to 0.127 Å-1 for Cascade, and 0.0147 Å-1 to 1.334 Å-1 for Cascade bound to target 
DNA. Scatter plots for the low and high concentrations were merged and background 
subtracted using PRIMUS (Konarev et al. 2003). One-dimensional scatter curves were 
transformed and distance distribution functions P(r) were calculated using GNOM 
(Svergun 1992). The pair-distribution function P(r), the frequency of interatomic vector 
lengths within the scattering particle, was calculated from the entire scattering curve 
I(q), by an indirect Fourier transform using GNOM. Ten independent models of each 
complex were generated using a simulated annealing method in DAMMIF (Franke 
and Svergun 2009). Ab initio reconstructions for each complex were aligned, filtered 
59
Structural baSiS fOr criSPr rna-guided dna recOgnitiOn by caScade
3
and averaged based on occupancy using DAMAVER (Volkov and Svergun 2003). The 
SAXS bead models were converted to volumetric format using the pdb2vol convolution 
kernel in the Situs software package (Wriggers et al. 1999). Volumes were calculated 
using VOIDOO (Kleywegt and Jones 1994). 
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Supplementary figures
Figure S3.1. All Cascade subunits are required for immunity. The efficiency of plaquing (EOP) was determined 
in E. coli BL21-AI containing complete Cascade, phage λ-targetting T1-4 CRISPR (see Fig. S3.2) and Cas3 (Brouns 
et al. 2008), and for strains expressing Cascade sub-complexes lacking one of the Cas proteins. Host strain E. coli 
BL21-AI does not contain cas genes (Barrick et al. 2009). Error bars indicate one standard deviation.
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3 Figure S3.2. CRISPRs used in this study. A) Phage λ genome map indicating the main genes and transcripts (dotted arrows), and the positions of the protospacers on the coding or template strand. B) Schematic overview of CRISPRs used in this study (repeats: diamonds, spacers: rectangles). The N CRISPR was designed as a non-
targeting control containing the naturally occurring spacers 1, 3, 5, and 7 from E. coli K12, which have no homol-
ogy to any known phage (Brouns et al. 2008). The number of plaque forming units obtained in the presence of this 
CRISPR was used to calculate the efficiency of plaquing (Fig. S3.1). The uniform CRISPR R44 was designed based 
on a natural spacer at the second position of the CRISPR in E. coli R44 (ECOR44) (Ochman and Selander, 1984; 
Mojica et al. 2005). This spacer was derived from the upfA gene of phage P1. The R44 CRISPR was designed such 
that the spacer was repeated seven times. The sequences of the CRISPRs are provided below.
K12 CRISPR, pWUR396
GCGTACCATGGCATAAGGAAATGTTACATTAAGGTTGGTGGGTTGTTTTTATGGGAAAAAATGCTTTAAGAACAAATGTATACTTTTAGAGAGT
TCCCCGCGCCAGCGGGGATAAACCGCTTTCGCAGACGCGCGGCGATACGCTCACGCAGAGTTCCCCGCGCCAGCGGGGATAAACCGCAGCCGAA
GCCAAAGGTGATGCCGAACACGCTGAGTTCCCCGCGCCAGCGGGGATAAACCGGGCTCCCTGTCGGTTGTAATTGATAATGTTGAGAGTTCCCC
GCGCCAGCGGGGATAAACCGTTTGGATCGGGTCTGGAATTTCTGAGCGGTCGCGAGTTCCCCGCGCCAGCGGGGATAAACCGCGAATCGCGCAT
ACCCTGCGCGTCGCCGCCTGCGAGTTCCCCGCGCCAGCGGGGATAAACCGTCAGCTTTATAAATCCGGAGATACGGAAACTAGAGTTCCCCGCG
CCAGCGGGGATAAACCGGACTCACCCCGAAAGAGATTGCCAGCCAGCTTGAGTTCCCCGCGCCAGCGGGGATAAACCGCTGCTGGAGCTGGCTG
CAAGGCAAGCCGCCCAGAGTTCCCCGCGCCAGCGGGGATAAACCGGGGGGCGCATGACCGTAAACATTATCCCCCGGGAGTTCCCCGCGCCAGC
GGGGATAAACCGGGAGTTCAGACATAGGTGGAATGATGGACTACGAGTTCCCCGCGTTAGCGGGGATAAACCGCCCGGTAGCCAGGTTTGCAAC
GCCTGAACCGAGAGTTCCCCGCGCCAGCAGGGATAAACCGGCAACGACGGTGAGATTTCACGCCTGACGCTGGGTACCGGACC
Non-targeting CRISPR (N), pWUR477
GGCGCGCCATGGAAACAAAGAATTAGCTGATCTTTAATAATAAGGAAATGTTACATTAAGGTTGGTGGGTTGTTTTTATGGGAAAAAATGCTTT
AAGAACAAATGTATACTTTTAGAGAGTTCCCCGCGCCAGCGGGGATAAACCGCTTTCGCAGACGCGCGGCGATACGCTCACGCAGAGTTCCCCG
CGCCAGCGGGGATAAACCGCAGCCGAAGCCAAAGAATTCGCCGAACACGCTGAGTTCCCCGCGCCAGCGGGGATAAACCGGGCTCCCTGTCGGT
TGTAATTGATAATGTTGAGAGTTCCCCGCGCCAGCGGGGATAAACCGTTTGGATCGGGTCTGGATCCTCTGAGCGGTCGGAGTTCCCCGCGCCA
GCGGGGATAAACCGCGAATCGCGCATACCCTGCGCGTCGCCGCCTGGAGTTCCCCGCGCCAGCGGGGATAAACCGTCAGCTTTATAAATATGCA
TATACGGAAACTAGAGTTCCCCGCGCCAGCGGGGATAAACCGGACTCACCCCGAAAGAGATTGCCAGCCAGCTTGAGTTCCCCGCGCCAGCGGG
GATAAACCGCAGCTCCCATTTTCAAACCCATCAAGACGCGGTACCTTAATTAA
Template CRISPR (T1-4), pWUR478GGCGCGCCATGGAAACAAAGAATTAGCTGATCTTTAATAATAAGGAAATGTTACATTAAGGTTGGTGGGTTGTTTTTATGGGAAAAAATGCTTT
AAGAACAAATGTATACTTTTAGAGAGTTCCCCGCGCCAGCGGGGATAAACCGCTGAGTGTGATCGATGCCATCAGCGAAGGGCCGAGTTCCCCG
CGCCAGCGGGGATAAACCGCAGCCGAAGCCAAAGAATTCGCCGAACACGCTGAGTTCCCCGCGCCAGCGGGGATAAACCGCAAGCAACAGGCAG
GCGTGACAGCCAGCAAACGAGTTCCCCGCGCCAGCGGGGATAAACCGTTTGGATCGGGTCTGGATCCTCTGAGCGGTCGGAGTTCCCCGCGCCA
GCGGGGATAAACCGTGGGATGCCTACCGCAAGCAGCTTGGCCTGAAGAGTTCCCCGCGCCAGCGGGGATAAACCGTCAGCTTTATAAATATGCA
TATACGGAAACTAGAGTTCCCCGCGCCAGCGGGGATAAACCGTGACAAGTCCACGTATGACCCGACCGACGATAGAGTTCCCCGCGCCAGCGGG
GATAAACCGCAGCTCCCATTTTCAAACCCATCAAGACGCGGTACCTTAATTAA
ECOR44-1.2 (7x), pWUR547
CCTGCATTAGGTAATACGACTCACTATAGGATAAACCGACGGTATTGTTCAGATCCTGGCTTGCCAACAGGAGTTCCCCGCGCCAGCGGGGATA
AACCGACGGTATTGTTCAGATCCTGGCTTGCCAACAGGAGTTCCCCGCGCCAGCGGGGATAAACCGACGGTATTGTTCAGATCCTGGCTTGCCA
ACAGGAGTTCCCCGCGCCAGCGGGGATAAACCGACGGTATTGTTCAGATCCTGGCTTGCCAACAGGAGTTCCCCGCGCCAGCGGGGATAAACCG
ACGGTATTGTTCAGATCCTGGCTTGCCAACAGGAGTTCCCCGCGCCAGCGGGGATAAACCGACGGTATTGTTCAGATCCTGGCTTGCCAACAGG
AGTTCCCCGCGCCAGCGGGGATAAACCGACGGTATTGTTCAGATCCTGGCTTGCCAACAGGAGTTCCCCGCGCCAGCGGGGATAAACCGGGTAC
C
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A)
5’OH–AUAAACCGACGGUAUUGUUCAGAUCCUGGCUUGCCAACAGGAGUUC-
CCCGCGCCAGCGGGG–2’, 3’-P
B)
C)
Sequence Position Theoretical mass (Da) Experimental mass (Da)
AUAAACCGp A1:G8 2596.597 2596.2
ACGp A9:G11 997.617 997.1
UAUUGp U13:G17 1610.94 1610.1
UUCAGp U18:G22 1609.955 1609.3
AUCCUGp A23:G28 1915.139 1914.9
CUUGp C30:G33 1280.745 1280.2
CCAACAGp C34:G40 2266.403 2266.1
AGp A42:G43 692.433 692.1
UUCCCCGp U44:G50 2196.298 2195.3
CCAGp C53:G56 1302.801 1302.3
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D)
E)
Sequence Position Theoretical mass (Da) Experimental mass (Da)
AUp A1:U2 / A14:U15 653.393 653.1
AAACp A3:C6 1310.826 1310.4
GACp / AGCp G8:C10 / A55:C57 997.617 997.1
GGUp G11:U13 1014.602 1014.2
GUp G17:U18 669.393 669.0
AGAUp A21:U24 1327.811 1327.3
GGCp G28:C30 1013.617 1013.4
AACp A36:C38 981.617 981.2
AGGAGUp A39:U44 2018.229 2017.7
GGGGp G58:G61 1398.851 1398.4
GGGG^p G58:G61 1380.836 1380.4
Figure S3.3. RNase digests of the crRNA. A) Sequence of mature crRNA with the R44 spacer sequence shaded, 
and the hairpin underlined. B) Base peak chromatogram of the RNase T1 digest of mature crRNA. The predominant 
oligoribonucleotide peaks assigned to the mature crRNA are highlighted. C) Summary of the identified oligoribo-
nucleotides assigned to mature crRNA from the RNase T1 digest. D) Base peak chromatogram of the RNase A 
digest of mature crRNA. The predominant oligoribonucleotide peaks assigned to the mature crRNA are highlighted. 
E) Summary of the identified oligoribonucleotides assigned to mature crRNA from the RNase A digest. ^ indicates 
cyclic 2’,3’-phosphate.
MS analysis of RNase digests. RNase T1 and RNase A digests of mature crRNA was performed using an ESI-MS/
MS using a HCT Esquire Quadruple Ion Trap (Bruker Daltonics) coupled to a Dionex. The oligoribonucleotide mix-
ture was separated on a PepMap C-18 RP capillary column (300 μm x 150 mm I.D., Dionex, UK) at 50 °C using 
a gradient condition starting at 20% buffer D (0.4 M 1,1,1,3,3,3,-Hexafluoro-2-propanol (Sigma-Aldrich) adjusted 
with triethylamine (TEA) to pH 7.0, 0.1 mM TEAA, and 50% methanol (v/v) (Fisher)) and extending to 35% D in 20 
min at a flow rate of 2 μl /min. The mass spectrometer was set select a mass range of 250−1500 m/z and the capil-
lary voltage was kept at -3650 V. Oligoribonucleotides with -2 to -4 charge states were selected for tandem mass 
spectrometry using collision induced dissociation. The theoretical masses of the crRNA and predicted digests were 
determined using the Mongo Oligo Mass Calculator.
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Figure S3.4. Native PAGE of Cascade-target DNA complexes. Coomassie-blue stained native PAGE analysis 
of Cascade and sub-complexes binding ssDNA oligonucleotides complementary to the R44 crRNA (BG3028, see 
Table S3.3). The gel shows the increased migration rates of Cascade complexes loaded with uniform R44 crRNA 
in the presence their complementary target ssDNA due to the additional charge negative charge of the ssDNA. By 
contrast, the migration rate of Cascade loaded with different crRNAs derived from the E. coli K12 CRISPR I array 
that does not contain the R44 spacer is not affected. In addition, differences in migration rates of the various com-
plexes (Cascade, CasBCDE and CasCDE) are visible. 
Figure S3.5. CasA complementation of non-specific DNA binding. Binding ability of uniform crRNA-loaded 
(R44) Cascade, CasBCDE + CasA, CasBCDE and CasA to non-target ssDNA is shown. While CasA does not ex-
hibit non-specific DNA binding on by itself, it is able to restore the non-specific DNA binding of CasBCDE.
64
chaPter 3
3
Figure S3.6. For full colour version see page 131. A) Native mass spectrum of Cascade after treatment with HRV3C 
protease. A dominant species with a mass of 401,279 Da (blue triangle) was observed, confirming the presence of 
two copies of CasB in the intact assembly. Indicated by the green triangles is the complex lacking CasA. B) Tandem 
mass spectrum of the 42+ ion of Cascade. Besides the dissociation of CasA (green) also CasC (orange) dissoci-
ated from the complex. The complex lacking CasA further expels a CasC subunit to form a 310 kDa Cascade sub-
complex (blue). The low m/z region of the spectrum shows the dissociated CasA, CasC and CasD proteins. Over-
lapping peaks of two different complexes are indicated by two colours. C) Native mass spectrum of Cascade bound 
to the ssDNA-probe. The mass of the complex increased by 10,201 Da, indicating the presence of one crRNA per 
Cascade. The inset shows the same spectrum after energetically activating the Cascade-ssDNA probe complex. 
The charge state distribution for the ssDNA probe is centred around 2,000 m/z.
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3Figure S3.7. Interactions between individual Cascade subunits. Composite of Coomassie blue-stained SDS-polyacrylamide gels and Western blots of affinity purified tagged Cascade subunits (underlined) co-expressed with untagged Cascade subunits and pre-crRNA. All subunits directly interact with CasC except CasA, which interacts with CasE. Western blots were probed with anti-Cascade antibodies. Note that the N-terminal Strep-tagged Cas-
cade subunits migrate slower through the gel than the untagged proteins.
Western blotting. The purified proteins transferred to nitrocellulose membrane (Perkin-Elmer), and incubated for 
1 h in Phosphate Buffered Saline (PBS) blocking buffer pH 7.5, supplemented with 0.1% Tween 20 and 5% milk 
powder. The membranes were incubated with anti-Cascade serum raised in rabbits (Eurogentec, Belgium) (1:1000) 
in blocking buffer for 12 h, followed by three 15 min wash steps in PBS supplemented with 0.1% Tween 20. The 
membrane was then incubated with HRP-conjugated anti-rabbit antibodies (GE) (1:5000) in wash buffer for 1 h, 
followed by three 15 min wash steps. Photographic film detection (KODAK) of the signal was performed using ECL-
plus substrate (GE).
Supplementary Tables
Table S3.1. Exact masses of individual Cas protein subunits of Cascade. The masses of the Cascade (sub-) 
complexes observed under native mass spectrometry conditions are also listed.
Cascade component Theoretical Mass (Da) Experimental Mass (Da)
CasA 55,972.4 55,972.2 ± 14.8
CasB with tag 21,260.4 21,261.5 ± 1.1
CasB without tag 19,204.0 19,201.9 ± 1.8
CasC 39,894.4 39,896.3 ± 1.3
CasD 25,208.9 25,210.4 ± 3.8
CasE 22,364.1 22,364.7 ± 1.1
crRNA 19,660.8 19,708a
Complex Theoretical Mass (Da) Experimental Mass (Da)
Cascade 405,095 405,365 ± 135
Cascade without CasA 349,122 349,399 ± 84
CasB dimer 42,521 42,524 ± 8
a The mass of crRNA was indirectly calculated via tandem mass spectrometry analysis of CasE-crRNA. Since only 
dissociation products for CasE were observed after collisional activation no standard deviation can be calculated 
for the mass of crRNA.
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Table S3.2. List of masses for all Cascade (sub)complexes present in solution, and their dissociated products that 
are formed in the gas phase after collisional activation during tandem mass spectrometry experiments. In addi-
tion for each complex the theoretical mass (based on amino acid sequence and a crRNA mass of 19,662 Da) and 
stoichiometric information is given. (A=CasA, B=CasB, C=CasC, D=CasD, E=CasE, minus (-) indicates the lacking 
subunit, n.d.is not determined. 
Mass of (sub) 
complexes in 
solution (Da)
Mass products 
(Da)
Theoretical 
mass (Da) Annotation
Stoichiometry
A  B  C  D  E  crRNA
405,256 405,095 Cascade 1  2  6  1  1  1
365,316 365,200 Cascade-CasC 1  2  5  1  1  1
349,384 349,122 Cascade-CasA 0  2  6  1  1  1
55,950 55,972 CasA 1  0  0  0  0  0
39,941 39,894 CasC 0  0  1  0  0  0
349,333 349,122 Cascade-CasA 0  2  6  1  1  1
324,389 323,914 Cascade-CasA-CasD 0  2  6  0  1  1
309,644 309,228 Cascade-CasA-CasC 0  2  5  1  1  1
270,031 269,334 Cascade-CasA-2•CasC 0  2  4  1  1  1
39,946 39,894 CasC 0  0  1  0  0  0
25,231 25,209 CasD 0  0  0  1  0  0
306,932 306,602 Cascade-CasA-2•CasB 0  0  6  1  1  1
281,915 281,393 Cascade-CasA-2•CasB-CasD 0  0  6  0  1  1
267,215 266,707 Cascade-CasA-2•CasB-CasC 0  0  5  1  1  1
227,267 226,813 Cascade-CasA-2•CasB-2•CasC 0  0  4  1  1  1
39,935 39,894 CasC 0  0  1  0  0  0
25,250 25,209 CasD 0  0  0  1  0  0
267,076 266,707 Cascade-CasA-2•CasB-CasC 0  0  5  1  1  1
241,503 241,498 Cascade-CasA-2•CasB-CasC-CasD 0  0  5  0  1  1
226,673 226,813 Cascade-CasA-2•CasB-2•CasC 0  0  4  1  1  1
39,928 39,894 CasC 0  0  1  0  0  0
25,227 25,209 CasD 0  0  0  1  0  0
227,127 226,813 Cascade-CasA-2•CasB-2•CasC 0  0  5  1  1  1
202,019 201,604 Cascade-CasA-2•CasB-2•CasC-CasD 0  0  4  0  1  1
187,241 186,918 Cascade-CasA-2•CasB-3•CasC 0  0  3  1  1  1
39,946 39,894 CasC 0  0  1  0  0  0
187,352 186,918 Cascade-CasA-2•CasB-3•CasC 0  0  3  1  1  1
161,882 161,710 Cascade-CasA-2•CasB-3•CasC-CasD 0  0  3  0  1  1
147,087 147,024 Cascade-CasA-2•CasB-4•CasC 0  0  2  1  1  1
39,910 39,894 CasC 0  0  1  0  0  0
25,218 25,209 CasD 0  0  0  1  0  0
147,210 147,024 Cascade-CasA-2•CasB-4•CasC 0  0  2  1  1  1
121,869 121,815 Cascade-CasA-2•CasB-4•CasC-CasD 0  0  2  0  1  1
n.d. 107,130 Cascade-CasA-2•CasB-5•CasC 0  0  1  1  1  1
39,916 39,894 CasC 0  0  1  0  0  0
25,219 25,209 CasD 0  0  0  1  0  0
107,431 107,130 Cascade-CasA-2•CasB-5•CasC 0  0  1  1  1  1
84,696 84,766 Cascade-CasA-2•CasB-5•CasC-CasE 0  0  1  1  0  1
22,375 22,364 CasE 0  0  0  0  1  0
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Table S3.3. Strains, plasmids and primers used in this study 
Strains Description Source
E.coli BL21(DE3) F- ompT gal dcm lon hsdSB(rB -mB -) λ(DE3 [lacI lacUV5-T7 gene 1 ind1 
sam7 nin5])
Novagen
E.coli BL21-AI F- ompT gal dcm lon hsdSB(rB -mB -) araB::T7RNAP-tetA Invitrogen
E.coli NEB5α fhuA2 _(argF-lacZ)U169 phoA glnV44 Φ80_ (lacZ)M15 gyrA96 
recA1 relA1 endA1 thi-1 hsdR17
New England Biolabs
E.coli DH5α F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG Φ80dlacZΔM15 
Δ(lacZYA-argF)U169, hsdR17(rK -mK +), λ– 
Plasmids Description and order of genes (5’-3’) Restriction sites Primers Source
pET-52b(+) T7 RNA polymerase based expression vector, AmpR Novagen 
pRSF-1b T7 RNA polymerase based expression vector, KanR Novagen 
pCDF-1b T7 RNA polymerase based expression vector, StrR Novagen 
pACYC
duet-1 T7 RNA polymerase based expression vector, Cam
R Novagen 
pWUR381 cas3 in pET-52b with both Strep-tag II (N-term) and His10-tag (C-term) BamHI/NotI
BG2243 + 
BG2244 This study
pWUR388 casA in pET-52b with both Strep-tag II (N-term) and His10-tag (C-term) (Brouns et al. 2008)
pWUR396 E. coli K12 CRISPR in pACYCDuet-1, see Fig S3.2 (Brouns et al. 2008)
pWUR397 cas3 in pRSF-1b, no tags (Brouns et al. 2008)
pWUR400 casA-casB-casC-casD-casE in pCDF-1b, no tags (Brouns et al. 2008)
pWUR401 casB-casC-casD-casE in pCDF-1b, no tags (Brouns et al. 2008)
pWUR402 casC-casD-casE in pCDF-1b, no tags (Brouns et al. 2008)
pWUR403 casD-casE in pCDF-1b, no tags (Brouns et al. 2008)
pWUR404 casE in pCDF-1b, no tags (Brouns et al. 2008)
pWUR405 casA-casB-casC-casD in pRSF-1b, no tags (Brouns et al. 2008)
pWUR406 casA-casB-casC in pRSF-1b, no tags (Brouns et al. 2008)
pWUR407 casA-casB in pRSF-1b, no tags (Brouns et al. 2008)
pWUR408 casA in pRSF-1b, no tags (Brouns et al. 2008)
pWUR413 casD in pRSF-1b, no tags NcoI/NotI BG2466 + BG2482 This study
pWUR477 non targeting CRISPR in pACYCDuet-1 (N), see Fig S3.2 (Brouns et al. 2008)
pWUR478 template CRISPR in pACYCDuet-1 (T1-4), see Fig S3.2 (Brouns et al. 2008)
pWUR479 coding CRISPR in pACYCDuet-1 (C1-4) (Brouns et al. 2008)
pWUR480 casB with Strep-tag II (N-term)-casC-casD in pET52b (Brouns et al. 2008)
pWUR482 casE in pET52-1b, with Strep-tag II (N-term) BamHI/NotI BG2586 + BG2253 This study
pWUR514 casB with Strep-tag II (N-term)-casC-casD-CasE in pET52b Acc65I/NotI
BG2573 + 
BG2586 This study
pWUR547 E. coli R44 CRISPR, 7x spacer nr. 2, in pACYCDuet-1, see Fig S3.2 EcoNI/Acc65I
(Mojica et al. 2005), 
Geneart, Germany
pWUR553 casB in pET52-1b, with Strep-tag II (N-term) Acc65I/NotI BG2573 + BG2484 This study
pWUR554 casC in pCDF-1b, no tags NcoI/NotI BG2465 + BG2483 This study
pWUR555 casC in pET52-1b, with Strep-tag II (N-term) BamHI/NotI BG2249 + BG2483 This study
68
chaPter 3
3
Table S3.3. continued
Experiment Primer Sequence (5’-3’) Description
Cloning
BG2243 GCGCGGGATCCTATGGAACCTTTTAAATATATATGCC cas3 + BamHI (fw)
BG2244 GGCCCGCGGCCGCTTTGGGATTTGCAGGGATGACT cas3 + NotI (rv)
BG2249 GCGCGGGATCCTATGTCTAACTTTATCAATATTCATGT casC + BamHI (fw)
BG2253 GCGCGGGATCCTATGTATCTCAGTAAAGTCATCATTG casE + BamHI (fw)
BG2316 GCGCGGGTACCAGATGAGATCTTATTTGATCTTGCGG casD + Acc65I (fw)
BG2465 GCGCGCCATGGCTATGTCTAACTTTATCAATATTCATGT casC + NcoI (fw)
BG2466 GCGCGCCATGGCTATGAGATCTTATTTGATCTTGCGG casD + NcoI (fw)
BG2482 GGCCCGCGGCCGCTTACTGAGATACATCCATACCTCC casD + NotI (rv) + stopcodon
BG2483 GGCCCGCGGCCGCTCACGCCTCGCCATTATTACGA casC +NotI (rv) + stopcodon
BG2484 GGCCCGCGGCCGCTTACGCATTTTTGTTTGTGGTCAAT casB + NotI (rv) + stopcodon
BG2573 GCGCGGGTACCAGATGGCTGATGAAATTGATGCAATG casB + Acc65I (fw)
BG2586 GGCCCGCGGCCGCCTGCAGTCACAGTGGAGCCAAAGA-TAGCAAG casE + NotI (rv) + stopcodon
BG3048 GCGCGGAATTCATGAGATCTTATTTGATCTTGCGG casD + EcoRI (fw)
BG3049 GGCCCCTGCAGTTACTGAGATACATCCATACCTCC casD + PstI + stopcodon (rv)
EMSA
BG3009 
AAGCTGATCGGCAAGCTCGAAAGCACGACGGTATTGT-
TCAGATCCTGGCTTGCCAACAGTGATTTGCTCAATTTTG-
TAGATTGAAG
Target with R44 protospacer, 
and flanking sequences1
BG3010  
CTTCAATCTACAAAATTGAGCAAATCACTGTTGGCAAGC-
CAGGATCTGAACAATACCGTCGTGCTTTCGAGCTTGC-
CGATCAGCTT
Target with R44 protospacer, 
and flanking sequences2
BG3011  
AAGCTGATCGGCAAGCTCGAAAGCACGTTGACTTGGAT-
CACCGACCTTGGCGATTACGATGATTTGCTCAATTTTGTA-
GATTGAAG
Target with scrambled R44 
protospacer and flanking 
sequences1
BG3012  
CTTCAATCTACAAAATTGAGCAAATCATCGTAATCGCCA-
AGGTCGGTGATCCAAGTCAACGTGCTTTCGAGCTTGC-
CGATCAGCTT
Target with scrambled R44 
protospacer and flanking 
sequences2
BG3032 ACGGTATTGTTCAGATCCTGGCTTGCCAACAG Target with R44 protospacer, without flanking sequences1
BG3033 CTGTTGGCAAGCCAGGATCTGAACAATACCGT Target with R44 protospacer, without flanking sequences2
In vitro tran-
scription 
(to generate 
RNA products 
for EMSA)
BG3030 CCATGGTAATACGACTCACTATAGGGCTTCAATCTA-CAAAATTGAGCAA
T7 promoter primer to gener-
ate a template for in vitro 
transcription3
BG3031 AAGCTGATCGGCAAGCTCGAAAGC Primer to generate a tem-plate for in vitro transcription3
BG3079 CCATGGTAATACGACTCACTATAGGGAAGCTGATCG-GCAAGCTCGAAAG
T7 promoter primer to gener-
ate a template for in vitro 
transcription3
BG3080 CTTCAATCTACAAAATTGAG Primer to generate a tem-plate for in vitro transcription3
ESI-MS
Native PAGE
EM
BG3028 biotin-TEG-CTGTTGGCAAGCCAGGATCTGAACAATACCGT R44 protospacer (A)
1 DNA sequence corresponds to crRNA sequence, 2 DNA sequence complementary to crRNA sequence, 3 These 
primers were used to prepare material for in vitro transcription by PCR by adding on a T7 promoter, using either 
BG3009-BG3010 or BG3011-BG3012 as template. Restriction sites are underlined, Proto-spacer sequences are in 
bold, Location of PAM in italics.
Matthijs M. Jore, Edze R. Westra, John van der Oost, Stan J. J. Brouns
Manuscript In preparation
Chapter 4
CRISPR interference requires a 
protospacer adjacent motif (PAM) and 
perfect basepairing at the PAM-side of 
the protospacer
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Abstract
CRISPR/Cas systems protect prokaryotes from invading nucleic acids. The CRISPRs 
contain spacer sequences that are derived from previously encountered invading 
nucleic acids, providing the basis for a sequence-specific defense system. In E. coli 
K12 long precursor CRISPR RNA is cleaved into mature crRNAs that remain bound to 
the Cas protein complex Cascade. Cascade loaded with crRNA and assisted by Cas3 
can successfully inhibit virus proliferation. It has been demonstrated that Cascade-
bound crRNA can recognize dsDNA and the crRNA can base pair to the complementary 
strand by strand displacement. It is currently unknown which nucleotide positions are 
important for base pairing and immunity. In addition to previously established anti-
virus activity, we here demonstrate that the CRISPR/Cas system of E. coli can inhibit 
transformation of a plasmid containing a protospacer. We examined which nucleotide 
positions in the protospacer and flanking the protospacer are essential for inhibition 
of plasmid transformation. A mutant library was generated, transformed to a resistant 
host and escape mutants were selected. Sequence analysis showed that most escape 
mutants contain nucleotide substitutions in the protospacer adjacent motif (PAM) and 
in the PAM-side of the protospacer; in addition, deletion of the protospacer region has 
been observed. The PAM might be a criterion to verify that only invading DNA is being 
targeted. The PAM-side of the protospacer might play a crucial role during recognition, 
base pairing and putative cleavage of the target. 
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Introduction
Prokaryotes have developed several sophisticated mechanisms to defend themselves 
against invading nucleic acids that are potentially harmful. One of the recently 
discovered systems is based on clusters of regularly interspaced short palindromic 
repeats (CRISPR) (reviewed in (van der Oost et al. 2009; Horvath and Barrangou 
2010; Karginov and Hannon 2010; Marraffini and Sontheimer 2010a). CRISPR loci 
contain short direct repeats that are separated by unique spacers which are identical to 
extrachromosomal elements such as phages and conjugative plasmids (the identical 
nucleic acid sequence is named the protospacer) (Bolotin et al. 2005; Mojica et al. 
2005; Pourcel et al. 2005; Lillestøl et al. 2006; Semenova et al. 2009). In close proximity 
of CRISPR a set of conserved cas (CRISPR associated) genes can be found. Based 
on the composition of the cas gene cluster, eight different subtypes can be recognized 
(Haft et al. 2005) that are each associated with one type (or few types) of CRISPR 
repeat sequence (Kunin et al. 2007). The CRISPR/Cas system is an adaptive and 
heritable immune system (van der Oost et al. 2009), which appears to be frequently 
transferred by horizontal gene transfer (Haft et al. 2005; Godde and Bickerton 2006; 
Makarova et al. 2006; Horvath et al. 2009).
CRISPR-mediated defense comprises three stages. During the first stage fragments 
of invading nucleic acids are integrated as spacers in the CRISPR locus (Barrangou et 
al. 2007; Deveau et al. 2008; Horvath et al. 2008; van der Ploeg 2009). These studies 
revealed that a conserved protospacer adjacent motif (PAM) can be found in proximity 
of the protospacer sequences in the phage genome (Deveau et al. 2008; Horvath et 
al. 2008; van der Ploeg 2009). This had been independently observed before (Bolotin 
et al. 2005). The PAM seems to be a common theme among the different CRISPR 
types, although each CRISPR type uses a specific motif (Mojica et al. 2009). During 
the second stage, a CRISPR is unidirectionally transcribed (Brouns et al. 2008; Hale 
et al. 2008; Marraffini and Sontheimer 2008; Semenova et al. 2009); the reported 
bidirectional transcription in Sulfolobus spp. seems to be an exception to this rule 
(Lillestøl et al. 2006; Lillestol et al. 2009). The precursor CRISPR RNA (pre-crRNA) is 
subsequently cleaved into small CRISPR RNA (crRNA) by CasE in E. coli (Brouns et 
al. 2008) and Cas6 in Pyrococcus furiosus (Carte et al. 2008). In E. coli crRNAs remain 
bound by the Cas protein complex Cascade. In P. furiosus the crRNAs are further 
trimmed at their 3’ end to generate mature crRNAs (also called psiRNAs) that form a 
stable interaction with the Cmr-complex (Hale et al. 2008; Hale et al. 2009). During 
the third stage, the CRISPR interference, crRNAs guide the Cas protein machinery 
to specifically target previously encountered genetic elements, nucleic acid fragments 
of which have previously been integrated in a CRISPR locus. The Cmr-complex from 
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P. furiosus has been shown to cleave complementary RNA in vitro (Hale et al. 2009). 
However, in Staphylococcus epidermidis it has been shown that DNA must be the target 
in vivo (Marraffini and Sontheimer 2008). DNA targeting has also been demonstrated 
in the case of E. coli; Cascade-bound crRNAs complementary to either the coding 
or the non-coding strand can prevent phage lambda infection, therein assisted by 
Cas3 (Brouns et al. 2008). This finding is supported by the observation that Cascade 
loaded with crRNA can sequence specifically bind to dsDNA by strand displacement 
(Chapter3). 
Here we describe the analysis of nucleotide positions in the protospacer and PAM 
that are important for interference in E. coli. To address this question we constructed a 
plasmid containing a protospacer flanked by a PAM. Compared to an empty plasmid, 
the transformation efficiency dramatically decreased when we transformed this plasmid 
to cells overproducing Cas3, Cascade and complementary crRNA. The non-coding 
nature of the protospacer and PAM enabled us to create a library by error-prone PCR. 
Plasmids that are entering the cell and can escape the CRISPR-based immunity result 
in colony growth after plating. Sequence analysis of these escape mutants revealed 
several positions in the protospacer and PAM that are crucial for interference.
Results 
To investigate whether the CRISPR/Cas system from E. coli K12 could prevent plasmid 
transformation we constructed a plasmid containing a KpnI-KpnI 1.5 kb fragment from 
phage λ (pUC-λ1500) (Fig. 4.1A). We designed a CRISPR containing 5 identical spacers 
that have perfect complementarity to a fragment in the λ DNA compatible with the 
PAM sequence 5’-AWG-protospacer-3’ (Mojica et al. 2009). Cascade, Cas3 and the λ 
targeting CRISPR (CRISPR λ) RNA were overproduced in E. coli BL21-AI, which lacks 
endogenous cas genes (Studier et al. 2009). These cells were made electrocompetent 
for plasmid transformation. The transformation efficiency of an empty pUC19 vector 
to the CRISPR λ carrying strain is 0.7 x 109 cfu/μg of plasmid DNA. This value is 
similar to the transformation efficiency of a control strain carrying a non-targeting 
CRISPR (CRISPR R44), which is 2.0 x 109 cfu/μg (Fig. 4.1B). The pUC-λ1500 plasmid 
transformed equally well to the non-targeting strain (0.7 x 109 cfu/μg), but showed a 
3,000-fold reduction in transformation efficiency to the CRISPR λ-carrying strain (2.0 
x 105 cfu/μg) (Fig. 4.1B). This clearly shows that the pUC-λ1500 plasmid is specifically 
being targeted and that the CRISPR/Cas system from E. coli K12 can prevent plasmid 
transformation.
To determine whether the pUC-λ1500 was affected by CRISPR/Cas, we selected four 
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Figure 4.1. CRISR/Cas of the Cse-subtype inhibits plasmid transformation. (A) Schematic representation of 
the pUC-λ1500 plasmid. The genome coordinates of the lambda fragment and the protospacer sequence are given. 
The restriction enzyme KpnI was used for cloning the lambda fragment into pUC19. Primers M13F and M13R were 
used for sequencing of the insert. A schematic representation of four sequenced escape mutants (Esc1-4) is shown 
below. Observed deletions in the plasmids are represented by dashed lines. (B) Transformation efficiencies of 
pUC19 and pUC-λ1500 to E. coli BL21-AI overproducing Cascade, Cas3 and either CRISPR R44 (grey) or CRISPR 
λ (white). Error bars indicate the standard deviation. 
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clones from the transformation of the pUC-λ1500 to the CRISPR λ carrying strain. The 
plasmids were isolated and the pUC-λ1500 insert was sequenced using flanking primers. 
Three out of four clones (Esc1, 3 and 4) showed a major deletion that included the 
protospacer (Fig. 4.1A). The transformation efficiencies of these isolated plasmids 
were equal to that of empty pUC19 plasmids (data not shown). One clone sequence 
was unaffected (Esc2). When this isolated plasmid was transformed, again a low 
transformation efficiency was obtained, showing that the escape colony in the initial 
experiment is not caused by the pUC-λ1500 plasmid. An explanation for the successful 
escape might be an unidentified recombination event in any of the other plasmids 
carrying either cas genes or the CRISPR sequence, thus neutralizing CRISPR-
mediated defense.
It has previously been shown that Cascade can bind dsDNA and that the crRNA can 
base pair with complementary DNA by strand displacement (Chapter 3). In order to 
reveal which positions in the protospacer and flanking sequence are essential for 
interference, a 350 basepair fragment containing the protospacer was cloned into 
a pUC19 vector (pUC-λ350) (Fig. 4.2A). A mutant library was created by error-prone 
PCR and the amplicons cloned into pUC19. This library contains approximately 5,000 
clones, of which 10 were sequenced to check the mutation content. Three out of 
ten clones contained one or two mutations or deletions, the other clones remained 
unchanged. Total plasmid DNA was isolated from this library and transformed to E. coli 
KRX overproducing Cascade, Cas3 and CRISPR λ. This strain is deficient in recA and 
endA1 to enhance the stability of the transformed plasmid (Hartnett et al. 2006). The 
transformation efficiency of an empty pUC19 vector is 1.5 x 106 cfu/µg DNA. pUC-λ350 
had a 10,000 fold lower transformation efficiency of 2.0 x 102 cfu/µg DNA (Fig. 4.2B). 
Next, plasmid DNA from the mutant library was transformed, showing an efficiency of 
~2 x 103 (data not shown). Unfortunately, the library contained empty plasmids which 
resulted in false positives. Therefore, the plasmids were first checked for inserts by 
colony PCR. Approximately fifty escape mutants that contain an insert of expected size 
were selected and sequenced. Eight different mutations were observed (Fig. 4.2C). 
Two mutations occur in the PAM at two different positions (Esc5 and 6). Five mutations 
occur at the PAM-side in the protospacer (Esc7, 8, 9, 10 and 11). Finally, one deletion 
at position 20 was observed (counted from the PAM-side of the protospacer). For each 
mutation one clone was selected and transformed back to E. coli KRX overproducing 
Cascade, Cas3 and CRISPR λ to determine its transformation efficiency. The values 
were similar to the transformation efficiency of an empty pUC19 vector, indicating 
that they can successfully bypass CRISPR defense and that each mutated position is 
indeed essential for resistance.
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Figure 4.2. Escape mutants contain mutations in the PAM or protospacer. (A) Schematic representation of the 
pUC-λ350 plasmid. A PCR product of the lambda fragment was cloned into pUC19 using the BamHI and HindIII 
sites that were introduced along with primers BG3218 and BG3219. The genome coordinates of the lambda frag-
ment and the protospacer sequence are given; please note that this lambda fragment is cloned in the opposite 
direction compared to pUC-λ350. The protospacer sequence is therefore reverse complement to the one given in 
Fig.4.1. In this orientation the PAM is located directly upstream the protospacer. For creation of the library the same 
cloning strategy was applied. Transformation efficiencies of pUC19, pUC-λ350 and the escape mutants to BL21-AI 
overproducing Cascade, Cas3 and CRISPR λ RNA are given in (B). Error bars indicate the standard deviation. (C) 
The sequence of the protospacer and flanking sequence of pUC-λ350 is given as a reference. Point mutations in 
the escape mutants are represented by the new base while deletions are shown as bars. Non-mutated positions 
are shown as dots.
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Discussion 
CRISPR/Cas inhibits plasmid transformation
CRISPR/Cas-mediated inhibition of transformation (and conjugation) has been 
previously shown in Staphylococcus epidermidis (Marraffini and Sontheimer 2008). 
The CRISPR/Cas system of the Cse-subtype has been shown to inhibit transduction of 
phage Lambda in E. coli (Brouns et al. 2008). Here we show that cells overproducing 
Cascade, Cas3 and crRNA can also inhibit transformation of a plasmid containing 
a protospacer and PAM. When this plasmid was transformed to E. coli BL21-AI 
overproducing Cas proteins and crRNA, we found that three out of four escape mutants 
contain major deletions in the transformed plasmid, including the protospacer and 
PAM. The fourth escape mutant most likely has encountered a recombination event 
in one of the plasmids carrying CRISPR or cas genes, since the escape is not caused 
by the transformed plasmid. Moreover, it is tempting to speculate that many, if not all, 
of the observed escape colonies carry deletions in either the plasmids that facilitate 
CRISPR interference or the transformed plasmid that is being targeted. However, 
more colonies should be screened to statistically found this hypothesis. If this were the 
case, the actual immunity against the protospacer containing plasmid is close to 100%. 
The three deletions that were identified occurred at different locations in the plasmid, 
indicating a non-specific deletion or recombination process. To reduce the number 
of deletions, further experiments were performed in E. coli KRX which lacks recA 
and endA and has partially defective restriction systems (hsd and e14). Interestingly, 
CRISPR interference in this strain was not affected and indirectly showed that RecA 
and EndA1 are not required for this defense mechanism.
Figure 4.3. Base pairing of crRNA with target dsDNA. Schematic overview of a crRNA molecule (top) binding to 
one strand of the dsDNA molecule by strand displacement as described in Chapter 3. One base of the PAM is com-
plementary to the 5’ repeat sequence (5’ handle) and can base pair, the other two cannot. Positions that are mutated 
in the escape mutants are marked with an asterisk. Please note that Cascade is not shown in this figure for simplicity.
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The PAM is important for interference
Two out of eight escape mutants contain a mutation in the PAM. Based on sequence 
analysis of the protospacer regions, PAMs have been examined for several CRISPR-
types (Bolotin et al. 2005; Deveau et al. 2008; Horvath et al. 2008; Mojica et al. 2009; 
Semenova et al. 2009; van der Ploeg 2009). The Cse-subtype, which is associated with 
the CRISPR-2 type (Kunin et al. 2007), contains an AWG motif (W = A or T) immediately 
upstream the protospacer (previously reported as CWT in the opposite strand) (Mojica 
et al. 2009) (Fig. 4.3). In our library we identified two escape mutations that result 
in an imperfect PAM; from ATG to TTG (Esc5) and from ATG to ACG (Esc6) (Fig. 
4.2C). The PAM has previously been demonstrated to be important for interference, as 
phages were found to evade CRISPR-based immunity in S. thermophilus by mutations 
in the PAM (and protospacer) (Deveau et al. 2008). The role of the PAM is not fully 
understood but it may actually help the Cas protein machinery to distinguish between 
the CRISPR DNA (self) and the invading DNA element (non-self). Intact PAMs are 
present in invading DNA but absent from chromosomal CRISPR DNA thus preventing 
auto-immunity. An alternative model to prevent auto-immunity has been proposed for 
S. epidermidis (Marraffini and Sontheimer 2010b). The CRISPR/Cas system inhibits 
transformation of a plasmid containing a protospacer, unless it is flanked by a sequence 
that is substantially similar to the CRISPR sequence (Marraffini and Sontheimer 
2010b). The potential of a flanking sequence to base pair with the CRISPR repeat 
thus determines whether a DNA sequence is subject to interference or not. In the 
case of E. coli one base of the PAM can base pair with the crRNA whereas the other 
two cannot (Fig. 4.3). A mutation from ATG to TTG (Esc5) does not influence the base 
pairing pattern, but does make a crucial difference for interference. this indicates that 
interference in E. coli is not only determined by the potential to base pair with the 
crRNA, but by the nucleotide sequence. However, to better understand the role of base 
pairing of the PAM with the crRNA and of the sequence itself during interference, the 
effect of all possible mutations in the PAM should be tested, ideally in combination with 
CRISPR mutagenesis, analogous to previous experiments (Marraffini and Sontheimer 
2010b).
Perfect base pairing requirements for interference
Five out of eight escape mutants (Esc7-11) contain a point mutation at the PAM-
side of the protospacer (Fig. 4.2C). It seems that base pairing at the PAM-side of 
the protospacer, and thus 5’ end of the spacer is essential for interference. A similar 
phenomenon has been observed in the case of S. thermophilus (Deveau et al. 2008). 
Nonetheless, it cannot be ruled out that plasmids with mutations at other positions in 
the protospacer, which would lead to escape, are absent from the library and thus not 
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identified. To determine the importance of each position, a site directed mutagenesis 
approach should be taken. The role of the 5’ end of the crRNA spacer could be crucial for 
base pairing with the target DNA. It might encompass a sequence where base pairing is 
initiated, similar to the seed sequence in miRNAs and siRNAs in eukaryotes (Lewis et 
al. 2005; Wang et al. 2009). Argonaute-bound miRNAs or siRNAs initiate base pairing 
at positions 2 - 8 from the 5’ end (the seed sequence) and then ‘zipper up’ forming a 
duplex of nucleic acids (Wang et al. 2009). What happens after binding of the crRNA 
to complementary dsDNA remains obscure. It is known that Cas3 is not needed for the 
binding in vitro (Chapter 3), but is essential for immunity in vivo (Brouns et al. 2008). 
Cas3 comprises a HD-type nuclease domain fused to a DEAD/H box helicase domain 
(Makarova et al. 2006). The HD domain protein SSO2001 from Sulfolobus solfataricus 
has metal-dependent endonuclease activity on double-stranded oligonucleotides (Han 
and Krauss 2009). Possibly the Cas3 protein is recruited or activated upon duplex 
formation of crRNA and target DNA, and subsequently catalyze cleavage of the target 
DNA. Perfect base pairing at the 5’ end of the spacer, as well as the presence of a 
perfect PAM, might be crucial to enable cleavage. Extensive stretches of mismatches 
at the 3’ end of the spacer, which is the case in Esc12 (Fig. 4.2C), might destabilize the 
crRNA interaction with its target and might also inhibit the catalytic activity, leading to 
escape of the phage or plasmid. Whether the observed mutations in the protospacer 
inhibit base pairing between the spacer and the target DNA should be tested by means 
of Electrophoretic Mobility Shift Assays (EMSAs), as described previously (Chapter 3). 
This might provide more insight of the importance of the 5’ end of the spacer for either 
base pairing and/ or target cleavage. 
Materials and methods
Strains and plasmids used
E. coli NEB5α (New England Biolabs) was used for plasmid construction. E. coli BL21-
AI (Invitrogen) and E. coli KRX (Promega) were used for transformation experiments. 
Construction of plasmids for overproduction of Cascade (pWUR400), Cas3 (pWUR397) 
and CRISPR R44 RNA (pWUR547) is described elsewhere (Chapter 2 and 3). The 
plasmid for overproduction of CRISPR λ RNA (pWUR564) was subcloned from a synthetic 
construct (GeneArt AG, Germany) into pACYCduet-1 (Novagen) with NcoI and Acc65I. 
The sequence of the insert is provided below. pUC-λ1500 (pWUR609) was constructed 
by digestion of λ DNA with KpnI, selection of the 1.5 kb fragment (17059-18556), and 
ligation of the fragment into a pUC19 vector (New England Biolabs) cleaved with kpnI. To 
generate pUC-λ350 (pWUR610) a fragment of ~350 bp (17918-18250) was amplified by 
PCR using primers BG3218 (5’-GGCCCGGATCCGTCGGGCGAGCGATGATGCG-3’) 
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and BG3219 (5’-CGCGCAAGCTTCATCGGCGTTTCATTCCCGTTT-3’) and cloned 
into pUC19 by digestion with BamHI and HindIII and subsequent ligation. 
Library construction
The mutant library was generated using a GeneMorph II Random Mutagenesis Kit 
(Stratagene). The PCR reaction contained 34.5 μl MQ, 5 μl Mutazyme II Reaction 
Buffer (10x), 1 μl dNTP mix (40 mM), 1.25 μl BG3218 (100 ng/ μl), 1.25 μl BG3219 (100 
ng/ μl), 6 μl pUC-λ1500 (220 ng/ μl) and 1 μl Mutazyme II (2.5 U/ μl). The program used 
is 2 min 95 °C, twenty cycles of the next three steps of 30 sec 95 °C, 30 sec 52 °C, 1 
min 72 °C, and finally one step of 10 min 72 °C. The PCR product and pUC19 vector 
were cleaved with BamHI and HindIII, ligated and transformed to E. coli NEB5α (New 
England Biolabs).
Transformation and mutant selection
E. coli BL21-AI cells carrying pWUR397, pWUR400 and either pWUR564 or pWUR547 
were grown in LB supplemented with the appropriate antibiotics at 37 °C till an OD600 
of ~ 0.3. The cells were induced with 1 μM Isopropyl β-D-1-thiogalactopyranoside 
and 0.2 % arabinose, and grown for 45 min at 37 °C prior to harvesting. E. coli KRX 
containing pWUR397, pWUR400 and pWUR564 was grown and harvested according 
to the same protocol. Cells were made electrocompetent by washing twice with ice 
cold MQ and subsequently twice with ice cold 10 % glycerol. Typically 10 ng of plasmid 
DNA is transformed. Transformation efficiencies were calculated based on duplicate 
or triplicate experiments. Isolated plasmids from escape mutants were sequenced at 
Baseclear (The Netherlands) using M13F (5’-TTTCCCAGTCACGACGTTG-3’) and 
M13R (5’-GGATAACAATTTCACACAGG-3’) primers.
pWUR564 insert: 
CCATGGAAACAAAGAATTAGCTGATCTTTAATAATAAGGAAATGTTACATTAAGGTTGGTGGGTTGTTTTTATGGGAAAAAATGCTTTAAGAAC
AAATGTATACTTCTAGAGAGTTCCCCGCGCCAGCGGGGATAAACCGCCAGTGATAAGTGGAATGCCATGTGGGCTGTCGAGTTCCCCGCGCCAG
CGGGGATAAACCGCCAGTGATAAGTGGAATGCCATGTGGGCTGTCGAGTTCCCCGCGCCAGCGGGGATAAACCGCCAGTGATAAGTGGAATGCC
ATGTGGGCTGTCGAGTTCCCCGCGCCAGCGGGGATAAACCGCCAGTGATAAGTGGAATGCCATGTGGGCTGTCGAGTTCCCCGCGCCAGCGGGG
ATAAACCGCAGCTCCCATTTTCAAACCCAGGTACC
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Chapter 5
The antiviral Cas protein machinery is 
located at cellular poles
82
chaPter 5
5
Abstract
The recently discovered Clusters of Regularly Interspaced Palindromic Repeats 
(CRISPRs) provide prokaryotes with an adaptive and inheritable immune system, 
which encompasses three distinct steps. Firstly, upon infection by previously non-
encountered extrachromosomal DNA such as a virus, fragments are integrated into the 
genomic CRISPR locus. Secondly, the CRISPR is transcribed and cleaved into small 
CRISPR RNAs (crRNAs). Thirdly, crRNAs guide CRISPR associated (Cas) proteins 
to counteract invasion by previously encountered DNA elements that are stored in the 
CRISPR archive. Little is known about the subcellular location of the molecular actors 
participating in the CRISPR-mediated battle between the host and parasite. Here 
we used nanoscale resolution Photo-Activated Localization Microscopy (PALM) to 
determine the spatial distribution of the Cas proteins in Escherichia coli. We found that 
Cas proteins are preferentially located at the poles of the bacterial cell. This subcellular 
location of Cas proteins might be advantageous for the host, since phages frequently 
infect and replicate in the same area of the cell.
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Introduction
Prokaryotes are constantly being attacked by extrachromosomal elements such as 
viruses and plasmids. To prevent infection of these foreign DNA entities, prokaryotes 
have developed several defense mechanisms, amongst which the recently discovered 
small RNA mediated CRISPR/Cas mechanism (for an overview, see Chapter 1). 
CRISPR arrays consist of short DNA repeats that are separated by unique spacers of 
similar length. The spacer sequences are derived from viral and plasmid DNA (Bolotin 
et al. 2005; Mojica et al. 2005; Pourcel et al. 2005; Lillestøl et al. 2006; Semenova et 
al. 2009). CRISPR-associated (cas) genes are generally located in close proximity to 
the CRISPR array. The encoded Cas protein machinery together with small CRISPR 
RNA that is complementary to the invading nucleic acid, confer specific resistance 
(see below). Several subtypes can be distinguished based on the composition of the 
cas gene cluster (Haft et al. 2005; Makarova et al. 2006; van der Oost et al. 2009), 
which are most likely acquired by horizontal gene transfer (Haft et al. 2005; Godde and 
Bickerton 2006; Makarova et al. 2006; Horvath et al. 2009).
CRISPR-mediated defense comprises three distinct stages. During the first stage, new 
spacers from invading nucleic acids are integrated in the CRISPR locus (Barrangou 
et al. 2007; Deveau et al. 2008; Horvath et al. 2009; van der Ploeg 2009). Not much 
is known about the spacer integration but it is hypothesized that the nucleases Cas1 
and Cas2 are involved (Marraffini and Sontheimer 2009; van der Oost et al. 2009; 
Wiedenheft et al. 2009). During the second stage, the CRISPR locus is transcribed 
and subsequently cleaved (Brouns et al. 2008; Carte et al. 2008; Hale et al. 2008; 
Marraffini and Sontheimer 2008). The generated mature crRNAs are retained by a 
complex of Cas proteins. In E. coli K12, this complex consists of CasABCDE and is 
termed Cascade (Brouns et al. 2008). During the third and final stage, the crRNAs 
guide the Cas protein machinery to their specific targets: previously encountered 
invading DNA. Successful interference generates resistance of the host against the 
predator (Brouns et al. 2008; Marraffini and Sontheimer 2008). 
In E. coli K12, Cascade loaded with crRNA binds the complementary strand from dsDNA 
by strand displacement (Chapter 3). However, in vivo studies revealed that, besides 
Cascade, the putative nuclease/helicase Cas3 is needed for resistance (Brouns et al. 
2008).  In Saphylococcus epidermidis the distinction between host DNA (the CRISPR 
itself) and invading DNA is determined by the flanking regions of the protospacer (this 
is the sequence in the extrachromosomal element that is identical to the spacer). If 
the flanking sequence is complementary to the repeat, no interference occurs, thus 
preventing the host from degrading its own DNA (Marraffini and Sontheimer 2010b). In 
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other subtypes, a conserved Protospacer Adjacent Motif (PAM), absent in the CRISPR, 
may determine whether the target is subject to interference (Deveau et al. 2008; Mojica 
et al. 2009). 
Although knowledge of the CRISPR expression and target recognition is increasing, 
little is known about the sub-cellular localization of the Cas protein machinery. A 
genome-wide localization study in E. coli has been established, in which every single 
gene was cloned in a plasmid fused to the gene encoding a GFP marker (Kitagawa 
et al. 2005) (http://ecoli.naist.jp/GB6/search.jsp). This study revealed that CasC forms 
foci at the cellular pole, whereas Cas3, CasA, CasE and Cas1 show a more uniform 
distribution over the cell. The different distribution of CasC on the one hand, and CasA 
and CasE on the other, is in contrast with the previous finding that they are all part 
of the Cascade complex. No localization data are available for the remaining Cas 
proteins. Therefore we decided to study the spatial organization of the Cas proteins 
in E. coli more thoroughly. With the use of Photo-Activated Localization Microscopy 
(PALM) imaging (Betzig et al. 2006), we found that the single Cas1, Cas2 and Cas3 
proteins as well as Cascade localize at the cellular poles. It has been previously 
reported that bacteriophages, such as phage lambda, infect and replicate E. coli at this 
same location (Edgar et al. 2008). Phage lambda infection can result in a release of 
50-100 viroids per host cell within 30-35 minutes (Hendrix and Casjens, 2006), not only 
killing the host cell but also threatening neighboring cells. To rapidly counteract such a 
potentially devastating infection, it would make sense if the interference components 
of the CRISPR/Cas system would be localized close to the site of infection. Moreover, 
the Cas proteins are spatially separated from chromosomal DNA, which is located in 
the center of the cell; this might contribute to preventing the protein machinery from 
targeting its own chromosomal CRISPR DNA. 
Results and Discussion
The E. coli K12 genome contains one cas gene cluster, encoding 8 Cas proteins, which 
is located upstream the CRISPR-I locus. The CasABCDE proteins form the Cascade 
complex that, loaded with crRNA and assisted by Cas3, targets invading DNA (Brouns 
et al. 2008) (Chapter 3). An earlier genome-wide localization study determined the 
spatial arrangement of individually overexpressed Cas proteins (Kitagawa et al. 2005). 
Since recent studies indicated that expression of cas genes is repressed under native 
conditions in E. coli (Pul et al. 2010) (Chapter 6) it is unlikely that the individually 
overexpressed Cas proteins are incorporated into a functional Cascade complex. This 
assumption is in agreement with the observation that CasC is spatially separated from 
both CasA and CasE (Kitagawa et al. 2005). In addition, the study mentioned above is 
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performed with a low resolution microscope. We therefore used PALM imaging as our 
spectroscopy method of choice to study the localization of both Cascade and Cas3. 
PALM employs photo-activatable fluorescent proteins that are sequentially being 
activated and recorded (Betzig et al. 2006). In this manner only a few fluorescent 
proteins are being activated and excited per image. This imaging cycle is repeated 
several times, until all proteins are photobleached. Finally the collected images are 
merged and the location of each fluorescent protein can be mathematically inferred 
with high accuracy (Betzig et al. 2006). PALM has also been used to study the cellular 
location of proteins involved in chemotaxis in E. coli (Greenfield et al. 2009).
Figure 5.1. PALM images of the location of the Cascade proteins and Cas3. For full colour version see page 
132. (A) An overview of CasB-Dronpa expressing cells visualized with PALM. A Differential Interference Contrast 
(DIC) image (inset) shows that cells look unhealthy. Several images of cells are selected, rotated and enlarged, as 
shown in (B). Most proteins are located in patches along the cell wall. (C) An overview of CasB-Dronpa expressing 
cells in the presence of Cascade is visualized with PALM. A DIC image (inset) shows that cells look natural. Several 
images of cells are selected, rotated and enlarged as shown in (D). In the presence of Cascade, CasB-Dronpa is 
differently distributed in the cell, mainly concentrated in one focus at one pole of the cell and in a ring-like structure 
at the other end. (E) PALM analysis of two mEos-Cas3 expressing cells (representing a large population of cells) 
shows that localization is very similar to that of CasB-Dronpa + Cascade (D), although the ring-like structure can be 
absent and replaced by a focused cluster. Each spot in the images represents one protein molecule. Cell borders 
are roughly indicated with dashed lines for clarity in (B), (D) and (E).
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Cascade and Cas3 are located in clusters near the cellular poles
First we expressed CasB fused to a photo-activatable fluorescent protein (CasB-
Dronpa) in E. coli BL21(DE3), a strain that lacks cas genes (Studier et al. 2009) and 
visualized the distribution with PALM (Fig. 5.1AB), in the absence of Cascade and 
CRISPRs. CasB-Dronpa was succesfully expressed, but the cells appeared to be very 
sick when viewed by Differential Interference Contrast (DIC) microscopy (see inset in 
Fig. 5.1A). The distribution of CasB-Dronpa is mainly located along the intracellular 
membrane. Previous attempts to affinity purify overexpressed StrepII-tagged CasB 
failed and polyacrylamide gel electrophoresis revealed that CasB was present in the 
insoluble fraction (data not shown), possibly due to the absence of the other Cascade 
subunits. The clustering of CasB might be explained by the formation of insoluble 
aggregates, or inclusion bodies. We therefore decided to co-express the Cascade 
protein complex, allowing CasB-Dronpa to integrate in the Cascade complex. The 
PALM images of CasB-Dronpa in the presence of Cascade show a striking difference 
to the images lacking Cascade (Fig. 5.1CD). CasB-Dronpa in the presence of Cascade 
is localized at the two poles of the E. coli cell, forming a focused cluster at one pole and 
a ring-like structure at the other pole (Fig. 5.1D). 
It has been shown that Cascade, Cas3 and crRNA are required for immunity in E. 
coli (Brouns et al. 2008), suggesting they might be in close proximity of each other. 
However, Cas3 does not co-purify with Cascade when tagged Cascade is affinity 
purified from cell extracts containing both Cascade, Cas3 and crRNA (data not shown). 
This suggests that Cascade and Cas3 do not stably interact. In line with the hypothesis 
of co-localization, we find a similar distribution for Cas3 (Fig. 5.1E). To confirm this 
co-localization, a similar experiment should be performed with a strain that contains 
mEos-Cas3, CasB-Dronpa and Cascade; mEos and Dronpa are compatible photo-
activatable fluorescent proteins with distinct spectral properties and can be visualized 
separately in a single experiment (Shroff et al. 2007). 
 
Cas1 and Cas2 are located near one pole
Cas1 has endonuclease activity both on single stranded (ss) and double stranded (ds) 
DNA (Wiedenheft et al. 2009). The small Cas2 protein has RNase activity on ssRNA and 
preferentially cleaves in U-rich regions (Beloglazova et al. 2008).  Both Cas1 and Cas2 
are not essential for CRISPR expression and interference (Brouns et al. 2008) and are 
the only two Cas proteins that are present in all subtypes. It has been hypothesized 
that these proteins are involved in spacer integration (Makarova et al. 2006; Marraffini 
and Sontheimer 2009; van der Oost et al. 2009). To investigate if they are localized 
in the same region of the bacterial cell, we first expressed Cas1-Dronpa and Cas2-
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mEos separately in different experiments. In analogy to the experiment described 
above, we used PALM to visualize the spatial distribution of both Cas proteins (Fig. 
5.2). Both Cas1-Dronpa and Cas2-mEos are mainly located at one pole. Therefore, it 
would be interesting to see if they are located at the same pole. This could be tested 
in future experiments with a coexpression culture, since both Cas proteins are fused 
to distinct compatible photo-activatable fluorescent proteins. However, our finding that 
Cas2-mEos is located at mainly one pole is in contrast with a recent study that reports 
on bipolar organization of Cas2-mEos, which is shown using a newly developed 3D 
PALM technique (Tang et al. 2010). Follow-up studies revealed that protein expression 
for a longer time results in distribution to both poles. The distribution patterns of 
Cas1 and Cas2 in this study show similarity to the localization of misfolded proteins. 
Misfolded proteins can form large polar aggregates (LPAs) at one cellular pole that 
will be transferred to one daughter cell to increase the fitness of the other daughter 
cell (Rokney et al. 2009; Winkler et al. 2010). Alternatively, proteins in LPAs can be 
refolded, resulting in functional polypeptides. However, care should be taken when 
interpreting this data since overexpression of proteins might lead to aggregation which 
may not reflect the native situation.
Figure 5.2. PALM images of the location of the Cas1 and Cas2 proteins. For full colour version see page 133. 
(A) An overview of Cas1-Dronpa expressing cells. Several images of cells are selected, rotated and enlarged as 
shown in (B). Some proteins localize uniformly over the cells, but most proteins form a cluster that localizes at one 
cellular pole close to the cell wall. (C) An overview of Cas2-mEos expressing cells. The inset shows a DIC image 
of the same cells. Several images of cells are selected, rotated and enlarged as shown in (D). As for Cas1-Dronpa, 
Cas2-mEos localizes mostly as one cluster at one pole of the cell. Each spot in the images represents one protein 
molecule. Cell borders are roughly indicated with dashed lines for clarity in (B) and (D).
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Implications of polar localization
We have found that Cas1, Cas2, Cas3 and CasB-Donpa co-expressed with Cascade, 
can localize at either one or two poles of the cells, implicating that the majority of the 
Cas protein machinery is located in this area. Control experiments with Dronpa and 
mEos only showed uniform distribution over the cells (data not shown). This finding 
is in agreement with  previous observations, where CasC was found to cluster in this 
area, but in contrast with CasA and CasE localization in the same study (Kitagawa et 
al. 2005) (http://ecoli.naist.jp/GB6/search.jsp). In this study we co-expressed Cascade 
and CasB-Dronpa which may result in a functional complex that localizes at a different 
location than the non-functional single Cascade subunits. This could be tested by affinity 
purification of CasB-Dronpa to determine whether the Cascade subunits copurify, and 
altogether form a full Cascade complex which is not affected by the fusion with Dronpa. 
In addition, an in vivo infection assay should be performed to test whether this complex 
is still functional.
It has been previously reported that several phages, such as phage lambda, preferably 
infect at the cellular poles of E .coli (Edgar et al. 2008). To inject its DNA, lambda 
requires the host protein ManY (Scandella and Arber 1974), which is located at the pole 
(Edgar et al. 2008). Replication of the lambda DNA takes place at the same location 
(Edgar et al. 2008). It seems to be a “smart decision” of E. coli to locate its antiviral Cas 
machinery in the vicinity of ManY. It could then immediately target lambda DNA that 
enters the cell and as such prevent the rapid and devastating effects of phage lambda 
infection. Clustering of Cas proteins and ManY could be confirmed in a future single 
experiment by labeling ManY and Cas proteins simultaneously. As an alternative to 
ManY, other proteins that are involved in lambda infection could be labeled. Another 
intriguing question concerns which factors determine where the Cas proteins go after 
synthesis. One model for protein localization in prokaryotes is the diffusion and capture 
model. According to this model proteins diffuse through the cell and are captured by 
other proteins (Shapiro et al. 2009). If this model applies to the Cas proteins, it remains 
to be seen to which other cytoplasmic or membrane proteins they attach. 
A secondary advantage is perhaps the spatial separation of the Cas protein machinery 
and the host chromosome. The chromosome is located around the center of the cell 
(Robinow and Kellenberger 1994). The physical distance may prevent the Cas protein 
machinery from targeting the chromosome, which contains a CRISPR with partial 
complementarity to the crRNA. This physical separation might contribute to prevention 
of auto-immunity, next to sequence requirements outside the protospacer (Deveau et 
al. 2008; Marraffini and Sontheimer 2010b).
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Materials and methods
Strains and plasmids used
Protein overexpression was performed in E. coli BL21 (DE3), a strain that lacks cas 
genes (Studier et al. 2009). The plasmids that were used include CasABCDE in 
pACYCduet, Cas1-Dronpa in pET52b, Cas2-mEos in pRSF1b, mEos-Cas3 in pET52b 
and CasB-Dronpa in pRSF1b. The construction of these plasmids will be described 
elsewhere (Jasper Akerboom).
Sample preparation
A fresh culture was inoculated from overnight cultures and grown in LB at 37 °C until 
the OD600 reached ~0.5. The protein expression was induced by the addition of 1 
mM IPTG, and the culture was grown until it appeared fluorescent under a UV light 
(typically 1 – 2 hours). Cells were spun down and resuspended in 1/10 volume PBS. 
They were subsequently spotted on a hydrophobic glass slip and air-dried, together 
with nanosphere fiducials. Forty-nanometer gold nanospheres were used in the case 
of Dronpa fusions, and 100-nm gold nanospheres in the case of mEos fusions (both 
purchased from Microspheres – Nanospheres).
Sample analysis
Samples were analyzed under an Olympus IX81 inverted microscope, equipped with 
a DIC optics and a 100x, 1.65 NA objective. Laser beams were delivered to the object 
from a customized table. The Dronpa and mEos protein fusions were activated with 
a 405-nm laser. Dronpa fusion proteins were excited with a 488-nm laser whereas 
mEos were excited with a 561-nm laser. Data sets were collected with a shutter time 
of 100 ms or 50 ms for Dronpa and mEos, respectively, until cells were photobleached 
(typically after a few hours). The data analysis was performed as described elsewhere 
(Greenfield et al. 2009). The drift during data collection was corrected by tracking the 
fiducials.
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Chapter 6
H-NS mediated repression of CRISPR-
based immunity in Escherichia coli K12 
can be relieved by the transcription 
activator LeuO
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Abstract
The recently discovered prokaryotic CRISPR/Cas defense system provides immunity 
against viral infections and plasmid conjugation. It has been demonstrated that in 
Escherichia coli transcription of the Cascade genes (casABCDE) and to some extent 
the CRISPR array, is repressed by heat-stable nucleoid-structuring (H-NS) protein, a 
global transcriptional repressor. Here we elaborate on the control of the E. coli CRISPR/
Cas system, and study the effect on CRISPR-based anti-viral immunity. Transformation 
of wildtype E. coli K12 with CRISPR spacers that are complementary to phage Lambda, 
does not lead to detectable protection against Lambda infection. However, when an 
H-NS mutant of E. coli K12 is transformed with the same anti-Lambda CRISPR, this 
does result in reduced sensitivity to phage infection. In addition, it is demonstrated that 
LeuO, a LysR-type transcription factor, binds to two sites flanking the casA promoter 
and the H-NS nucleation site, resulting in derepression of casABCDE12 transcription. 
Over-expression of LeuO in E. coli K12 containing an anti-Lambda CRISPR leads to 
an enhanced protection against phage infection. This study demonstrates that in E. coli 
H-NS and LeuO are antagonistic regulators of CRISPR-based immunity.
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Introduction
Invasions by viruses and conjugative plasmids pose a threat to microbial cells. To 
neutralize selfish DNA elements, bacteria and archaea have developed several 
defense strategies, such as receptor masking, restriction/modification and abortive 
infection (Hyman and Abedon, 2010; Labrie et al., 2010). Recently it was discovered 
that Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) (Ishino 
et al., 1987) and CRISPR associated (cas) genes (Jansen et al., 2002) form a 
sophisticated immune system that uses small RNAs to target mobile genetic elements, 
reviewed by (Horvath and Barrangou, 2010; Karginov and Hannon, 2010; Marraffini 
and Sontheimer, 2010a; van der Oost et al., 2009). CRISPRs consist of repeating 
sequences of approximately 30 nucleotides that are separated by unique sequences of 
similar size, called spacers (Mojica et al., 2000). The spacer sequences are commonly 
derived from phages and plasmids (Bolotin et al., 2005; Mojica et al., 2005; Pourcel et 
al., 2005), and new spacers can be added to the existing CRISPR array, expanding the 
invader repertoire (Barrangou et al., 2007), in a process known as CRISPR adaptation. 
The presence of a spacer matching a viral or plasmid sequence confers resistance 
to invasion by these elements (Barrangou et al., 2007; Brouns et al., 2008; Marraffini 
and Sontheimer, 2008). The biochemical pathways underlying CRISPR defense are 
partially known and involve transcription of the array into a long precursor CRISPR 
RNA. This precursor is cleaved in the repeat sequences by a Cas endonuclease (CasE 
in E. coli (Brouns et al., 2008), Cas6 in Pyrococcus furiosus (Carte et al., 2008)), 
releasing small crRNAs that serve to guide the defense.
The cas genes encode the protein machinery that carries out the various steps of 
CRISPR defense. Approximately 45 families of cas genes have been identified (Haft 
et al., 2005) that are classified in eight typical combinations or subtypes named after 
a representative organism, e.g. type E after E. coli (Haft et al., 2005). The type E 
CRISPR/Cas immune system in E. coli K12 is composed of 8 cas genes (cas1, cas2, 
cas3 and casABCDE) and a downstream CRISPR locus with type 2 repeats (Kunin 
et al., 2007) containing 12 spacer-repeat units (CRISPR I) (Fig. 6.1A). An additional 6 
spacer-containing CRISPR (CRISPR II) and a 2 spacer CRISPR (CRISPR III) with type 
2 repeats, as well as a CRISPR with type 4 repeats (Kunin et al., 2007) containing 1 
spacer repeat unit (CRISPR IV) are located elsewhere on the genome (Diez-Villasenor 
et al., 2010). In addition to a CRISPR containing an anti-invader sequence, only Cas3 
and CasABCDE, forming the protein complex Cascade (CRISPR-associated complex 
for antiviral defense), are required for CRISPR interference (Brouns et al., 2008). A 
recent study has demonstrated that in E. coli K12 transcription from the casA and 
CRISPR I promoters is repressed by heat-stable nucleoid-structuring protein (H-NS) 
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(Pul et al., 2010), a global repressor of transcription in many Gram-negative bacteria. 
A microarray study indicates that transcription of casABC and cas2 is elevated in an 
E. coli K12∆hns strain compared to wt E. coli K12 (Hommais et al., 2001). In addition, 
H-NS was shown to possess high binding affinity for the intergenic region between 
cas3 and casA (Oshima et al., 2006; Pul et al., 2010). H-NS has a preference for 
binding AT-rich DNA sequences (Navarre et al., 2006). After initial binding of H-NS to 
high affinity nucleation sites (Bouffartigues et al., 2007; Lang et al., 2007) repression 
of transcription is mediated by cooperative spreading along the DNA (defined as DNA 
stiffening (Liu et al., 2010)) and by creating looped structures through formation of DNA-
protein-DNA bridges (Dame et al., 2005). Moreover, H-NS acts as a DNA structuring 
protein (Liu et al., 2010; Stoebel et al., 2008).
Overcoming H-NS mediated repression of cas gene transcription may be a key 
requirement for CRISPR/Cas functionality. Generally, H-NS repression can be relieved 
by a number of proteins, such as SlyA, VirB and others (Stoebel et al., 2008). One of 
these proteins is the regulator LeuO (Chen and Wu, 2005; De la Cruz et al., 2007), 
which belongs to the LysR family of transcription factors (Stoebel et al., 2008) and is 
found in all proteobacteria, except the δ subdivision (Maddocks and Oyston, 2008). The 
leuO gene maps next to the leuABCD operon (Chen et al., 2005; Chen and Wu, 2005; 
Hertzberg et al., 1980), whose gene products are required for leucine synthesis (Vartak 
et al., 1991). Recent data indicate that LeuO is involved in regulating transcription of 
many genes, often as an H-NS antagonist (Shimada et al., 2009; Stoebel et al., 2008). 
However, since under laboratory growth conditions the genomic leuO gene itself is 
repressed by H-NS (Klauck et al., 1997; Majumder et al., 2001) all LeuO regulation 
studies make use of plasmid encoded leuO under control of constitutive or ininducible 
promoters. In the host environment leuO is likely to be induced under certain conditions 
as for example virulence of Salmonella enterica leuO mutants is attenuated (Lawley et 
al., 2006). A genomic screen for LeuO-binding DNA fragments in E. coli K12 revealed 
12 gene clusters, including the casA-cas2 operon (ygcL, ygcK, ygcJ, ygcI, ygcH, ygbT, 
ygbF) (Shimada et al., 2009). When LeuO was over-expressed, increased expression 
of casA and cas2 was observed in E. coli (Shimada et al., 2009), and of casA (STY3070) 
in Salmonella enterica serovar Typhi (Hernandez-Lucas et al., 2008). We therefore 
investigated whether LeuO can mediate H-NS derepression of cas gene and CRISPR 
transcription. In this study we demonstrate that LeuO counteracts H-NS-dependent 
repression of the casA promoter by reorganizing the DNA protein contacts within the 
transcription initiation region. The resulting change results in increased transcription 
of the Cascade genes, the limiting factor for CRISPR-based defense against phage 
infection in E. coli K12.
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Results
LeuO activates cas gene expression
To study the effect of LeuO on cas gene expression, transcript levels of the E. coli K12 
cas genes in mid-exponential growth phase were examined using a DNA microarray 
approach. RNA samples isolated from a wt E. coli K12 strain containing a leuO encoding 
plasmid were compared to RNA isolated from a strain containing the empty vector. In 
addition, RNA isolated from a ΔleuO mutant carrying the empty vector was analyzed. 
Comparison of cas gene transcription levels between the LeuO-expressing strain and 
the control strain revealed a significant upregulation of transcription of casABCDE and 
cas1 and cas2 transcription, showing a gradual decrease from casA (65-fold) to cas2 
(5-fold) (Table 6.1). No change in the transcription level of cas3 was detected. These 
results are consistent with a polycistronic transcription of the casABCDE and possibly 
the cas1, cas2 genes, with polar effects for the transcription of the more downstream 
genes. However, we did not observe significant differences in cas gene transcription 
in the ΔleuO mutant compared to the wildtype strain (Table 6.1), indicating that leuO is 
not expressed under the growth conditions used here. 
To verify the observed increase in cas gene expression levels, quantitative PCR (qPCR) 
was performed on total RNA isolated from 3 strains during mid-exponential phase: wt 
E. coli, a ∆hns strain and a wt strain expressing leuO from a plasmid. This analysis 
showed that casABCDE displayed increased transcription in both hns knockout and 
leuO expressing strains (Fig. 6.1B). While the increase in casABCDE transcripts was 
pLeuO / wt ΔleuO / wt
gene fold-changea p valueb fold-changea p valueb
cas3 1.0 n. s. 0.93 1.1 n. s. 0.76
casA 65.4 < 0.05 -1.2 n. s. 0.08
casB 30.0 < 0.05 -1.1 n. s. 0.20
casC 24.8 < 0.05 1.0 n. s. 0.81
casD 17.5 < 0.05 1.1 n. s. 0.68
casE 15.4 < 0.05 -1.2 n. s. 0.31
cas1 8.8 < 0.05 1.2 < 0.05
cas2 5.4 < 0.05 1.1 n. s. 0.34
a The fold change of cas genes expression was determined by microarray analysis. pLeuO / wt indicates the ratio 
of cas transcripts detected upon overexpression of LeuO (using plasmid pKEDR13) as compared to wildtype E.coli 
K12 (transformed with the empty vector plasmid pKESK22). ΔleuO / wt indicates the ratio of cas transcripts detected 
in a ΔleuOFRT mutant as compared to wildtype.
b n.s. is not significant
Table 6.1. Microarray analysis of activation of cas genes by LeuO
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modest in hns knockout strains, on average 5-fold, the effect of introducing leuO was 
more dramatic, with an average increase of 236-fold after induction of leuO expression. 
An increase in casABCDE transcripts was also observed when leuO expression was 
not induced, due to leakage from the PT5/lac promoter. The cas1 and cas2 genes 
also displayed increased transcript abundance in leuO expressing strains, although at 
lower levels than casABCDE. Consistent with the microarray data, a trend of transcript 
fold change was observed, with polar effects downstream of casA, again suggesting 
a polycistronic mRNA of the casABCDE12 operon. Compared to the effect on the 
other cas genes, only a small increase of cas3 transcription was observed in leuO 
expressing strains.
Figure 6.1. LeuO and H-NS regulate cas gene expression. A) Schematic illustration of the CRISPR/Cas locus 
in E. coli K12 that consists of 8 cas genes (cas3 (ygcB), casA (ygcL or cse1), casB (ygcK or cse2), casC (ygcJ or 
cse4), casD (ygcI or cas5e), casE (ygcH or cse3), cas1 (ygbT) and cas2 (ygbF)) and a downstream CRISPR locus 
containing 12 spacers and 13 repeats (CRISPR I). The cas3, anti-cas3 (anti-Pcas), casA (Pcas) and CRISPR I 
promoter are indicated with an arrow (Pul et al., 2010). B) qPCR analysis of cas gene transcript abundance in E. 
coli Δhns and E. coli W3110 expressing leuO (induced or non-uninduced). Fold changes are given as compared to 
wt E. coli W3110 expression levels. Error bars indicate one standard deviation.
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To further evaluate the effects of H-NS and LeuO on transcription from the casA 
promoter (known as Pcas (Pul et al., 2010)), RNA samples from wt strains expressing 
leuO from a plasmid and strains lacking hns were compared by primer extension 
analysis. No cas transcripts were detected in wt cells containing an empty expression 
vector. Transcripts directed from Pcas were only detected in cells expressing leuO 
from a plasmid or in hns knockout strains (Fig. S6.1), indicating that transcription of the 
casABCDE12 operon is tightly controlled by H-NS and LeuO. 
LeuO causes increased crRNA abundance
The CRISPR I locus is transcribed in E. coli K12 and the transcript is cleaved by 
the CasE subunit of Cascade into small crRNAs that subsequently remain bound by 
Cascade (Brouns et al., 2008; Pul et al., 2010). In K12 small crRNAs were virtually 
undetectable by Northern blot analysis (Brouns et al., 2008) and (Fig. 6.2A). To 
investigate whether this was due to too low transcription levels of casABCDE, the wt 
strain was transformed with a plasmid encoding the Cascade protein components under 
control of an arabinose-inducible promoter. In the wt strain expressing casABCDE from 
a plasmid, crRNAs with a length of about 60 nt could be detected. The requirement 
for plasmid-encoded synthesis of Cascade for detection of small crRNAs indicates 
that the level of Cascade in wt E. coli is insufficient for generating and stabilizing 
mature crRNAs. Furthermore we analyzed the levels of crRNAs in an hns knockout 
Figure 6.2. Formation of mature crRNA. A) Northern analysis of total RNA from wt E. coli K12 and wt E. coli K12 + 
casABCDE (pNH6) using the single stranded spacer sequence NH30 (Table S6.2) as a probe. B) Northern analysis 
as in (A) of total RNA from E. coli K12 Δhns and C) wt E. coli K12 expressing leuO from a plasmid (pNH41) with an 
OD600 of 0.5, 1 and 3.0. M, size marker (pUC19/MspI ladder). E. coli K12 ΔcasA (JW2730) serves as a control and 
marker for mature crRNA.
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strain and in the wt strain expressing leuO constitutively from a plasmid. Both deletion 
of hns and over-expression of leuO caused significant crRNA accumulation, due to 
enhanced expression of Cascade in these two strains (Fig. 6.2B and C). The CasA 
knockout strain (JW2730) serves as a control and marker for the mature crRNA. It was 
previously shown that a CasA knockout strain generates elevated levels of mature 
crRNA (Brouns et al., 2008), due to read-through of the downstream cas genes from 
the kanamycin resistance marker containing recombination cassette by which the casA 
gene is replaced (Pougach et al., in press).
Binding of LeuO and H-NS to the DNA sequence upstream of casA
The casA-cas3 intergenic region (here denoted IGLB) contains Pcas, for which H-NS 
has strong binding affinity as well as the divergently oriented anti-cas3 (known as anti-
Pcas) promoter, that is located 80 bp upstream of Pcas and gives rise to an antisense 
transcript of unknown function (Fig. 6.1A and Fig. 6.3C) (Pul et al., 2010). Both LeuO 
and H-NS bind the IGLB fragment, as determined by Electrophoretic Mobility Shift 
Assay (EMSA) (Fig. 6.3A, lanes 2-4 and 5-7). Pre-bound LeuO impedes cooperative 
binding of H-NS to the IGLB fragment (Fig. 6.3A, lanes 9-11). In line with this, pre-
bound H-NS is partly released from the DNA when LeuO is added to the complex (Fig. 
6.3A lanes 12-15). In order to map the binding region of LeuO within the IGLB fragment 
DNase I footprint analysis was performed. Upon limited DNase I hydrolysis of the IGLB 
DNA fragment, H-NS causes an extended footprint (Fig. 6.3B), as shown before (Pul 
et al., 2010). In addition, LeuO protects two sites (site 1 and site 2) within the IGLB 
fragment that flank the high affinity H-NS nucleation site (Fig. 6.3B and 6.3C). LeuO 
site 1 is located 20 bp downstream of Pcas and LeuO site 2 spans the divergent anti-
Pcas (Fig. 6.3B and C). Interestingly, in the presence of LeuO the extended protection 
by H-NS is no longer visible (Fig. 6.3B, compare lanes 2 and 4), indicating that due to 
LeuO binding the DNA region containing the H-NS high-affinity binding site is no longer 
protected from DNase I cleavage, in agreement with decreased cooperative binding 
(Fig. 6.3A). 
In order to analyze the effect of LeuO on RNA polymerase (RNAP) binding to the 
promoter sites, DNase I footprints were performed in the presence of RNAP and LeuO. 
Moreover, the effect on transcription initiation and RNAP open complex formation was 
analyzed by KMnO4 footprints of stable initiation complexes. RNAP binds to the two 
promoters (Pcas and anti-Pcas) (Fig. 6.4A, lanes 3 and 3’, indicated I (Pcas) and II 
(anti-Pcas)) (Pul et al., 2010). Addition of the DNA binding proteins LeuO or H-NS 
alone does not cause changes in the KMnO4 reactivity (Fig. 6.4A, lanes 2’, 4’ and 5’). 
Binding of LeuO abolishes the spreading of H-NS along the DNA, resulting in a lack of 
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Figure 6.3. H-NS and LeuO binding to the DNA region upstream of casA (the IGLB fragment). A) Electropho-
retic Mobility Shift Assay (EMSA) of the IGLB fragment with LeuO and H-NS, either alone (lanes 5-7) or with pre-
bound LeuO and subsequent addition of H-NS (lanes 8-11) or pre-bound H-NS and subsequent addition of LeuO 
(lanes 12-15). B) DNase I footprint of IGLB in the presence of either H-NS or LeuO or both. LeuO was pre-incubated 
with the reaction mixture. The 2 main regions protected by LeuO are indicated. The ladder indicates the IGLB coor-
dinates relative to the casA start codon, indicated in C) the sequence and coordinates of IGLB, with the H-NS and 
LeuO binding sites indicated with boxes. See also Fig. 6.4A for footprints showing the LeuO binding region I.
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protection by H-NS in the region between positions -160 to -240 (Fig. 6.4A, compare 
lanes 2 and 5), as observed before (Fig. 6.3B). When RNAP binding was studied in the 
presence of both transcription factors it turned out that the order of addition to the DNA 
is crucial for the resulting footprint. RNAP binding was only affected when H-NS and/or 
LeuO were added to the DNA prior to RNAP. While prior binding of H-NS to the IGLB 
DNA fragment completely abolished RNAP-promoter interaction and open complex 
formation (Fig. 6.4A and B, compare lanes 3’ and 6’), prior binding of LeuO had a 
repressive effect only on RNAP binding at anti-Pcas (Fig. 6.4A and B, compare lanes 
3’ and 7’; Fig. 6.4E, lane 5’). This can also be seen on the retardation gels (Fig. 6.4C 
and D), where the DNA/RNAP complex II is lost in the presence of LeuO (Fig. 6.4C, 
lane 7). This complex remains stable when H-NS is added last (Fig. 6.4C, lane 9), in 
contrast to a sample with only H-NS or where H-NS is added before LeuO (Fig. 6.4C, 
lanes 6 or 8, respectively). Moreover, the change in nucleotide reactivities indicates 
that LeuO binding alters the architecture of the transcription initiation complex at the 
Pcas promoter (compare Fig. 6.4B, lanes 7’ with Fig. 6.4A, line 3’ and Fig. 6.4E, lane 
3’ with lane 5’). Altogether these data indicate that LeuO plays an important role in 
the regulation of casABCDE12 gene expression by antagonizing H-NS-dependent 
repression of Pcas.
H-NS and LeuO regulate CRISPR-based immunity against phage infection 
The effect of H-NS on CRISPR-based defense against phage infection was analyzed in 
wt and ∆hns E. coli strains, grown in Luria Bertani broth. Since none of the spacers of E. 
coli K12 target known bacteriophages, an artificial seven spacer CRISPR (J3) with the 
native promoter was designed containing one spacer that targets the template strand 
of the gene encoding the phage Lambda tail protein (J). A non-targeting (N) CRISPR 
(Brouns et al., 2008) served as a negative control. Introducing the J3 CRISPR reduced 
the sensitivity to virulent phage Lambda  (λvir) infection 4-fold in the ∆hns but not in the 
wt strain (Fig. 6.5A). Complementation of the ∆hns strain reversed the reduction in 
phage sensitivity, demonstrating that CRISPR-based defense is negatively regulated by 
H-NS (Fig. 6.5A). When cells were grown in richer media (2YT) until stationary growth 
phase, higher resistance levels were observed, up to a 10-fold reduced sensitivity 
compared to a non-targeting strain (data not shown). Moreover, plaques were much 
smaller in the hns knockout strains equipped with the J3 CRISPR when using 2YT.
Further evidence that H-NS controls CRISPR-based immunity was obtained using 
genetically engineered strains (Table S6.4) in which the genomic CRISPR I locus was 
replaced by the J3 or a non-targeting CRISPR. E. coli K12∆CRISPRI::CRISPRJ3 (E. 
coli J3) was fully sensitive to infection by phage Lambda, despite the presence of a 
genomic J3 spacer (Fig. S6.2). However, when the dominant negative hnsG113D mutant 
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Figure 6.4. Effects of LeuO and H-NS on RNA polymerase open complex formation at the IGLB fragment. 
A) and B) show either DNase I (lanes 1-14) or KMnO4 (lanes 1’-14’) footprint analyses of the non-template strand 
of IGLB after binding of RNA polymerase, H-NS or LeuO, either individually or in combination. The numbers above 
the lanes indicate the order of addition of the respective proteins. The casA promoter (Pcas) (I) and the anti-cas3 
promoter (anti-Pcas) (II) are indicated. The arrowheads indicate the nucleotides within open complexes at the pro-
moter sites. C) and D) show the binding of RNA polymerase, H-NS or LeuO, either individually or in combination. 
C) shows Electrophoretic Mobility Shift Assays of the samples in (A) and (B). The numbers above the lanes indicate 
the order of addition of the respective proteins. D) shows Electrophoretic Mobility Shift Assays of the samples in (E). 
The positions of the free DNA and complexed DNA are given on the left. The retardation gels (C) and (D) are not 
standard retardation gels but controls for the footprint complexes to see if no major decomposition has occurred. 
Because complexes are kept at 30°C for some time under RNAP binding conditions these gels are sometimes dif-
ferent from standard retardation experiments (e.g. Fig. 6.3A). E) Shows a similar analysis as in (A) and (B) for the 
template strand of IGLB (DNase I footprint lanes 1-8; KMnO4 footprint lanes 1’-8’). The protein concentrations used 
are H-NS (1 μM), LeuO (1 μM) and RNA polymerase (50 nM).
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was expressed from a plasmid, the sensitivity of E. coli J3 to phage λvir infection was 
reduced 3.6 fold (Fig. S6.2). This mutant still forms heterodimers with wt H-NS, but does 
not bind DNA and therefore interferes with H-NS mediated transcriptional repression 
resulting from the formation of higher-order DNA-protein complexes (Ueguchi et al., 
1996). This observation is consistent with the reported finding that expression of hns 
mutant G113D induces transcription from Pcas in wt E. coli (Pul et al., 2010).
When plaque assays were performed in E. coli J3 over-expressing leuO from a 
plasmid, a ~6 fold reduced sensitivity to phage λvir infection was observed (Fig. 6.5B), 
demonstrating that LeuO activates CRISPR-based defense in E. coli. A 3-fold reduced 
sensitivity was observed when leuO expression was not induced, probably due to 
Figure 6.5. Effect of H-NS and LeuO 
on CRISPR-based resistance in 
vivo. A) A synthetic CRISPR with one 
spacer (J3) targeting phage Lambda on 
a plasmid (pWUR564) is introduced in 
E. coli K12Δhns, E. coli K12, and com-
plemented E. coli K12Δhns expressing 
hns from the pHOP11 plasmid. Phage 
resistance is monitored by determin-
ing the efficiency of plaquing (EOP) 
after challenge with virulent Lambda 
phage. B) The effects of leuO (pKE-
DR13) and cas3 (pWUR608) expres-
sion on phage resistance is monitored 
in E. coli K12ΔCRISPRI::CRISPRJ3 
(indicated as J3) C) The effect of intro-
ducing the casABCDE12 (pWUR607), 
cas3 or a CRISPR on phage re-
sistance is monitored in E. coli 
K12ΔCRISPRI::CRISPRJ3 (indicated 
as J3).
103
tranScriPtiOnal regulatiOn Of criSPr/caS by h-nS and leuO 
6
leakage from the Ptac promoter. When E. coli J3 cells were grown to stationary phase 
in rich 2YT medium, an increased resistance level was observed with turbid and very 
small plaques in the leuO over-expressing strains containing a targeting CRISPR (data 
not shown), whereas plaques in the same strain containing a non-targeting CRISPR 
were clear and of normal size. Although cas3 gene expression was not strongly induced 
when LeuO was expressed from a plasmid (Table 6.1 and Fig. 6.1B), the expression 
of cas3 was not a limiting factor for resistance, since introduction of a cas3 expression 
plasmid into E. coli J3 expressing leuO did not lead to elevated resistance levels 
(Fig. 6.5B). When a plasmid expressing casABCDE12 was introduced in E. coli J3, 
a 2.5-fold reduced sensitivity to phage infection was observed (Fig. 6.5C), which was 
not observed when a CRISPR expression vector containing spacer J3 or a plasmid 
encoding cas3 was introduced (Fig. 6.5C), indicating that expression of the genes 
encoding Cascade (casABCDE) is limiting for CRISPR-based defense in wt E. coli .
Discussion
The type E CRISPR/Cas system (Cse (Haft et al., 2005)) is present in many 
proteobacteria and in some actinobacteria, firmicutes and methanogenic archaea. 
A recent analysis of a collection of natural isolates shows that this CRISPR/Cas 
subtype occurs in approximately 60% of the E. coli strains (Diez-Villasenor et al., 
2010). The study presented here provides experimental evidence for regulation of the 
type E CRISPR/Cas system in E. coli K12 by the antagonists H-NS and LeuO. These 
antagonistic DNA-binding proteins regulate the expression of several genes in E. coli, 
such as the bgl operon (utilization of β-glucosides) (Ueguchi et al., 1998), the yjjQ-bglJ 
operon (virulence factor and activator of bgl, respectively) (Stratmann et al., 2008) 
and the Salmonella enterica Serovar Typhi ompS1 gene (outer membrane protein and 
pathogenicity determinant) (De la Cruz et al., 2007).
We demonstrate that relieving H-NS-mediated repression of cas gene transcription 
is required for CRISPR-based immunity and that derepression is mediated by LeuO 
through direct binding of DNA sequences upstream of casA. The EMSA and footprint 
results (Fig. 6.3) support the finding that elevated amounts of LeuO counteract H-NS-
mediated repression of casABCDE12 in vivo. Moreover, these data indicate that LeuO-
induced activation of transcription from the casA promoter (Pcas) does not simply 
result from a displacement of bound H-NS, since LeuO cannot facilitate the binding of 
RNA polymerase when H-NS is pre-bound. Instead, LeuO abrogates the cooperative 
spreading of H-NS upon binding to the casA promoter region. Interestingly, the transcript 
levels of the casABCDE12 operon were higher in cells expressing leuO than in hns 
knockout strains (Fig. 6.1B), suggesting that either LeuO functions as an enhancer of 
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casABCDE12 transcription, or that derepression in K12∆hns is incomplete. The latter 
could be due to additional repressors involved in silencing casABCDE12, or due to 
functional redundancy between suppressors of gene transcription. In particular, StpA 
has been reported to possess high binding affinity for Pcas (Pul et al., 2010). Although a 
K12∆stpA strain showed similar cas gene transcript levels as a wt K12 strain (Pul et al., 
2010) it cannot be excluded that StpA-mediated repression of cas gene transcription 
takes place in the absence of H-NS.
Cells expressing leuO showed higher resistance levels compared to hns knockout 
strains, due to the higher expression of the cas genes and higher abundance of 
mature crRNA (Fig. 6.1B and Fig. 6.2BC). Compared to the CRISPR-based resistance 
levels to phage infection observed in Streptococcus thermophilus (Barrangou et al., 
2007) or E. coli BL21-AI over-expressing the cas genes and the CRISPR (Brouns 
et al., 2008), the resistance levels of wt E. coli over-expressing leuO are relatively 
low. However, at present it is unknown whether a similar level of CRISPR-based 
immunity can be reached by wt E. coli, and if it can, under what conditions. Although 
we were able to show that CRISPR-based immunity is activated by overproducing 
LeuO, the natural growth conditions that induce CRISPR-based defense are still 
unknown. Our experiments show that a genomic anti-Lambda spacer alone does not 
provide resistance to phage infection in wt E. coli due to the absence of Cascade. 
We speculate that leuO expression levels under laboratory growth conditions are too 
low to induce derepression of Pcas, and that phage exposure itself does not activate 
CRISPR-defense. Unaltered expression of leuO and the cas genes was also observed 
during infection with bacteriophage PRD1 (Poranen et al., 2006).
Since H-NS is known to bind DNA of incoming phage or plasmid directly (Navarre et 
al., 2006; Navarre et al., 2007) this might result in redistribution of H-NS (Dillon et al., 
2010; Doyle et al., 2007), allowing expression of the Cascade genes due to decreased 
local concentrations of the repressor. As leuO expression is negatively regulated by 
H-NS and positively by LeuO itself (Chen et al., 2005; Hommais et al., 2001), this 
would further amplify the activating signal for cas gene transcription. Interestingly, leuO 
expression levels are induced by the alarmone guanosine tetraphosphate (ppGpp) 
(Chen et al., 2001; Fang et al., 2000; Majumder et al., 2001). ppGpp is involved in stress 
signaling cascades leading to the stringent response under nutrient limiting conditions. 
Since these conditions slow down phage proliferation dramatically (Schrader et al., 
1997), bacterial cells may then stand a better chance of surviving phage encounters, 
hence inducing CRISPR-based defense may be more beneficial. However, induction 
of the stringent response by amino-acid starvation, e.g. by serine hydroxamate (Tosa 
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and Pizer, 1971) neither increased the transcription from Pcas nor the formation of 
mature crRNA (data not shown). Although under laboratory conditions CRISPR-based 
defense is suppressed, the diversity in spacer content in natural isolates of E. coli 
strongly suggests that the CRISPR/Cas system as a whole is active and functional in 
natural ecosystems (Diez-Villasenor et al., 2010).
In an independent parallel study, it has been shown that an E. coli hns knockout strain 
containing an anti-Lambda spacer is less sensitive to phage infection (Pougach et al., 
in press), in agreement with the data presented here. It seems that the ∆hns strain 
containing the T3 spacer used in (Pougach et al., in press), shows higher levels of 
resistance than the ∆hns strain containing the J3 spacer that was used in this study. 
The T3 spacer has originally been described (Brouns et al., 2008) as the spacer that 
confers the highest level of immunity of 8 different spacers tested. In BL21-AI over-
expressing the casABCDE and cas3 genes together with either the T3 CRISPR or the 
J3 CRISPR showed that the T3 CRISPR provides 10-fold more resistance (data not 
shown), indicating that the observed difference in immunity between (Pougach et al., 
in press) and this study is most likely resulting from a difference in the efficiency of the 
spacers used. 
Although a number of studies involving H-NS and LeuO have been carried out in E. 
coli and S. enterica (Hernandez-Lucas et al., 2008; Hommais et al., 2001; Lucchini et 
al., 2006; Navarre et al., 2006; Shimada et al., 2009), the outcome of these studies 
has never been interpreted in the light of CRISPR-based defense. Based on these 
genome-wide analyses we propose that the expression of the type E (Cse) cas genes 
from Salmonella enterica are likely to be regulated by H-NS and LeuO as well. For 
instance, in S. enterica Serovar Typhi transcription of casA (STY3070) appears to 
be affected by H-NS and LeuO (Hernandez-Lucas et al., 2008), despite the poor 
conservation of the intergenic region between the divergently oriented cas3 and casA 
genes in this strain. In S. enterica Serovar Typhimurium strain LT2 H-NS binding sites 
were found encompassing the translation start site of the cas3 gene (Lucchini et al., 
2006). Another study showed that in this strain the transcription of cas3, casB, casC 
and casD is elevated in the absence of H-NS (Navarre et al., 2006). Perhaps the cas 
genes are controlled by a single promoter in this strain, since the intergenic region 
between cas3 and casA is only 12 nucleotides in length. Altogether, this study provides 
evidence that the type E CRISPR/Cas system in E. coli is regulated by the antagonists 
H-NS and LeuO, and we propose that this regulatory mechanism is conserved in S. 
enterica as well. The upcoming challenge will be to identify conditions that activate this 
sophisticated defense system to allow defense against invasion by foreign DNA.
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Experimental procedures
Strains
The wildtype E. coli K12 W3110 (BW25113) strain and the E. coli K12 W3110 derivative 
∆hns (JW1225) and ∆casA (JW2730) from the KEIO collection (Baba et al., 2008), 
supplied by the American Type Culture Collection (ATCC), and E. coli K12 MC4100 
(Peters et al., 2003) derivative ∆hns (PD32) (Dersch et al., 1993) were used throughout 
the study.
Gene cloning and recombination 
A synthetic recombination cassette was designed corresponding to 400 bp flanking 
regions on each side of the CRISPR I locus separated by a kanamycin resistance 
gene flanked by FRT-sites (GAAGTTCCTATACTTTCTAGAGAATAGGAACTTC). The 
construct contained a PstI site followed by 400 nt of the CRISPR I upstream region 
of the E. coli K12 W3110 genome (2875875-2876274), followed by a NcoI site, then 
the sequence AAACAAAGAATT, a KpnI site, followed by an FRT-site, a SphI site, a 
kanamycin resistance gene with a sequence corresponding to pJJDuet30 (2186-1276), 
a XhoI site, an FRT site, a NotI site, and 395 nt of the CRISPR I downstream region of the 
E. coli K12 W3110 genome (2877225-2877619) (GeneArt AG, Regensburg, Germany). 
A synthetic CRISPR sequence including leader sequence containing 7 spacers and 8 
repeats was used (Table S6.1) (Geneart AG, Regensburg, Germany). This synthetic 
CRISPR was cloned between the flanking regions using the NcoI and KpnI sites 
(Fig. S6.3). The NcoI and EcoRI sites in the leader and second spacer were used to 
exchange the first spacer sequence of the CRISPR; the constructs created were named 
J3 and R44 (Table S6.1). The other spacers in the CRISPR were sequences with no 
homology to phage Lambda. These constructs were used as recombination cassettes 
to replace the existing CRISPR I locus in the E. coli K12 W3110 genome, following a 
protocol described elsewhere (Datsenko and Wanner, 2000), with minor modifications. 
For recombination, the sequences were PCR-amplified using primers BG3017 and 
BG3019 (Table S6.2) with high fidelity pfu-turbo polymerase and transformed by 
electroporation into E. coli K12 W3110 containing pKD46, kindly provided by the 
ATCC. Transformants were grown at 30°C and plated on LB-Agar + kanamycin (50 µg 
ml-1). The pKD46 plasmid has a temperature sensitive origin of replication, and was 
removed through growth at 37°C (Datsenko and Wanner, 2000). Recombination was 
validated by PCR and sequencing. The antibiotic resistance cassette was removed 
using Flp recombinase encoded on plasmid pCP20, and subsequent growth at 37°C, 
as described (Datsenko and Wanner, 2000). The ΔleuO mutant was constructed with 
the λred-gam system using oligonucleotides T209 and T210 (Table S6.2), as described 
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(Datsenko and Wanner, 2000). After deletion of leuO the resistance cassette used for 
selection was removed using Flp recombinase encoded on plasmid pCP20 (Datsenko 
and Wanner, 2000).
Plasmids and Vectors
Plasmid pWUR607 (TetR) contains the casABCDE12 operon, which was PCR-amplified 
from E. coli K12 MG1655 genomic DNA using primers BG2173 and BG2174 (Table 
S6.2), and cloned into vector pACYC184 using the restriction sites EcoRI and NcoI. 
Plasmid pWUR608 (CamR) was constructed by cloning a cas3 amplicon generated with 
primers BG2171 and BG2172 (Table S6.2) into pACYC184 using the restriction enzymes 
BamHI and SphI. In the experiments where a CRISPR was introduced on a plasmid, 
the pACYCduet-1 vector (CamR) (Novagen) was used, using the NcoI and Acc65I 
restriction sites. pWUR477 containing the non-targeting CRISPR (N) was described 
previously (Brouns et al., 2008). Expression of the CRISPR from this plasmid in K12 
was under control of the leader sequence that contains the CRISPR I promoter (Pul 
et al., 2010). pWUR564 is a derivative of pWUR477 that has the NcoI-EcoRI fragment 
(containing the leader sequence up to half of the second spacer) replaced with the NcoI-
EcoRI fragment of construct J3 (Table S6.1). For expression of wt hns and hnsG113D the 
previously described pHOP11 and pHM52 plasmids were used, respectively (Pul et al., 
2010). The pCA24N plasmid from ASKA(-) clone JW0075 encodes leuO behind an PT5/
lac promoter (IPTG inducible). pKEDR13, encoding leuO behind a Ptac promoter (IPTG 
inducible), and the control vector pKESK22 were described earlier (Madhusudan et al., 
2005; Stratmann et al., 2008). The IPTG inducible leuO expression plasmid pNH41 
was constructed by cloning the leuO amplicon, generated using primers NH329 and 
NH330 (Table S6.2), into the 2.2 kb XbaI fragment of pZE12-luc, following a previously 
published protocol (Urban and Vogel, 2007). Plasmid pNH6 contains the casABCDE 
operon (PCR amplified with pre-phosphorylated primer NH193 and primer NH194 
(Table S6.2)) inserted by blunt end and EcoRI cloning into vector pCU01 (pBAD-TOPO 
vector derivative), as described (Unoson and Wagner, 2008). Plasmid pUC18-IGLB 
was described before (Pul et al., 2010). 
Microarray
E. coli K12 MG1655 was transformed with plasmid pKEDR13 (KanR lacIq Ptac leuO) 
(Stratmann et al., 2008) for expression of LeuO or with control vector pKESK22 (KanR 
lacIq Ptac). Exponential cultures were inoculated from fresh overnight cultures to an 
OD600 of 0.1 in LB supplemented with 25 µg ml
-1 kanamycin. IPTG was added after 30 
min of growth to a final concentration of 1 mM. After additional 60 minutes the bacteria 
were harvested using Qiagen RNAprotect and used for RNA isolation using the Qiagen 
108
chaPter 6
6
RNeasy MiniKit system. In brief, 1 ml of each culture (OD600 between 0.5 and 0.6) 
was used and processed according to the manufacturer’s instructions including DNase 
I on-column treatment. RNA quality was assayed by denaturing urea-PAGE and by 
measuring the ratio of absorption at 260/280 nm in a GeneQuant II spectrophotometer 
(Amersham). RNA concentration was determined by measuring UV light absorption at 
260 nm. The procedure was carried out four times with independent clones. Synthesis 
of cDNA (and cRNA) and hybridization of Affymetrix GeneChip® E. coli Genome 2.0 
microarrays was carried out according to the manufacturer’s instructions. In total, 
four independent RNA samples of each group (wildtype, leuO expressing and leuO 
deficient strains) were used. Data analysis was performed using Affymetrix Software. 
Fluorescence values were normalized to the GeneChip standard reference probes. 
Differential expression values were calculated as fold-change of leuO expressing 
samples compared to samples of LeuO-deficient control strains.
qPCR analysis of gene expression
qPCR analysis of cas gene transcript abundance was performed on cDNA synthesized 
using High Capacity Reverse Transcription Kit (Applied Biosystems) from RNA 
extracted by the hot-phenol method (Blomberg et al., 1990) and DNase-treated using 
Turbo DNA-free kit (Ambion). 10 ml samples for RNA extraction were taken at OD600 
~0.5 from E. coli W3110, E. coli W3110 carrying pCA24N (leuO) and E. coli Δhns 
(JW1225-2). When LeuO expression was induced, samples were taken 30 min after 
addition of 0.5 mM IPTG. The qPCR reactions were performed using Power SYBR 
green PCR master mix (Applied Biosystems) according to manufacturer’s instructions, 
and primers were designed using Primer Express 3.0 (Applied Biosystems). For the 
complete list of primers used see Table S6.3. Two primer pairs were designed against 
casA as internal control. The PCR reactions were performed on a 7300 Real Time PCR 
System (Applied Biosystems) and analyzed using 7300 System SDS Software 1.3 
(Applied Biosystems). Fold change of cas gene transcription was calculated using the 
relative quantification method with tmRNA as endogenous control and E. coli W3110 
cas gene transcript abundance as calibrators. All PCR reactions were performed in 
six replicates. Control PCRs without template or without cDNA (produced by standard 
cDNA synthesis but excluding reverse transcriptase) were performed to monitor general 
contamination levels and genomic DNA contamination of RNA extracts, respectively.
Northern Blotting
Total RNA was extracted at the OD600 indicated using TRIZOL reagent (Invitrogen) 
according to the manufacturer’s protocol. Expression of casABCDE from pNH6 was 
induced at an OD600 of 0.5 by adding 0.2% of arabinose for 15 min. 10 µg of total 
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RNA was denatured at 95°C with an equal volume of formamide loading dye, FD 
(90% formamide, 15 mM EDTA, 0.05% bromophenol blue and 0.05% xylene cyanol), 
and subsequently separated on an 8% denaturing polyacrylamide gel. A 32P-labeled 
pUC19 DNA/MspI ladder (Fermentas) was used as size marker. The RNA was 
electrotransferred to Nylon N+ membranes (GE Healthcare) at 10 V for 15h. Transfer 
was performed in a BIORAD blotting chamber in 1xTBE buffer at 4°C followed by 
drying of the membrane and UV-crosslinking. Prehybridization was carried out for 2–4 
h at 42°C in 15 ml prehybridization buffer (5x SSC, 5x Dernhardt, 0.05 M sodium 
phosphate pH 6.7, 1% dextran sulphate, 0.1% SDS) together with 75 µl herring sperm 
DNA (20 mg ml-1). Hybridization was carried out overnight at 42°C in the same buffer 
lacking herring sperm DNA but containing [γ-32P]-ATP-labeled oligonucleotide probe 
NH30 (Table S6.2) specific for spacer 2 of the CRISPR1 locus. The probe was labeled 
with [γ-32P]ATP (40 pmol DNA, 10x kinase buffer, T4 polynucleotide kinase (PNK, 
Ambion), [γ-32P]ATP) by incubation at 37°C for 45 min. Prior to hybridization, the probe 
was purified over a G-50 column (GE Healthcare). Membranes were washed once for 
20 min at 60°C in 2xSSC, 0.5% SDS and once for 20 min in 0.5x SSC, 0.5% SDS. 
Signals were quantified in a Molecular Dynamics PhosphorImager model 400S with 
ImageQuant software version 4.2a (Molecular Dynamics).
Electrophoretic Mobility Shift Assay
E. coli RNAP, LeuO and H-NS were purified according to published procedures (Pul 
et al., 2010; Stratmann et al., 2008). The IGLB fragment (position -1 to -414, relative 
to the first nucleotide of the casA (ygcL) start codon) was obtained by EcoRI/HincII 
or BamHI/SacI digestion of plasmid pUC18-IGLB. Purified DNA fragments were end-
labelled by Klenow (Promega) and [α-32P]-dATP. Binding reactions with the indicated 
amounts of protein were performed in 50 mM Tris-HCl, pH 7.4, 70 mM KCl, 15 mM 
NaCl, 1 mM EDTA, 10 mM β-mercaptoethanol at a final heparin concentration of 20 ng 
µl-1. Complexes were separated on native 5% (w/v) polyacrylamide gels and visualized 
by autoradiography as described (Pul et al., 2010).
Footprint analyses
DNase I footprinting of free DNA and DNA-protein complexes was performed as 
described (Pul et al., 2010). Formation of open RNAP-promoter complexes was 
analyzed by KMnO4 modification of single-stranded nucleotides within the transcription 
bubble. 40 µl RNAP-DNA complexes were treated with 160 mM KMnO4 for 2 min 
at 30°C. The reaction was stopped by addition of 5.3 µl β-mercaptoethanol and 5.3 
µl 500 mM EDTA and the samples were ethanol precipitated after phenol/chloroform 
extraction. Pellets were dissolved in 10% piperidine and incubated at 90°C for 30 min. 
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After two rounds of washing with distilled water followed by lyophilizing, the pellets were 
dissolved in 50 µl distilled water and precipitated with ethanol. Cleavage products were 
separated on 10% denaturing polyacrylamid gels and visualized by autoradiography. 
The following protocol was used in footprint experiments with more than one protein: 
LeuO or the protein-free buffer, and H-NS or the respective buffer, were incubated with 
the template DNA for 5 min at 30°C. Next RNAP or the RNAP dilution buffer was added 
and incubated for another 10 min. Finally heparin was added to a final concentration 
of 200 ng µl-1 with a further incubation at 30°C for 5 min. An aliquot of this solution was 
loaded on a native gel to verify complex formation and the remaining solution was used 
for the different footprint experiments. 
Primer extension analysis
Primer extension reactions with 25 µg total RNA hybridized to a radiolabeled specific 
cas primer oligonucleotide (5’-ATACAATTAATCTATACATATATTAAGATG-3’) were 
performed with AMV reverse transcriptase (Promega) as described (Afflerbach et al., 
1998).
Phage Lambda infection studies
Host sensitivity to phage infection was tested using a virulent phage Lambda (λvir), as 
before (Brouns et al., 2008). The host strains for infection were either wt E. coli K12 
W3110, E. coli K12 W3110 ∆hns, or the engineered E. coli K12 W3110 strains (E. 
coli K12∆CRISPRI::CRISPRJ3 and E. coli K12∆CRISPRI::CRISPRR44) (Table S6.4). 
The sensitivity of the host to infection was calculated as the efficiency of plaquing (the 
plaque count ratio of a strain containing an anti-Lambda CRISPR to that of the strain 
containing an non-targeting CRISPR) (Brouns et al., 2008). 
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Supplementary figures
Figure S6.3. Recombination cassette used to generate strains E. coli K12ΔCRISPRI::CRISPRJ3 and E. coli 
K12ΔCRISPRI::CRISPRR44, that differ in the first spacer of the CRISPR.
Figure S6.1. Antagonistic regulation of 
transcription from the casA promoter 
(Pcas) by H-NS and LeuO.The transcrip-
tional activity of the casA promoter (Pcas) 
was tested by primer extension analysis us-
ing 25 µg total RNA isolated from wt or Δhns 
cells transformed with the control vector 
pKESK22 or the LeuO expression plasmid 
pKEDR13. RNA was isolated 2h after IPTG 
induction. In lane 5 a G+A-sequencing lad-
der was separated as size marker. The po-
sition of the resulting cDNA product and the 
primer are indicated on the left.
Figure S6.2. Expression of the dominant negative hns mutant G113D causes reduced sensitivity of E. coli 
K12ΔCRISPRI::CRISPRJ3 to phage λ infection as measured by plaque assay. The efficiency of plaquing (EOP) 
is expressed as a ratio of plaque number with E. coli K12ΔCRISPRI::CRISPRR44 (non-targeting CRISPR), as de-
scribed before (Brouns et al., 2008). For these experiments bacteria were grown in 2YT medium.
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Summary 
This thesis focuses on the antiviral and antiplasmid CRISPR/Cas (clusters of regularly 
interspaced short palindromic repeats/CRISPR associated) system of Escherichia coli 
K12, which belongs to the Cse-subtype. In total eight different subtypes have been 
identified in prokaryotes, four of which have been studied experimentally, as described 
in Chapter 1. In general, CRISPR-mediated defense comprises three distinct stages 
and shows clear analogies with RNAi in eukaryotes as described in Chapter 1 (Fig. 
7.1). During the first stage (adaptation) DNA fragments of invading viruses or plasmids 
are integrated as spacers into a CRISPR. During the second stage (expression), which 
is described in Chapter 2, CRISPR loci are transcribed into long precursor CRISPR 
RNA (pre-crRNA) which is subsequently processed by the metal-independent nuclease 
CasE. CasE cleaves within each repeat, generating mature crRNAs that all contain 
an eight nucleotide 5’ handle of the repeat, a spacer and a part of the next repeat 
which includes the stemloop. CasE and the crRNA were shown to be members of the 
CRISPR-associated complex for antiviral defense (Cascade), which also contains the 
protein components CasA, B, C and D. In conjunction with Cas3, Cascade loaded 
with crRNA successfully inhibits phage lambda proliferation as was shown by plaque 
assays using a synthetic CRISPR complementary to the phage nucleic acids. Both 
crRNAs containing spacers complementary to the coding and the non-coding strand 
could inhibit phage proliferation suggesting that  DNA is being targeted. A CasE mutant 
deficient in pre-crRNA processing abolishes immunity, showing that the formation of 
mature crRNAs is essential. The mechanism of recognition, which is at the basis of 
the third stage (interference), is described in Chapter 3. Cascade has the capacity to 
bind dsDNA. The spacer sequence of the crRNA can basepair with its target through 
ATP independent strand displacement, a process which is enhanced by CasA. This 
chapter also provides a more detailed mass and sequence analysis of  crRNA which 
revealed that crRNAs are 61 nucleotides in length, corresponding to one spacer and 
one repeat, and contain a 2’, 3’ cyclic phosphate group. ESI-MS analysis of Cascade 
revealed that it has an unusual stoichiometry of CasA1B2C6D1E1-crRNA1. EM and SAXS 
analysis showed that it adopts a seahorse-like shape in which the backbone is formed 
by 6 CasC subunits. Comparison with the stable subcomplexes CasB2C6D1E1-crRNA1 
and CasC6D1E1-crRNA1 revealed the location of the CasA and two CasB subunits. It 
was also shown that all the subunits and Cas3 are essential for immunity. Chapter 4 
describes how Cas proteins and an anti-lambda CRISPR could successfully inhibit 
transformation of a plasmid that contains a lambda fragment including a protospacer. 
A mutant library was created by error-prone PCR and transformed to cells resistant 
against the unmodified plasmid. Escape mutants were selected and the transformed 
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plasmid was sequenced. The sequence data of the escape mutants revealed three 
types of mutants. These mutants contained mutations in the protospacer and in the 
protospacer adjacent motif (PAM) as well as deletions of the entire protospacer region. 
The PAM might be a criterion to verify that only invading DNA is being targeted. Next 
to mutations in the PAM, mutations in the side of the protospacer that directly flanks 
the PAM can lead to escape. These data show that the PAM and perfect base pairing 
at the PAM-side of the protospacer are essential for immunity. 
Since lambda phages enter their E. coli host at the cellular poles and rapidly replicate, 
we hypothesized that the antiviral Cas protein machinery might be co-located. In order 
to test this hypothesis we used photo-activatable localization microscopy (PALM) 
to determine the location of the Cas proteins at nanoscale resolution (Chapter 5). 
Indeed, at least some of the Cas proteins are located at the cellular pole, which 
might be advantageous to initiate a swift antiviral response. Additionally, it may yet be 
another mechanism of the host to prevent autoimmunity since the chromosome and 
thus CRISPRs are spatially separated from the actual antiviral machinery. Chapter 
6 finally focuses on transcriptional regulation of the system. H-NS was identified as 
a transcriptional repressor. The expression of most cas genes (with the exception of 
cas3), as well as the CRISPR were elevated in an H-NS knockout of E. coli. LeuO 
was identified as a transcriptional activator that functions as an antagonist of H-NS. 
Overexpression of LeuO in a wt E. coli background resulted in elevated casABCDE12 
transcription and crRNA levels. Plaque assays finally demonstrated that H-NS indeed 
represses the CRISPR/Cas system, contrary to LeuO that activates CRISPR/Cas 
mediated defense.  
Figure 7.1. Three different stages in CRISPR-mediated antiviral defense. For full colour version see page 133. 
The different stages are explained in more detail in Chapter 1. Picture adapted from (van der Oost et al. 2009).
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General discussion 
Molecular mechanism
Spacer integration
Although the rapidly expanding research field on CRISPR/Cas results in a steady gain 
of insight, many questions about this fascinating defense system still remain to be 
answered. One poorly understood aspect is the mechanism of spacer integration during 
the adaptation stage. Spacer acquisition in the laboratory has only been observed in 
the lactic acid bacteria Streptococcus thermophilus (Barrangou et al. 2007; Deveau 
et al. 2008; Horvath et al. 2008) and Streptococcus mutans (van der Ploeg 2009). 
An interesting finding is that in most cases spacers were acquired at the leader side 
of the CRISPR. The CRISPR thus provides a chronological record of previously 
encountered phages and/or plasmids. This idea is supported by bioinformatics 
analyses that show that the variation between different similar CRISPRs mainly occurs 
at the leader proximal side (Lillestøl et al. 2006; Diez-Villasenor et al. 2010). A second 
interesting finding is that the protospacer fragment carried a conserved protospacer 
adjacent motif (PAM), which is essential for immunity during the interference stage 
(Chapter 4) (Deveau et al. 2008). If the PAM would only be important at this stage, as 
shown in Chapter 4, one would expect that when multiple spacers are simultaneously 
incorporated in the CRISPR locus only one spacer would match a protospacer with a 
PAM (the other spacer thus being dispensable). However all spacers, including those 
that were simultaneously incorporated, corresponded to a fragment carrying a PAM, 
albeit sometimes imperfect (Deveau et al. 2008). This suggests that the PAM is not 
only important during interference but might also determine whether fragments are 
selected for integration. A PAM sequence is not unique for invading DNA. It is also 
present in the host genome and therefore most likely not the only selection marker 
for integration. Moreover, careful analysis of spacer sequences from a large database 
revealed that protospacers can be found in bacteriophages that are distinct in infection 
characteristics and genome features (Mojica et al. 2009). 
How do cells recognize invading DNA and incorporate this as spacer DNA into the 
CRISPR locus? Integration of spacers could be a random and rare event; the mutants 
that have acquired spacer-directed immunity then become dominant in the population 
by natural selection; Most cells that do not acquire spacers will most likely die. After 
recognition of the invading DNA, either specifically or randomly, it is most likely being 
cleaved into smaller fragments prior to integration. A prime candidate to be involved 
in this process is the Cas1 protein, since it is very well conserved among different 
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subtypes (Jansen et al. 2002; Haft et al. 2005; Makarova et al. 2006; Marraffini and 
Sontheimer 2009), it has non-specific nuclease activity (Wiedenheft et al. 2009), and 
it is not essential for crRNA processing or target interference (Brouns et al. 2008). 
The Cas1 endonuclease generates DNA fragments of ~80 basepairs (Wiedenheft et 
al. 2009), which should be further trimmed before they are incorporated. How these 
fragments are then integrated and why there is a preference for the leader proximal 
side of the CRISPR remains unknown, and should be investigated experimentally. 
Most likely motifs in the leader sequence play a role in this process. It is noteworthy that 
Cas2 has also been hypothesized to be involved in the process of spacer integration 
(van der Oost et al. 2009) since it is neither essential for crRNA processing nor target 
interference (Brouns et al. 2008) and is closely associated with Cas1 (Haft et al. 2005; 
Makarova et al. 2006). Cas2 has endonuclease activity on U-rich regions in ssRNA 
(Beloglazova et al. 2008). How this would fit in the model of spacer integration is 
a mystery. Cas2 could be involved in the primary cleavage of phage mRNA which 
might subsequently be converted into DNA through a reverse transcription step, prior 
to integration. However, this seems to be an elaborate way for the host to integrate 
DNA fragments from a DNA phage. Alternatively, Cas2 might process RNA derived 
from RNA phages, prior to reverse transcription and subsequent spacer integration. 
However, no spacers against RNA elements have been observed till now. To study the 
mechanism of spacer integration in E. coli K12 we have tried to obtain mutants that 
had acquired immunity to phage lambda or phage T3. Different approaches resulted 
in many resistant mutants, but none of them had integrated a spacer in the CRISPR 
locus against the phage (Brouns and Jore, unpublished). A possible explanation for 
this is the high background of other mutations that lead to resistance. One out of 
several strategies for E. coli to escape infection (reviewed in Labrie2010) is by mutating 
essential genes needed by the phage, such as phage receptors; phage lambda binds 
to the maltoporin receptor while phage T3 attaches to the lipopolysaccharides (LPS). 
Indeed, E. coli can mutate the maltoporin directly (Hofnung et al. 1976) and the LPS 
indirectly by mutations in genes involved in the LPS biosynthesis pathway (Qimron et 
al. 2006). An alternative explanation could be the low transcription levels of cas genes 
and CRISPRs due to transcriptional silencing by H-NS (Chapter 6) (Pul et al. 2010). To 
obtain higher rates of spacer integration other E. coli strains carrying the same Cse-
subtype should be subjected to phage infections. Perhaps these strains have a more 
active CRISPR/Cas system. However, lactic acid bacteria such as S. thermophilus 
seem to be the ideal organisms to study the mechanism of spacer integration, since 
spacer integration has been observed in laboratory experiments. 
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CRISPR expression and processing
CRISPR-mediated defense is based on small CRISPR RNAs (crRNAs) . crRNAs have 
been detected in Archaeoglobus fulgidus (Tang et al. 2002), Sulfolobus solfataricus 
(Tang et al. 2005), Sulfolobus acidocaldarius (Lillestøl et al. 2006; Lillestol et al. 2009), 
E. coli (Brouns et al. 2008), Pyrococcus furiosus (Hale et al. 2008), Xanthomonas 
oryzae (Semenova et al. 2009) and Staphylococcus epidermidis (Marraffini and 
Sontheimer 2008). Transcription has been shown to be unidirectional from the AT-rich 
leader sequence (Jansen et al. 2002), Sulfolobus acidocaldarius. being an exception 
to this rule (Lillestøl et al. 2006; Lillestol et al. 2009). The biogenesis of mature crRNAs 
have only been analyzed in E. coli (Brouns et al. 2008) (Chapter 3) and P. furiosus 
(Carte et al. 2008; Hale et al. 2008). In the E. coli Cse-system the mature crRNAs are 
a product of a single endonucleolytic cleavage event by CasE, after which the crRNA 
is retained by Cascade. The 3’ end of the crRNA carries a 2’, 3’ cyclic phosphate. This 
finding in Chapter 3 explains why we had previously cloned and sequenced a pool of 
crRNAs with a well defined 5’ end and less well defined 3’ ends (Chapter 2). During the 
cloning procedure we used poly(A) polymerase to add an adapter to the crRNA, but 
poly(A) polymerase cannot elongate a 2’, 3’ cyclic phosphate end. Most likely partly 
degenerated crRNAs were cloned instead. Mature crRNAs in E. coli differ in their 3’ 
end from the ones that can be found P. furiosus (Hale et al. 2008). In P. furiosus, pre-
crRNA is cleaved by Cas6, which is structurally similar to CasE, and subsequently 
remains bound to Cas6 as shown by in vitro assays. How these crRNAs are further 
processed at the 3’ end to yield mature crRNAs of 39 and 45 nucleotides, and how 
these are transferred to the Cmr-complex is unknown. Perhaps one of the subunits 
of the Cmr-complex is responsible for further processing to mature crRNA. The anion 
exchange chromatography analysis of ribonucleoprotein (RNP) complexes comprising 
mature crRNAs by Hale and coworkers showed at least two distinct peaks (Hale et 
al. 2008). One peak contains dominant crRNAs of 39 and 45 nucleotides. The other 
peak contains crRNAs of 45 nucleotides and a slightly longer species. The complex 
containing the mature crRNAs of 39 and 45 nucleotides is the Cmr-complex, but the 
composition of the other complex has not yet been reported. Perhaps this complex 
is another variant of the Cmr-complex containing proteins that are involved in further 
processing of the intermediate crRNAs. Another interesting question concerns the role 
of the Cst proteins that are encoded in the same CRISPR/Cas locus. Do they form a 
complex containing mature crRNA products, initially cleaved by Cas6, analogous to 
the Cmr-complex? Alternatively, are the Cst proteins involved in generation of mature 
crRNA in the Cmr-complex? Further trimming of the 3’ end has not only been observed 
in P. furiosus, but also in S. epidermidis (Marraffini and Sontheimer 2010b). 
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Despite the differences between crRNAs of the Cmr- and Cse-systems, analogies are 
also present; crRNAs are part of large RNPs and the crRNAs have a conserved eight 
nucleotide 5’ handle, the latter has also been observed in S. epidermidis (Marraffini 
and Sontheimer 2008).
Target recognition and degradation
Some first light has been shed on how these mature crRNAs guide the Cas protein 
machinery to their complementary target in E. coli (Chapter 3) and P. furiosus (Hale 
et al. 2009). In E. coli, crRNA guides Cascade to complementary dsDNA and can 
base pair by strand displacement. The CasA subunit has been proposed to enhance 
target localization of Cascade, CasC forms the backbone of the complex and CasE 
cleaves the pre-crRNA. The role of CasB and CasD is currently unknown. The X-ray 
crystal structure of CasB revealed conserved basic patches on one side of its surface, 
suggesting that it might be involved in RNA or DNA binding (Agari et al. 2008). CasD 
belongs to the diverse Repeat-Associated Mysterious Protein (RAMP) superfamily 
(CasE also belongs to this family); members of this family are hypothesized to be 
involved in RNA binding (Makarova et al. 2006). CasD and CasE might each bind to 
one of the crRNA handles which are the common part of the crRNAs. More details of 
the function of each Cascade subunit are expected to be revealed in the near future. 
Inhibition of phage proliferation is most likely not achieved through just binding of the 
DNA, since overproduction of Cascade and crRNA are not sufficient for resistance 
in vivo (Chapter 2). In addition the Cas3 protein is needed for interference. Cas3 is 
composed of an HD-domain with putative nuclease function and a DEAD-box helicase 
domain. It is very well possible that the HD-domain is important for cleavage of the 
target, thus neutralizing the foreign DNA. Indeed the truncated HD-protein (SSO2001) 
from S. solfataricus has been shown to possess nuclease activity in vitro (Han and 
Krauss 2009). SSO2001 preferably cleaves GC rich regions. The repeats associated 
with this cas gene cluster of the Csa-subtype belong to the CRISPR-7 type (Kunin et al. 
2007). This type is associated with a PAM sequence of NGG (Mojica et al. 2009). One 
cannot rule out the possibility that the G-nucleotides could be a recognition sequence 
for the HD nuclease. However, it is more likely that the activity and specificity of the HD 
nuclease (or other nuclease cleaving the target DNA) is determined by a Cascade-like 
RNP complex. Whether the PAM sequence carries the scissile phosphoester bond is 
not known, but the PAM is at least essential for interference (Chapter 4).
In contrast to DNA being targeted by the Cse-subtype in E. coli and Csm-subtype 
in S. epidermidis (Brouns et al. 2008; Marraffini and Sontheimer 2008), the Cmr-
subtype of P. furiosus has been demonstrated to degrade complementary RNA. The 
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Cmr-complex cleaves complementary RNA following a molecular ruler mechanism, 
which is convincingly shown in vitro (Hale et al. 2009). An obvious question concerns 
which subunit has the nuclease activity. This could be easily determined by site-
directed mutagenesis of conserved motifs in the subunits of the Cmr-complex. A good 
candidate is the Cmr2 protein which contains an HD domain that is fused to a predicted 
polymerase domain. Moreover, the presence of this potential polymerase in the Cmr-
complex is interesting. What would be its role? Polymerases are present in three 
subtypes (van der Oost et al. 2009). Makarova and coworkers predicted that it might 
use the crRNA as a primer to amplify the targeted RNA molecule (Makarova et al. 2006). 
This dsRNA could subsequently be cleaved by other Cas proteins in the complex or 
RNaseIII domain containing proteins. The observation that the crRNAs are lacking a 
3’ handle that would inhibit polymerase activity is well in line with this proposed model. 
RNA cleavage has been shown in vitro but what is the biological function? Is the Cmr-
complex targeting RNA from DNA viruses, which seems less efficient then targeting 
the DNA directly? Alternatively, are there RNA viruses out there that can be targeted? 
Unfortunately no infective viruses for P. furiosus have been described so far to address 
these questions. Moreover, thermophilic RNA viruses have not been identified so far. 
An alternative target for the Cmr complex might be mRNA from P. furiosus itself, which 
would come down to a role for the Cmr-subtype in gene regulation. 
The Cmr-subtype has thus been demonstrated to target RNA (Hale et al. 2009), 
while the Csm-subtype targets DNA (Marraffini and Sontheimer 2008). Interestingly, 
the composition of the Cmr- and Csm-subtype are similar, each containing a putative 
polymerase and four or three RAMP proteins respectively (Haft et al. 2005). It will 
be interesting to study and compare the differences between these two subtypes. 
In general one can say that, although common themes between the CRISPR/Cas 
subtypes are present, the types substantially differ in composition and mechanism of 
action, reflecting the different targets they (might) have.
An ongoing battle between bacteria and phages
One of the most appealing aspects of phage research is the real-time monitoring of the 
ongoing battle between phages and bacteria. Phages can develop different pathways 
to bypass the defense systems of their host, to which the host respond inactivating 
these pathways resulting in resistance to this phage. This is beautifully illustrated by the 
ongoing war between E. coli and phage T4; E. coli adopted a restriction-modification 
system, the phage responded by incorporation of hydroxymethylcytosine (HMC) into 
its genome to bypass restriction, E. coli acquired systems that can specifically cleave 
HMC-containing DNA and so on (reviewed in (Labrie et al. 2010)). The ongoing war at 
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the CRISPR level has been demonstrated using metagenomic data. Viruses in a biofilm 
population undergo extensive gene shuffling to evade CRISPR-based immunity. Only 
the most recently acquired spacers matched viral genome sequences (Andersson and 
Banfield 2008). Another study of a metagenomic data set revealed silent mutations 
in viral sequences within protospacer elements, again illustrating the virus respons 
to escape the CRISPR-system (Heidelberg et al. 2009). Mutations in phages to 
bypass CRISPR/Cas immunity have also been observed in laboratory experiments. A 
first study revealed that the Streptococcus phages 858 and 2972 escaped CRISPR-
mediated acquired immunity by mutating either the protospacer or the PAM sequence 
(Deveau et al. 2008). A mutation in the PAM of phage Xop411 might also explain the 
sensitivity of Xantomonas oryzae strain Xo21 to this phage, while carrying a perfect 
protospacer (Semenova et al. 2009). An analogous observation has been done 
in Chapter 4 where we describe the transformation of a plasmid to E. coli BL21-AI 
expressing the appropriate cas genes and a CRISPR targeting the plasmid. The 
colonies that are formed contain the plasmids that have recombined and contain major 
deletions, including the protospacer. Apparently the selection force for escape mutants 
is high enough to obtain these spontaneous mutants. A possible other mutation event 
to bypass CRISPR immunity can be found in Chapter 3. For designing a CRISPR 
with 7 identical spacers we selected a wildtype spacer from E. coli R44 that gave a 
perfect hit with the phage P7 genome (Mojica et al. 2005). The protospacer is flanked 
at the 5’ end by ACG. Mojica and coworkers proposed AWG (alternatively CWT on the 
complementary strand) as the PAM for the Cse-subtype (Mojica et al. 2009). When 
we overexpressed the R44 CRISPR together with the required cas genes we did not 
observe any resistance towards phage P7, compared to strain carrying a different non-
targeting CRISPR. This could be explained by the imperfect PAM sequence. Indeed, 
the transformation experiments described in Chapter 4, where we constructed a library 
of plasmids with single mutations, revealed that a mutation in the PAM from ATG to 
ACG caused a successful escape of a plasmid. We then analyzed the Upf62.1 gene 
of phage P7 which contains the protospacer. Blastp analysis of the Upf62.1 protein 
revealed two homologous proteins, UpfA from phage P1 and a hypothetical protein 
from a P1 prophage in E. coli O111:H-str. 11128. An alignment of these three 130 amino 
acid-long proteins showed in total 6 positions that were not completely conserved. One 
of these amino acids coincides with the PAM position. Indeed in the P1 and P7 phage 
this position is ACG, in contrast to an ATG sequence in the E. coli strain, the latter 
being a perfect PAM. UpfA and Upf62.1 have an arginine at this position while the 
hypothetical E. coli protein has an histidine at this position. It is tempting to speculate 
that the P1 and P7 phages have mutated the middle nucleotide of the PAM sequence 
to bypass CRISPR-mediated defence in E. coli R44 or a non-sequenced strain carrying 
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the same spacer. The E. coli O111:H-str. 11128 does not carry a CRISPR that contains 
this spacer, but it would be interesting to see if a CRISPR could target the protospacer 
and thus its own genome. The possible spatial separation of the Cas protein machinery 
and the chromosome may prevent this autoimmune reaction (Chapter 5).
Alternative roles for CRISPR/Cas?
Besides antiviral and antiplasmid defense other functions have been assigned to 
CRISPRs and cas genes. First, in 1995 Mojica and coworkers tested the effect of 
transformation of a plasmid containing a CRISPR (which they named TREP) to the 
archaeum Haloferax volcanii (Mojica et al. 1995). They observed diminished growth, 
lowered viability, and impaired genome segregation during cell division. The authors 
hypothesized that the CRISPRs were involved in replicon partitioning. Interestingly, we 
also observed an approximately two-fold slower growth when any CRISPR containing 
plasmid was transformed to E. coli, confirming the previously observed results. Perhaps 
replication of chromosomal CRISPR DNA is a delicate process which is highly affected 
by abundant non-chromosomal CRISPR elements. A second function was proposed 
by Makarova and coworkers. Before cas genes were found to be associated with 
CRISPRs, they stumbled on these regions of conserved gene contexts (Makarova 
et al. 2002). Bioinformatical analysis assigned putative nuclease, polymerase and 
helicase functions to these genes. These functional features made the authors 
propose that these genes are part of a previously undetected DNA repair system, 
which is largely specific to thermophilic prokaryotes. This hypothesis is supported by 
observed upregulation of one operon of cas genes in P. furiosus after exposure to 
ionizing gamma radiation (Williams et al. 2007). A third putative function was proposed 
when an infection study in Pseudomonas aeroginosa revealed that strains carrying 
a lysogenized DMS3 phage lost the ability to swarm and form biofilms (Zegans et al. 
2009). This inhibition requires the genomic CRISPRs, suggesting that CRISPRs might 
play a role in biofilm formation. Finally, another study revealed that the cas genes in 
Myxococcus xanthus are cotranscribed with dev genes which are important for the 
development of spores in fruiting bodies (Viswanathan et al. 2007). Since the above 
proposed functions of CRISPR/Cas are yet poorly understood, more research will be 
needed to unravel the underlying mechanisms. 
Applications
The adaptive and heritable antiviral and antiplasmid CRISPR/Cas system described 
in this thesis has many (potential) applications in research (e.g., silencing of genes 
in prokaryotes), in medical diagnostics (e.g., strain typing by comparison  of CRISPR 
spacer sequences) and industry (e.g., development of phage resistant strains) (Sorek 
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et al. 2008). Some of these applications will be described in more detail below.
Gene silencing
The Cmr-complex has been shown to target RNA in vitro (Hale et al. 2009). The Cmr-
subtype or potentially other subtypes with RNA degrading activity that have not been 
characterized up till now might be a potential tool for gene silencing. Gene silencing 
in prokaryotes can be achieved through development of genomic disruptions of your 
gene of interest. However, this is labor intensive and for many prokaryotes a genetic 
system is lacking. An alternative strategy involves the antisense (as) RNA technology 
(reviewed in (Rasmussen et al. 2007)), which has been successfully applied in a few 
organisms, among which E. coli (Alessandra et al. 2008). However the use of asRNA is 
still limited due to the lack of a robust design strategy. Moreover, one asRNA is needed 
per mRNA. Introducing a Cmr-like system including a CRISPR targeting one or multiple 
mRNAs might thus provide a good alternative strategy. The recycling of the Cmr-like 
complex after target cleavage might enhance the silencing efficiency, a feature that 
is lacking in the antisense technology. An extra advantage of the use of CRISPRs for 
gene silencing is that multiple genes can be simultaneously silenced with one CRISPR 
construct, while asRNA technology requires one construct for each target mRNA.
No CRISPR/Cas has been demonstrated in eukaryotic genomes. However, an 
interesting question is whether the CRISPR/Cas system would be functional in 
eukaryotes either, at the RNA or DNA level. Gene silencing in eukaryotes is frequently 
performed by short interfering (si) RNA technology (reviewed in (Castanotto and Rossi 
2009)). Implementing sequence specific silencing of invading RNA elements using 
CRISPR/Cas might provide a useful alternative. Moreover, silencing of DNA elements 
might open new opportunities. Achieving this goal depends on whether host factors are 
involved in CRISPR-mediated silencing in prokaryotes. The proposed model for transfer 
of CRISPR/Cas cassettes through horizontal gene transfer (Haft et al. 2005; Godde 
and Bickerton 2006; Makarova et al. 2006; Tyson and Banfield 2008; Chakraborty 
et al. 2009; Horvath et al. 2009) supports the idea that either host factors are not 
essential, or that only those proteins that are very well conserved among prokaryotes 
are involved. Cleavage of RNA by the Cmr-complex has been reconstituted in vitro 
(Hale et al. 2009), but it is not known whether non-Cas proteins are needed for crRNA 
maturation.
Strain differentiation
The CRISPR locus of E. coli was the first to be sequenced (Ishino et al. 1987). A few 
years later it became clear that CRISPR loci can vary between strains. Researchers 
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found that the CRISPR loci from 14 different Mycobacterium tuberculosis strains were 
polymorphic in composition and length (Hermans et al. 1991). The same research 
group subsequently developed a fast molecular method for both detection and strain 
differentiation of M. tuberculosis. The method combined PCR amplification of CRISPR 
loci and subsequent hybridization with probes containing different spacers and this 
new form of genotyping was named ‘spoligotyping’ (derived from spacer oligotyping) 
(Kamerbeek et al. 1997). This technique can be used for diagnostic and epidemiological 
studies and is widely used (Driscoll 2009). Direct sequencing of CRISPRs has been 
used for strain typing in other organisms, such as Campylobacter jejuni (Schouls et al. 
2003) and Thermotoga neapolitana (DeBoy et al. 2006).
 
Industrial processes
The first study that observed CRISPR-based acquired immunity in S. thermophilus 
(Barrangou et al. 2007) indirectly demonstrated the potential applications for industry. 
Phages are a substantial problem in industry that relies on bacteria, such as fermentations 
in the dairy industry. The phages rapidly multiply in a bacterial culture, which can lead 
to a dramatic decrease or complete loss of desired products in a fermentation batch. To 
prevent phage infection, several techniques have been developed and used, such as 
superinfection exclusion, restriction-modification systems and adsorption interference 
(Sturino and Klaenhammer 2006). An alternative strategy might be the development of 
CRISPR-mediated resistant strains. This can either be achieved by selection of CRISPR 
mutants from cultures that are challenged with your phage of interest or by designing 
artificial CRISPRs against this phage (and possibly others). The CRISPR approach 
might be advantageous because multiple spacers can be incorporated against one 
or multiple phages. Having more spacers against one phage significantly decreases 
the chance of the evolution of escape mutants, since multiple simultaneous mutations 
are needed to bypass the CRISPR/Cas system. Knowledge about the functioning of 
CRISPR/Cas is a requirement, since elements like the PAM should also be taken into 
account. Researchers at Danisco filed a patent on CRISPRs as a tool to develop 
immune strains (Horvath et al. 2007).
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Figure 1.2. Overview of the four CRISPR/Cas subtypes that are described in this chapter. For an overview of 
all eight CRISPR/Cas subtypes, see (Haft et al. 2005; van der Oost and Brouns 2009). (A) cas gene neighborhoods 
in 4 experimentally studied organisms, each representing a different subtype indicated between brackets. CRISPRs 
consist of a leader (grey box), repeats (red diamonds) and spacers (blue boxes); only a fragment of the CRISPR is 
shown. Genes are indicated as arrows. Blue arrows indicate genes that are (possibly) involved in spacer acquisi-
tion. Yellow arrows indicate genes that are involved in CRISPR transcription and processing and target interference. 
The endonucleases that cleave pre-crRNA generating crRNA are highlighted as bold arrows. Hatching patterns in-
dicate gene similarity: RAMP genes have vertical lines, polymerase genes have horizontal lines, CasC homologues 
have diagonal lines, and other genes that are not related to each other are filled. Genes that encode proteins from 
isolated complexes (Cse-complex from E. coli and Cmr-complex from P. furiosus) are underlined. (B) CRISPR RNA 
repeat sequences from each organism are given. The cleavage site is indicated by a triangle. Although the repeat 
sequences are different, all CRISPR RNA cleavage events generate an 8 nucleotide 5’ handle. Please note that the 
cleavage site in S. thermophilus CRISPR RNA has not been determined. Palindromic sequences are underlined. 
(C) Predicted secondary structures of the different CRISPR RNA repeats. Cleavage sites are indicated with an ar-
row. As described previously by Kunin et al., the repeat of P. furiosus is not likely to form a stem loop (Kunin et al. 
2007). (D) Mature crRNA from E. coli K12.
Colour figures
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Figure 1.3. Integration of a new spacer. 
A new spacer is acquired at the leader 
proximal side of the CRISPR during vi-
rus infection, resulting in resistance. The 
CRISPR consist of a leader (grey box), 
repeats (red diamonds) and spacers (blue 
boxes). The newly acquired spacer is 
numbered 0 and matches the sequence of 
the virus (proto-spacer). The protospacer 
adjacent motif (PAM) is located upstream 
or downstream the protospacer.
Figure 1.4. The catalytic sites of CasE and Cas6, and the proposed reaction mechanism of pre-crRNA cleav-
age. (A) Proposed catalytic site of CasE from T. thermophilus showing the conserved histidine residue (H26) and 
the glycine-rich C-terminal loop. The catalytic site of Cas6 from P. furiosus (B) contains a catalytic triad of tyrosine 
(Y31), histidine (H46) and lysine (K52) and a glycine-rich C-terminal loop. The loop and the overall duplicated ferre-
doxin fold are conserved among CasE and Cas6. Pre-crRNA cleavage might follow a general acid-base hydrolysis 
mechanism (D). A base (B) draws a proton from the 2’OH of the ribose ring. A subsequent nucleophilic attack on 
the phosphorus atom is simultaneously compensated by the acid (A) that donates a proton to the leaving 3’RNA. 
The tyrosine residue of Cas6 is proposed to be the base and the histidine the acid residue (Carte et al. 2008a). In 
CasE the histidine and a water molecule might be the catalytic residues. Pictures in (A) and (B) are generated with 
pymol (www.pymol.org), potential catalytic residues are depicted in blue; the glycine-rich loop is depicted in red. 
Coordinates were obtained from the Protein Data Bank (www.pdb.org).
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Figure 1.5. Antiviral DNA and RNA silencing pathways in prokaryotes and eukaryotes. (A) crRNA mediated 
DNA silencing pathway in E. coli. pre-crRNA is cleaved by the CasE subunit of Cascade (Cse-complex) and the 
mature crRNA remains bound to Cascade. When encountering viral dsDNA containing a sequence identical to the 
spacer sequence of the crRNA, it may basepair with the complementary DNA strand by a strand displacement 
event. The HD-domain of Cas3 is likely to be activated and cleave the viral DNA only when the 2 bases PAM on the 
viral DNA is present (marked with an asterisk). The helicase domain might subsequently separate the RNA:DNA 
duplex generating free Cascade that can be used in a next cleavage event. (B) crRNA mediated RNA silencing 
pathway in P. furiosus. Pre-crRNA is cleaved by Cas6 and then further trimmed to generate crRNAs of two differ-
ent lengths. These crRNAs are bound by the Cmr-complex. This loaded Cmr-complex specifically binds viral RNA 
and cleaves the complementary strand 14 nucleotides away from the 3’ end of the crRNA. This pathway shares 
functional analogies with siRNA mediated antiviral resistance in eukaryotes (C) siRNAs are generated from viral 
dsRNA by dicer. The first (random) cleavage event by dicer generates dsRNA with a 3’ dinucleotide overhang. The 
second cleavage by dicer takes place 20-25 bases away from the overhang generating short dsRNAs. The dsRNA 
is transferred to the Argonaute protein of the RISC complex and the passenger strand is removed. The retained 
guide strand can basepair with a complementary viral mRNA molecule, followed by a cleavage of the scissile bond 
between the 10th and 11th base from the 3’ end of the guide strand. The cleaved target RNA dissociates and the 
recycled RISC can be used in a second round of RNA binding and cleavage. Please note that dashed arrows indi-
cate processes that are based on hypotheses.
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Figure S2.1 
B. Ribbon diagram of the structure of TTHB192, a CasE homolog from Thermus thermophilus HB8 (PDB ID: 1WJ9) 
(Ebihara et al. 2006). Structural features are indicated as in A. Structurally disordered residues 108 to 115 and 156 
to 169 are depicted by dashed lines. Note that the highly conserved glycine-rich loop between secondary structure 
elements α5 and β12 is spatially close to His26.
B
Figure 3.5.  A) Native nano-ESI mass spectrum of Cascade. Two charge state distributions are present at high m/z 
values, corresponding to complexes of 405 kDa (purple) and 349 kDa (pink). The charge state distribution indicated 
in red indicates the CasB dimer. B) Cascade (sub-)complexes analyzed by native mass spectrometry. The sub-
complexes were formed in solution after adding 5% 2-propanol to the buffer solution containing Cascade.
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Figure 3.8.  A) Schematic diagram of crRNA base paired to double stranded target DNA, indicating the local strand 
displacement, and the additional rG-dC basepair between the eighth base of the crRNA (rG) with the PAM (dC). B) 
Seahorse morphology and structural model of Cascade.
Figure 3.7. Solution scattering model of Cascade obtained with Small-Angle X-ray Scattering. Scattering 
data for Cascade were collected at 10 keV (1.24 Å λ) from two protein concentrations, and include scattering vec-
tors (q), ranging from A) 0.015 Å-1 to 0.127 Å-1 for Cascade and B) 0.015 Å-1 to 0.133 Å-1 for Cascade bound to target 
DNA. The pair-distribution function (insert) indicates that the radius of gyration for both particles is ~5.6 nm. C) Ab 
initio reconstructions of Cascade reveal a seahorse shaped complex, consistent with EM imaging. D) DNA binding 
induces a conformational change in Cascade. E) Superposition of the solution structures of Cascade without (yel-
low) and with target DNA (mesh) suggest that regions of the complex assigned to the CasA and CasB are reposi-
tioned in the DNA bound state. Images have been rendered using Chimera (Goddard et al. 2005). 
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Figure S3.6. A) Native mass spectrum of Cascade after treatment with HRV3C protease. A dominant species with 
a mass of 401,279 Da (blue triangle) was observed, confirming the presence of two copies of CasB in the intact as-
sembly. Indicated by the green triangles is the complex lacking CasA. B) Tandem mass spectrum of the 42+ ion of 
Cascade. Besides the dissociation of CasA (green) also CasC (orange) dissociated from the complex. The complex 
lacking CasA further expels a CasC subunit to form a 310 kDa Cascade sub-complex (blue). The low m/z region of 
the spectrum shows the dissociated CasA, CasC and CasD proteins. Overlapping peaks of two different complexes 
are indicated by two colours. C) Native mass spectrum of Cascade bound to the ssDNA-probe. The mass of the 
complex increased by 10,201 Da, indicating the presence of one crRNA per Cascade. The inset shows the same 
spectrum after energetically activating the Cascade-ssDNA probe complex. The charge state distribution for the 
ssDNA probe is centred around 2,000 m/z.
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Figure 5.1. PALM images of the location of the Cascade proteins and Cas3. (A) An overview of CasB-Dronpa 
expressing cells visualized with PALM. A Digital Image Correlation (DIC) image (inset) shows that cells look un-
healthy. Several images of cells are selected, rotated and enlarged, as shown in (B). Most proteins are located in 
patches along the cell wall. (C) An overview of CasB-Dronpa expressing cells in the presence of Cascade is visu-
alized with PALM. A DIC image (inset) shows that cells look natural. Several images of cells are selected, rotated 
and enlarged as shown in (D). In the presence of Cascade, CasB-Dronpa is differently distributed in the cell, mainly 
concentrated in one focus at one pole of the cell and in a ring-like structure at the other end. (E) PALM analysis of 
two mEos-Cas3 expressing cells (representing a large population of cells) shows that localization is very similar 
to that of CasB-Dronpa + Cascade (D), although the ring-like structure can be absent and replaced by a focused 
cluster. Each spot in the images represents one protein molecule. Cell borders are roughly indicated with dashed 
lines for clarity in (B), (D) and (E).
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Figure 5.2. PALM images of the location of the Cas1 and Cas2 proteins. (A) An overview of Cas1-Dronpa ex-
pressing cells. Several images of cells are selected, rotated and enlarged as shown in (B). Some proteins localize 
uniformly over the cells, but most proteins form a cluster that localizes at one cellular pole close to the cell wall. (C) 
An overview of Cas2-mEos expressing cells. The inset shows a DIC image of the same cells. Several images of 
cells are selected, rotated and enlarged as shown in (D). As for Cas1-Dronpa, Cas2-mEos localizes mostly as one 
cluster at one pole of the cell. Each spot in the images represents one protein molecule. Cell borders are roughly 
indicated with dashed lines for clarity in (B) and (D).
Figure 7.1. Three different stages in CRISPR-mediated antiviral defense. The different stages are explained in 
more detail in Chapter 1. Picture adapted from (van der Oost et al. 2009).
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Nederlandse samenvatting
Dit proefschrift beschrijft het onderzoek aan het antivirale en antiplasmide prokaryote 
CRISPR/Cas systeem uit Escherichia coli, behorend tot het Cse-subtype. Het CRISPR/
Cas systeem bestaat uit clusters van repeterend DNA waartussen zich unieke stukjes 
DNA van een gelijke lengte (CRISPR) bevinden. In de buurt van dit repeterend DNA 
bevindt zich een groep van cas genen. Op basis van de compositie van de cas genen 
zijn er 8 subtypen te onderscheiden, waarvan er 4 experimenteel zijn onderzocht. Wat 
er tot nu toe bekend is over deze subtypen wordt beschreven in Hoofdstuk 1. De 
verschillende CRISPR/Cas systemen zijn variaties op een thema en werken volgens 
een mechanisme dat lijkt op RNA interferentie in eukaryoten wat ook wordt beschreven 
in dit hoofdstuk. Er zijn drie verschillende stadia te onderscheiden in CRISPR/Cas 
resistentie. Tijdens het eerste stadium wordt een stuk DNA van een virus of plasmide 
ingebouwd tussen twee repeterende eenheden DNA in de CRISPR (adaptatie). Tijdens 
het tweede stadium (expressie), wat beschreven wordt in Hoofdstuk 2, wordt CRISPR 
DNA afgeschreven in precursor CRISPR RNA (pre-crRNA), wat vervolgens verwerkt 
wordt door het metaal-onafhankelijke nuclease CasE. Laatstgenoemde knipt in elke 
repeterende eenheid van het RNA. Op deze wijze worden er functionele crRNAs 
gegenereerd die elk een 8 nucleotiden tellende 5’ handle, een spacer en tot slot een 
haarspeldstructuur bevattende 3’ handle bevatten. CasE en het crRNA zijn onderdeel 
van het Cascade complex waar ook CasA, B, C en D toe behoren. Cascade, geladen 
met crRNA en geassisteerd door Cas3, verhindert faag lambda infectie in E. coli. Met 
behulp van een kunstmatig gesynthetiseerde CRISPR met lambda fragmenten wordt 
dit in dit hoofdstuk gedemonstreerd in plaque assays. Zowel crRNAs complementair 
aan de coderende als aan de niet coderende streng van het lambda genoom zijn 
effectief. Dit suggereert dat DNA het doelwit is van dit systeem. Een mutatie in CasE, 
waardoor CasE geen pre-crRNA meer kan knippen, doet de resistentie teniet en laat 
zien dat crRNAs nodig zijn voor interferentie. Het mechanisme van herkenning van het 
doelwit, waarmee fase drie (interferentie) begint, wordt beschreven in Hoofdstuk 3. In 
dit hoofdstuk wordt gedemonstreerd dat Cascade dubbelstrengs DNA kan binden. De 
van oorsprong virale of plasmide sequentie van het crRNA baseparen kan vormen met 
het complementaire DNA door ATP-onafhankelijke strand displacement, een proces 
wat versterkt wordt door CasA. Dit hoofdstuk geeft ook een meer gedetailleerde 
massa- en sequentie-analyse van het crRNA. crRNA is 61 nucleotiden lang, wat 
in totaal overeenkomt met het van oorsprong virale stuk RNA en een repeterende 
eenheid RNA, en bevat een 2’,3’ cyclische fosfaat groep. De stoichiometrie van 
Cascade, CasA1B2C6D1E1-crRNA1, is bepaald met behulp van ESI-MS analyse. EM 
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en SAXS analyses laten zien dat Cascade de vorm van een zeepaard heeft, waarbij 
de ruggengraat gevormd wordt 6 CasC moleculen. Vergelijking van deze structuur 
met de structuren van de stabiele subcomplexen CasB2C6D1E1-crRNA1 en CasC6D1E1-
crRNA1 toont de locatie van de CasA en de twee CasB moleculen aan. Ten slotte 
wordt in dit hoofdstuk aangetoond dat alle subunits essentieel zijn voor resistentie. 
Hoofdstuk 4 beschrijft hoe Cas eiwitten en een anti-lambda CRISPR de transformatie 
van een plasmide, met daarin dezelfde lambda sequentie als in de CRISPR, kunnen 
tegenhouden. Een bibliotheek van gemuteerde plasmiden, gemaakt met behulp 
van foutgevoelige PCR, is getransformeerd naar cellen die immuun waren voor het 
niet gemuteerde plasmide. De sequenties van de mutanten die het immuunsysteem 
konden omzeilen zijn te verdelen in drie klassen: de mutanten bevatten mutaties in het 
DNA complementair aan de crRNA, mutaties in het flankerende DNA motief (PAM) of 
deleties van het hele stuk wat aangevallen wordt. De PAM kan een herkenningspunt 
zijn voor het systeem zodat alleen ‘vreemd’ DNA wordt aangevallen. Mutaties in het 
complementaire stuk van het plasmide bevinden zich vooral aan de PAM-zijde. Deze 
data laat zien dat de PAM en perfecte baseparing aan de PAM-zijde in het aangevallen 
stuk DNA essentieel zijn voor resistentie.
Omdat lambda fagen E. coli vooral infecteren bij de polen en zich snel vermenigvuldigen, 
veronderstelden we dat het CRISPR/Cas afweer systeem hier ook gelokaliseerd zou 
zijn. Om dit te testen hebben we PALM gebruikt om op nanometerschaal te kijken 
waar de Cas eiwitten gelokaliseerd zijn (Hoofdstuk 5). Inderdaad bleken ten minste 
een aantal Cas eiwitten zich bij de celpool te bevinden, waardoor een snelle respons 
kan worden gestart. Daarbij kan de fysieke scheiding tussen de Cas eiwitten en de 
chromosomale CRISPR ook een mechanisme zijn om auto-immuniteit te voorkomen. 
Hoofdstuk 6 ten slotte richt zich op de transcriptionele regulatie van het systeem. 
H-NS wordt geïdentificeerd als transcriptie- repressor; de expressie van de meeste 
cas genen (met uitzondering van cas3) en de CRISPR is verhoogd in een H-NS 
knockout mutant van E. coli. LeuO is juist een transcriptionele activator en antagonist 
van H-NS. Overexpressie van LeuO in een wildtype E. coli resulteert in verhoogde 
casABCDE12 transcriptie en crRNA niveaus. Met behulp van plaque assays wordt tot 
slot aangetoond dat H-NS inderdaad het CRISPR/Cas systeem onderdrukt en LeuO 
juist dit systeem activeert.
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Overview of completed training activities
Discipline specific activities
Meetings:
Annual Meeting Study Group Molecular Genetics. 2006. Lunteren, NL.**•	
Annual Meeting Study Group Protein Research. 2006. Lunteren, NL.•	
RNA Silencing: Mechanism, Biology and Application. 2007. Keystone CO, •	
USA.**
Annual Meeting Study Group Molecular Genetics. 2007. Lunteren, NL.•	
Annual Meeting Study Group Protein Research and Nucleic Acids. 2007. •	
Lunteren, NL.*
Bijvoet Tutorial Symposium. 2008. Utrecht, NL.•	
Molecular Genetics of Bacteria and Phages. 2008. Cold Spring Harbor NY, •	
USA.*
Annual Meeting Study Group Protein Research and Nucleic Acids. 2008. •	
Veldhoven, NL.**
General Meeting of the American Society for Microbiology. 2009. Philadelphia •	
PA, USA.* 
Annual Meeting Protein Research, Nucleic Acids, and Lipids & Biomembranes. •	
2009. Veldhoven, NL.
FASEB Conference on Nucleic Acid Enzymes. 2010. Saxtons River VT, USA.*•	
*Oral presentation
**Poster presentation
Courses:
Guest scientist - Hands on course Photo-Activated Light Microscopy. 2009. •	
Janelia Farm Research Campus, HHMI, Ashburn VA, USA.
Protein Interactions and Networks. 2009. Wellcome Trust Genome Campus, •	
Hinxton, UK.
General courses
Supervising Undergraduate Students. 2006. Wageningen, NL.•	
VLAG PhD Week. 2007. Bilthoven, NL.•	
Philosophy and Ethics of Food Science and Technology. 2009. Wageningen, •	
NL.
Scientific writing. 2009. Wageningen, NL.•	
Optionals
Preparing PhD Research Proposal.•	
PhD trip 2006. California, USA.•	
PhD trip 2009. Northeast Coast, USA.•	
Bacterial Genetics Group Meetings (weekly).•	
Laboratory of Microbiology PhD/PostDoc Meetings (biweekly).•	
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